Medication and symptom management in persons living with HIV. perceptions and collaboration of persons living with HIV, their close support persons and healthcare providers by Nicca, Dunja
  
 
 
 
Medication and Symptom Management in Persons Living with HIV: 
Perceptions and Collaboration of Persons Living with HIV,  
their Close Support Persons and Healthcare Providers 
 
 
Inauguraldissertation 
 
 
 
 
zur Erlangung der Würde eines Doktors der Pflegewissenschaft 
vorgelegt der Medizinischen Fakultät der Universität Basel 
 
 
von 
Dunja Nicca, 
von Sufers und Donath / Graubünden 
 
 
 
 
Basel, 2009 
  
 
 
Genehmigt von der Medizinischen Fakultät 
 
auf Antrag von: 
Fakultätsverantwortliche Prof. Rebecca Spirig 
Dissertationsleitung  Prof. Rebecca Spirig 
Co-Referat   Prof. Wolf Langewitz 
Externe Experin  Prof. Sally H. Rankin 
 
Basel, den 28.10.2009 
 
 
 
Dekan    
Prof. Albert Urwyler 
 
 
 
Table of Content 
 
Table of Content 
Acknowledgements................................................................................................................................ 3 
Summary................................................................................................................................................ 5 
Introduction ......................................................................................................................................... 13 
Chapter 1 Collaborative medication and symptom management in the context of chronic HIV 
management......................................................................................................................................... 16 
Treatment success and future challenges for the management of HIV/AIDS................................... 16 
The management of chronic conditions ............................................................................................ 18 
Self-management: a collaborative endeavor ..................................................................................... 19 
Self-management of PLWH .............................................................................................................. 21 
Collaboration in medication and symptom management .................................................................. 24 
Medication and symptom management ......................................................................................... 24 
PLWH’s collaboration with close support persons and healthcare providers.............................. 27 
Role of Self-management programs for PLWH................................................................................ 28 
HIV self-management in the Swiss context ...................................................................................... 29 
Chapter 2 Aims of the research program.......................................................................................... 38 
Chapter 3 Comprehensive Clinical Adherence Interventions to Enable Antiretroviral Therapy: 
A Case Report...................................................................................................................................... 41 
Abstract ............................................................................................................................................. 42 
Introduction ....................................................................................................................................... 43 
Presentation of the case study ........................................................................................................... 44 
Background of the intervention strategies......................................................................................... 46 
Implementation of interventions and clinical progress ..................................................................... 49 
Discussion and implications for practice........................................................................................... 52 
Chapter 4 Literaturzusammenfassung zur Frage: „Welche Interventionen bewirken eine 
Verbesserung der Adhärenz von HIV-Patienten unter ART?“ Interventions to Enhance 
Adherence of Patients with HIV on ART: A Literature Review .................................................... 56 
Zusammenfassung............................................................................................................................. 57 
Abstract ............................................................................................................................................. 57 
Einleitung .......................................................................................................................................... 58 
Literatursuche.................................................................................................................................... 59 
Beschreibung der Studien.................................................................................................................. 60 
Zusammenfassung der Resultate ....................................................................................................... 67 
Schlussfolgerung und Empfehlung ................................................................................................... 68 
Chapter 5 Keeping a grip on HIV: A Qualitative Investigation on Collaborative Medication and 
Symptom Management Experiences of Persons with HIV living in Switzerland.......................... 74 
Abstract ............................................................................................................................................. 75 
Introduction ....................................................................................................................................... 76 
Methodology and Methods................................................................................................................ 77 
Table of Content 
 
Results ............................................................................................................................................... 78 
Discussion ......................................................................................................................................... 86 
Chapter 6 Symptom management in HIV/AIDS: A mixed methods approach to describe 
collaboration and concordance between persons living with HIV and their close support persons
............................................................................................................................................................... 94 
Abstract ............................................................................................................................................. 95 
Introduction ....................................................................................................................................... 96 
Methodology and Methods................................................................................................................ 97 
Results ............................................................................................................................................. 100 
Discussion ....................................................................................................................................... 112 
Chapter 7 Discussion......................................................................................................................... 118 
Discussion of key findings .............................................................................................................. 118 
The complexity of HIV self-management..................................................................................... 118 
PLWH as active self-managers ................................................................................................... 120 
Self-management collaboration .................................................................................................. 122 
Discussion of methods..................................................................................................................... 124 
Implications for future research and clinical practice ..................................................................... 127 
Future research ........................................................................................................................... 127 
Implications for clinical practice ................................................................................................ 128 
Conclusion....................................................................................................................................... 133 
Curriculum Vitae .............................................................................................................................. 145 
 
Acknowledgements 
3 
Acknowledgements 
My deepest gratitude goes to my advisor, Prof. Rebecca Spirig, who introduced me to the world of 
research, then accompanied and supported my development for many years. I appreciate most her 
critical perspective on research and social phenomena, which broadened my own perspective through 
her provocative and inspiring discourses.  
I also wish to express special thanks to the other members of my PhD committee, who have all given 
close support and guidance throughout the dissertation process on numerous levels, enabling my 
learning and progress. I want to thank Prof. Kim Moody, of the University of Southern Maine, for her 
extremely cheerful and motivating mentorship throughout the process. She also gave me the 
opportunity to gain an in-depth knowledge of the academic and clinical work of nurses in the US, 
which provided me with a vision to guide my learning process. I greatly appreciated Prof. Manuel 
Battegay’s, quick and substantial feedback and his continuous structural guidance throughout the 
process of my PhD studies. Many thanks also to Prof. Marcel Tanner, whose broad experience in 
mentoring PhD students, which was apparent in the calm and structured guidance he provided, I 
appreciated very much. 
I gratefully thank Prof. Langewitz, for his spontanous effort as faculty co-evaluator of this thesis. I 
enjoyed working with him in different projects and in particular learned from his expertise in patient-
provider communication. His feedbacks were always substantial and motivating. 
And I also gratefully thank Prof. Sally Rankin, of the University of California, San Francisco, for her 
willingness to evaluate this thesis as an external expert. I greatly respect her broad scientific expertise 
in HIV and other chronic illness management, and her openness and willingness to share her expertise. 
I especially wish to thank Prof. Sabina De Geest, head of the Institute of Nursing Science, University 
of Basel, for providing personal support and a rich scientific environment, allowing constant learning 
opportunities and inspiration from her network of renowned international researchers. I also want to 
thank her for chairing the defense colloquium as representative and chair of the Medical Faculty’s 
PhD Commission (University of Basel). 
I wish to express my deepest gratitude to Katharina Fierz and Dr. Jan Fehr who have both been 
most supportive colleagues for many years. They were always reliable and inspiring discussion 
partners for a range of questions that arose throughout my study process and contributed substantially, 
as co-authors, to the improvement of my dissertation project. 
Many thanks also go to the following persons, all of whom contributed substantially to this 
dissertation project: 
Prof. Mary Beth Happ who introduced me into mixed method research and has been an appreciated 
mentor throughout the process of data analysis and description. 
Acknowledgements 
4 
Christine Spitz for her contributions regarding qualitative data analysis, which included many 
inspiring discussions. 
Sabine Bigler who has been an appreciated colleague in many HIV related projects, contributed to 
data collection and conducted a broad literature review on adherence interventions. 
Christine Vincenzi who contributed in data collection and added appreciated input in research 
meetings. 
Dr. Luigia Elzi who contributed by collaboratively caring for patients and discussing and writting up 
the case report 
The study nurses and physicians at the SHCS centers in Basel, Bern, St. Gallen and Zürich, who 
were involved in recruitment of participants and therefore supported the research process substantially. 
Chris Shultis and Leslie Nicholls, for their careful editing of my manuscripts and dissertation. 
Working with them improved my writing and English language skills considerably. 
All participants who shared their stories 
During my PhD education, I also had the excellent opportunity to work part time at the HIV outpatient 
clinic in St. Gallen. I want to give a special thanks to the “Infekt-Team”, who supported my work by 
providing an atmosphere where new ideas could be discussed and clinical care and research processes 
were reflected thoughtfully. I therefore wish to thank every member of the team for their 
contributions. 
I am deeply thankful to Prof. Pietro Vernazza, head of the Division of Infectious Diseases and 
Hospital Hygiene, Cantonal Hospital, Basel, for giving me the opportunity to work in a setting with 
regular scientific and clinical exchange, and for introducing me to many experts in the field of HIV 
care and research. Diverse discussions and his visionary attitude inspired and broadened my own 
perspectives.  
Many thanks go to Marianne Graf, from department of organizationl developement at the University 
of Basel for her thoughtful coaching and encouragement. 
I am also extremely grateful to the Ebnet Foundation for their grant support, their careful supervision 
of the research process, and their encouraging feedback. 
Finally, my profound personal thanks go to my partner, Marcel Zürcher, for his ongoing commitment 
and support throughout this project, and to my closest friends, who encouraged my work but provided 
me with many pleasant diversions to replenish my energy.  
  
Summary 
5 
Summary 
Over the past two decades, developments in the treatment and monitoring of HIV Infection have 
radically reduced morbidity and mortality rates among those affected by it [1]. Between 1996 and 
2005, the estimated life expectancy for persons living with HIV (PLWH) placed on combined 
antiretroviral therapy (cART) at age 20 rose from 36.1 to 49.4 years [2].  
Focusing on the improvement of health outcomes for the estimated 33 million PLWH worldwide, the 
situation differs considerably between low- and high-resource settings. Broader access to cART 
should substantially improve health outcomes for PLWH in low-resource settings, where supplies 
currently meet only 31% of the estimated global need [3]. However, such steep improvements are no 
longer a realistic option for high-resource settings. In western and central Europe, for example, long-
term treatment is already provided to 90 -100% of PLWH and initial drops in mortality and morbidity 
have been sustained [4]. 
In high resource settings, though, long-term treatment experiences have shown that non-adherence to 
medication regimens is a serious issue. Since ART demands a constant level of medication to suppress 
viral replication, once started it has to continue without interruption. Compelling evidence has linked 
treatment interruptions, including medically guided ones, with poorer clinical outcomes compared to 
continuous treatment, i.e., near-perfect adherence [5].  
However, long term adherence is complicated by a range of barriers, including the medications’ 
adverse effects: estimates of prescribed cART doses actually taken in Europe and Northern America 
range from 60%-70% [5-8]. As a result, medications’ adverse effects, opportunistic infections and co-
morbidities keep the prevalence of symptoms consistently high, averaging 8-14 symptoms per person 
[9-12]; and a high number of distressing symptoms has been shown to further complicate adherence to 
cART [9]. 
Regarding the stabilization of health outcomes for this treatment-experienced population of PLWH, 
major advances are no longer possible based solely on treatment access. It is clearly necessary to 
formulate new management strategies that consider multiple aspects of this chronic condition, 
focusing in particular on the skills needed by PLWH and their close support persons (CSPs) to manage 
their condition at home on a daily basis.  
In order to improve health outcomes for patients with chronic conditions, various studies have shown a 
need for profound changes across diverse levels of the health care system [9, 13, 14]. The WHO 
publication ‘Innovative Care for Chronic Conditions’ structures chronic care management areas 
requiring change into micro, meso, and macro levels, with each level interacting with and dynamically 
influencing the others. The macro level consists of policy makers who influence standards and 
incentives for quality care; the meso level includes healthcare organizations and communities; and the 
micro level is the level of patient interaction, where patients’ self management and collaboration 
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between health care providers and patients are key issues [15]. By providing a fuller understanding of 
PLWH’s self-management and collaboration with CSPs and health care providers (HCPs) within the 
care process, the research represented here should help answer questions of how and where to improve 
care for PLWH on the micro (patient) level.  
 In the context of chronic disease management, “self-management” has become a widely used 
term, encompassing the day-to-day activities a chronic illness patient performs to minimize the 
consequences of his or her condition. Such actions vary based on the person’s perceptions, experiences 
and expertise, but share the focus of optimizing health outcomes, whether by retarding deterioration, 
maintaining a given level of health, or improving overall wellness [16-18]. Additionally self-
management is increasingly recognized as a dynamic process that includes active collaboration with 
others, especially close support persons (e.g., partners, friends, family) and healthcare providers [18, 
19]. Yet the skills that enable healthcare providers and close support persons to work with PLWH’s 
self-management have only been vaguely described. 
 Although patient self-management shows similarities across a range of chronic conditions, 
every condition has unique challenges that require specialized self-management tasks. HIV specific 
self-management tasks have been summarized into eight categories: medication management, 
symptom management, substance use management, lifestyle management, emotional management, 
role management, transmission management, and social management. From a medical perspective 
with a focus on improving health outcomes, medication and symptom management may be regarded 
as the core tasks of HIV self-management. After all, a person’s experience of symptoms is closely 
related to adherence to cART (i.e., adherence decisions are often based upon symptoms), and 
adherence is closely related to treatment success [9, 20, 21]. 
 In the current literature, medication management and symptom management – the two self-
management tasks upon which this thesis focuses – have mainly been described in a fragmented way, 
with close attention paid only to one or the other, despite considerable evidence linking the two 
closely [9, 21-23].  
Medication management encompasses decisions related to initiating or changing cART regimens [24-
26]. Once started, the new or changed regimens have to be integrated into daily life and adherence 
maintained over time. Eventually, this also entails the management of adherence related obstacles [6, 
27]. Opportunistic diseases and/or co-morbidities often require further medication management.  
Symptom management encompasses the assessment, evaluation and monitoring of symptoms [21]. 
Decisions are necessary on how to deal with symptoms, such as when to contact healthcare providers, 
whether or not to alter exercise or diet, and when to take — or not take — certain medications [28]. 
For PLWH, the formulation and adoption of many medication and symptom management strategies 
involves collaboration with their HCPs and CSPs; yet, despite the seemingly obvious benefits of such 
collaboration, the related processes are only vaguely understood. Since self-management activities 
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regarding both medications and symptoms are closely associated with health outcomes, a fuller 
understanding of such activities is necessary to improve related services.  
The overall aim of this exploratory mixed method research program was to describe PLWH’s 
symptom and medication management activities, focusing on collaboration between PLWH, CSPs and 
HCPs, from the perspectives of all three groups. Four articles presented the results. 
The first, a clinical case report, describes the complexity of self-management support in clinical care 
and illustrates how interventions that were individualized, culturally sensitive, and provided by a team 
of health care providers enabled the patient to optimize his adherence, which led to significant 
improvement in his clinical surrogate markers and subjective quality of life. 
Second, a literature review summarized the evidence resulting from randomised controlled trials of 
interventions designed to enhance medication adherence to antiretroviral therapy. The review showed 
that effective programs combine several methods, and highlighted a continuing need for long term 
programs tailored to patient needs. 
 The third article dealt with PLWH’s experiences with the management of medications and 
symptoms, along with their collaborations with close support persons and health care providers within 
this process. The narratives of 13 PLWH revealed that even small changes in health and treatment 
could change participants’ impressions of maintaining or “losing their grip” on HIV. To keep their 
grip, participants constantly monitored their condition, developed expertise in care and symptom 
management, and included input from healthcare providers and close support persons in their 
management processes. Despite the clear need for partnerships with HCP, PLWH described this area 
of collaboration as sometimes supportive, sometimes a hindrance. 
The final article reported on the use of an exploratory mixed methods approach to examine the 
collaboration of PLWH and their CSP within the process of symptom management, including a 
comparison of the two players symptom reports. Qualitative results revealed that collaboration 
typically depended on distinct but integrative positions of PLWH and CSP, with the PLWH in a clear 
leadership role.  
These roles were reflected in diverse themes of daily symptom management, and later confirmed in 
the quantitatively assessed symptom experience reports, where PLWH reported significantly more 
symptoms over the previous week – an average of 16 (Q1=9; Q3=24), compared to CSPs’ 12 (Q1=5; 
Q3=17). This disproved two of our initial hypotheses – first, that certain symptoms would be reported 
more often by CSPs (this was never the case), and second, that where the PLWH reported symptoms 
as very distressing, symptom reports by PLWH and CSP would not differ. 
The results of this research program contributed to the existing knowledge by using the 
conceptualization of Loring and Holman to describe HIV specific self-management tasks and skills 
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[17]. This comprehensive description can be used as a guiding framework to plan both clinical self-
management support interventions and HIV self-management oriented research projects.  
Another important contribution was the replication of the observation by Thorne et al. that chronically 
ill patients at some point made an active decision to control the effects of their condition [18]. The 
constitutive pattern “I have a grip on HIV - HIV has a grip on me” revealed a similar phenomenon. 
However, in contrast to earlier investigations, examining this phenomenon provided insights into a 
dynamic process. Throughout the course of the condition, health and/or treatment changes could 
influence the perception of “having a grip on HIV” or losing it. These alternating conditions could 
constitute a phenomenon more pregnant in HIV than in chronic conditions with more predictable 
illness trajectories. Additionally, since the “HIV has a grip on me” perception was associated with 
feelings of uncertainty, fear and loss of morale, and since depressive symptoms clearly hinder 
effective self-management, this phenomenon certainly warrants clinical examination [28-30]. 
A particularly important outcome of this research program is the deepening of our understanding of 
collaboration between PLWH and CSP. Concordant with earlier reports, the narratives of PLWH and 
CSP presented in Chapter Six revealed that PLWH collaborated closely with their CSPs to manage 
their condition [31-33]. Yet, in contrast to earlier investigations, this collaboration was characterized 
by distinct roles: as ‘managers’, the PLWH took a clear lead on the overall management of the 
condition, whereas, as ‘companions’, their CSPs tried to find and support aspects of self-management. 
The PLWH’s leadership role was, in fact, much clearer here than in previous studies, which 
emphasized the partnership aspects of the PLWH/CSP relationship. This insight into the collaboration 
of PLWH and CSP may provide a foundation upon which to integrate CSP into research based clinical 
interventions. 
To our knowledge, concordance between the symptom reports of patients and their CSPs has never 
before been described for the PLWH population. We therefore provide the first recorded insights into 
the issue. Compared to earlier investigations in cancer populations, where CSPs reported more 
symptoms than patients [34, 35], PLWH in this study consistently reported significantly more.  
Additionally, we described an inter-method inconsistency that indicates a need to better understand 
management of neurocognitive symptoms from PLWH’s and CSP’s perspectives. Our qualitative 
analysis revealed a cluster of neurocognitive symptoms that CSPs recognized but did not wish to 
discuss with their partners; and the quantitative assessment of concordance between symptom reports 
revealed that all symptoms were reported more often by the PLWH.  
Regarding collaborations with HCPs, in accord with previous research, our results illustrated that this 
group can both hinder and enable PLWH’s self-management [36-38]. PLWH’s narratives provided 
insights into the respective negative and positive aspects of their relationships with HCPs. On one 
hand, the need for providers to use a patient centered approach, including recognizing each person as a 
unique human being, is highlighted and has already proved important in a broad range of studies [36, 
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38-40]. On the other hand, our findings also highlight the importance of HIV-specific competence on 
the part of healthcare providers. Second in importance to overall medical competence, this includes the 
ability to assess a patient’s symptom experience in a non-judgmental manner, to collaboratively 
develop medication and symptom management strategies, to provide ongoing education on those 
topics, and finally to assist patients in decision making and in the coordination of their various health 
problems. 
Also significantly, this research program determined that CSP were only very slightly integrated into 
clinical care, meaning their collaboration with health care providers was marginal. Since PLWH need 
their CSPs to act as active partners to manage the disease, not integrating them into self-management 
support is a missed opportunity to strengthen PLWH’s self-management. 
In summary, this study program provided new insights and raised further questions. Subsequent 
research should focus on a qualitative meta-synthesis and development of the phenomenon of “having 
a grip” or “being in control” of a chronic condition, descriptions of HCPs’ perspectives of 
collaboration, a better understanding of the concordance between PLWH’s symptom reports and those 
of CSP – particularly in relation to neurocognitive symptoms and regarding strategies for integrating 
CSP’s into intervention programs and clinical processes. 
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Introduction 
Over the past decades, developments in the treatment and monitoring of HIV-Infection have radically 
reduced morbidity and mortality of those affected by it [2]. In countries with broad access to combined 
antiretroviral therapy (cART), HIV infection has turned into a manageable chronic condition: persons 
living with HIV (PLWH) can carry on productive lives, often for decades after infection [1]. As with 
all chronic conditions, optimal health outcomes result from a combination of state of the art medical 
care and effective patient self-management [14, 41, 42]. For PLWH, self-management has two main 
aspects: first, the management of medications, since near-perfect adherence to long-term antiretroviral 
treatment is required [20, 43, 44]. Second, the management of symptoms linked to the disease itself, 
medications’adverse effects, opportunistic infections and co-morbidities have been shown to influence 
adherence to cART and health related quality of life [9, 21, 45, 46]. For PLWH, managing 
medications and managing symptoms have become two central and interwoven processes in their 
lifelong engagement with their chronic condition, their close support persons (CSPs), and their 
healthcare providers (HCPs) [22, 31]. For example, after discussing the management of side effects 
with a CSP, a PLWH might decide to see a healthcare provider, who might then assess symptoms and 
discuss self-management strategies or possible treatment changes.  
So far, medication and symptom management strategies of PLWH have been described in rather 
fragmented ways, focusing either on adherence or on symptom management. Additionally, despite 
anecdotal reports praising the often complex collaboration between the different players (PLWH, 
CSPs, and HCPs), it has been largely neglected as a topic of research. A fuller understanding of 
collaborative support networks linking medication and symptom management is needed to improve 
long term clinical care and to inform the further development of comprehensive self-management 
support programs.  
This thesis will address this need by exploring interactions between participants in HIV medication 
and symptom management, from the perspectives of PLWH and CSPs, using a mixed methods 
(qualitative/quantitative) approach. More specifically, since so little was understood of the 
collaboration between the various players, a exploratory design, with a greater emphasis on qualitative 
methodology, was chosen [47].  
The project’s first phase was qualitative: data were gathered through interviews with PLWH and 
CSPs. In the second, based on these data, which provided insight into the collaborative processes, 
hypotheses relating to the collaboration of PLWH and CSPs in symptom management were drawn and 
tested quantitatively with a larger sample of PLWH and CSPs. Results so far are presented in two 
articles, the first using qualitative data alone (chapter 5), and the second combining qualitative and 
quantitative data (chapter 6). 
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The research presented in this thesis was conducted within the framework of the larger multi-center 
Symptoms and other Life Experiences and Adherence (SOLEXA) investigation (Spirig, 2003). From 
the perspective of patients and their close support persons, the SOLEXA study focuses on the 
relationships between symptom experience, symptom manageability, adherence, health related quality 
of life, and HIV progression. It is organized in collaboration within the Swiss HIV Cohort Study 
(SHCS), an ongoing multi-center research project established in 1988 and focusing on patient oriented 
HIV research. While seven HIV outpatient clinics across Switzerland are enrolled in the SHCS, to 
avoid the complications inherent in using translated questionnaires, the SOLEXA component, 
including the research presented here, is implemented only in Basel, Bern, St. Gallen, and Zürich, the 
four centers where German is the official and most spoken language.  
This thesis is divided into seven chapters. Chapter 1 provides a literature base introduction into the 
need for chronic illness management strategies for PLWH, with a focus on self-management. Further, 
this chapter elaborates the roles of symptom and medication management within overall HIV self-
management and collaboration with others in these processes. Chapter 2 describes the aims of the 
research program. The next four chapters incorporate publications. Chapter 3 presents the publication 
“Comprehensive Clinical Adherence Interventions to Enable Antiretroviral Therapy: A Case Report” 
(the Journal of the Association of Nurses in AIDS Care, Volume 18, Issue 6, pp 44-53). Focusing on 
the complexity of self-management support in clinical care, this article provides evidence based 
support strategies with a focus on collaboration between PLWH and teams of healthcare providers. 
Chapter 4 focuses on a structured literature review summarizing evidence on adherence interventions 
for PLWH, titled “Interventions to Enhance Adherence of Patients with HIV on Antiretroviral 
Therapy”. Originally published in German (Pflege, Volume 20, Issue 5 (Oct, 2007), pp 268-77) for 
maximum accessibility to German speaking nurses, this article was submitted to the publisher before 
the publication of a similar meta-analytic review on adherence interventions by Simoni et al. [23]. 
Chapter 5 features “Keeping a Grip on HIV: collaborative Medication and Symptom Management 
Experiences of Persons with HIV living in Switzerland”. From the perspective of PLWH, this article 
summarizes the results of the qualitative exploration of the first phase of the current study. This article 
has been submitted for publication in International Journal of Nursing Studies. Similarly, Chapter 6 
incorporates mixed methods results of the same study phase, focusing on the collaboration of PLWH 
and CSPs in symptom management. This article, “Symptom management in HIV/AIDS: A mixed 
methods approach to describe the collaboration and concordance of persons living with HIV and their 
close support persons”, has also been submitted for publication in Journal of Mixed Methods 
Research. In Chapter 7 the findings are discussed as a whole and suggestions provided for further 
research and clinical implementations are made. 
Introduction 
15 
References 
1. Hogg, R.S.S., J. A.; Graber, S.; Battegay, M.; Bonarek, M.; D'Arminio Monforte, A.; Esteve, 
A.; Harris, R.; Justice, A.; Hayden, A.; Lampe, F.; Mocroft, A.; Mugavero, M. J.; Staszewski, 
S.; Wasmuth, J.C.; van Sighem, A.; Kitahata, M.; Guest, J.; Egger, M.; May, M., Life 
expectancy of individuals on combination antiretroviral therapy in high-income countries: a 
collaborative analysis of 14 cohort studies. Lancet, 2008. 372(9635): p. 293-9. 
2. Sterne, J.A., et al., Long-term effectiveness of potent antiretroviral therapy in preventing AIDS 
and death: a prospective cohort study. Lancet, 2005. 366(9483): p. 378-84. 
3. Bodenheimer, T., E.H. Wagner, and K. Grumbach, Improving primary care for patients with 
chronic illness. Jama, 2002. 288(14): p. 1775-9. 
4. Schoen, C., et al., In chronic condition: experiences of patients with complex health care 
needs, in eight countries, 2008. Health Aff (Millwood), 2009. 28(1): p. w1-16. 
5. Sochalski, J., et al., What works in chronic care management: the case of heart failure. Health 
Aff (Millwood), 2009. 28(1): p. 179-89. 
6. Bangsberg, D.R., D.L. Kroetz, and S.G. Deeks, Adherence-resistance relationships to 
combination HIV antiretroviral therapy. Curr HIV/AIDS Rep, 2007. 4(2): p. 65-72. 
7. King, M.S., S.C. Brun, and D.J. Kempf, Relationship between adherence and the development 
of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or 
nelfinavir. J Infect Dis, 2005. 191(12): p. 2046-52. 
8. Harrigan, P.R., et al., Predictors of HIV drug-resistance mutations in a large antiretroviral-
naive cohort initiating triple antiretroviral therapy. J Infect Dis, 2005. 191(3): p. 339-47. 
9. Ammassari, A., et al., Self-reported symptoms and medication side effects influence adherence 
to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic 
Syndr, 2001. 28(5): p. 445-9. 
10. Badia, X., et al., Evaluating changes in health status in HIV-infected patients: Medical 
Outcomes Study-HIV and Multidimensional Quality of Life-HIV quality of life questionnaires. 
Spanish MOS-HIV and MQOL-HIV Validation Group. Aids, 2000. 14(10): p. 1439-47. 
11. Hudson, A., K. Kirksey, and W. Holzemer, The influence of symptoms on quality of life 
among HIV-infected women. West J Nurs Res, 2004. 26(1): p. 9-23; discussion 24-30. 
12. Portillo, C.J., W.L. Holzemer, and F.Y. Chou, HIV symptoms. Annu Rev Nurs Res, 2007. 25: 
p. 259-91. 
13. Bischofberger, I. and R. Spirig, [The work profile of family caregivers of persons affected by 
HIV/AIDS]. Pflege, 2004. 17(3): p. 176-86. 
14. Wilson, H.S., S.A. Hutchinson, and W.L. Holzemer, Reconciling incompatibilities: a 
grounded theory of HIV medication adherence and symptom management. Qual Health Res, 
2002. 12(10): p. 1309-22. 
15. Creswell, J.W.P.C., V.L, Designing and Conducting Mixed Methods Research. 2007, 
Thousand Oaks: Sage Publications. 
16. Simoni, J.M., et al., Efficacy of interventions in improving highly active antiretroviral therapy 
adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. 
J Acquir Immune Defic Syndr, 2006. 43 Suppl 1: p. S23-35. 
 
 
Chapter 1 
16 
Chapter 1 
Collaborative medication and symptom management in the context of 
chronic HIV management 
This Chapter provides an introduction to the challenges of HIV care in the context of chronic disease 
management. The current state of evidence related to two important aspects of a chronic disease 
management approach - self-management of patients and collaboration between patients, families and 
healthcare providers - are described with a focus on HIV care. 
Treatment success and future challenges for the management of HIV/AIDS 
Since the introduction of combined and highly active antiretroviral therapies (in the following 
abbreviated: cART) in the mid-nineties, improvements have been documented in diverse health 
outcomes such as quality of life, morbidity and mortality for PLWH in countries where treatment was 
available. For example, 14 linked cohort studies in high income countries illustrated an increase in 
estimated life expectancy for PLWH placed on cART at age 20 from 36.1 years to 49.4 years, for the 
period between 1996 and 2005 [2]. 
Nevertheless, more than a decade after the adoption of effective combination regimens, HIV/AIDS 
remains a global health problem. In 2007 an estimated 33 million people (30.3-36.1 million) were 
living with HIV, of whom Sub-Saharan Africa accounted for two thirds (67%). In North America and 
Western and Central Europe, the number of PLWA was estimated at approximately 2 million (1.4-2.8 
million) [3]. Worldwide, ca. 2.7 million (2.2 - 3.2 million) new HIV infections and 2 Million (1.8-2.3 
million) AIDS related deaths occurred last year [3].  
So far, the number of new HIV infections globally continues to outstrip advances in treatment and 
accessibility to it [3]. Globally, this situation demands further advances in prevention and testing 
strategies. In particular, though it highlights the need for further improvements to treatment access in 
low and middle income countries, where, at the end of 2007, nearly 3 million people were receiving 
antiretroviral treatment. Even while this figure represents a striking one-year improvement of 45%, it 
covers only 31% of the estimated global need [3]. Another important global change in the epidemic 
has recently become evident: after decades of increasing mortality, the annual global number of AIDS 
deaths has declined, partly as a result of greater access to treatment in resource-limited settings [1, 3]. 
In resource-rich settings, AIDS death rates began to decline dramatically early in the cART era: since 
September, 1998, the incidence of AIDS or related deaths has fallen by 8% per 6-month period (rate 
ratio 0.92, 95% CI 0.88-0.95, p<0.0001) [4]. On the negative side, this trend toward higher life 
expectancy has also increased the need for long term treatment and care [2]. 
Treatment strategies differ strongly between resource-rich and resource-limited settings. In the latter, 
the provision of ART usually follows a public health approach [48], generally characterized by a 
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limited number of standardized treatment regimens and standardized clinical and laboratory 
monitoring [49]. This strategy reflects the level of training of healthcare workers, the high patient 
burden and the limited number of drugs available in such settings. In contrast, HIV care in high 
income countries is usually provided in specialized facilities and includes highly individualized 
treatment strategies. Based on constantly updated treatment guidelines, frequent monitoring of 
important surrogate markers such as CD4 cell counts and viral loads, and medication resistance 
testing, individualized treatment regimens draw on a range of more than 20 approved antiretroviral 
drugs [50]. Developments in antiretroviral treatment over recent years have provided more convenient 
regimens with less problematic adverse effects, lower pill counts and treatment options including new 
drug classes. Still, while such regimens suppress viral replication, they do not eradicate the virus. 
Actual HIV eradication (via drugs, gene therapy or vaccines) will probably take many more years to 
develop, test and deploy [51-53]. 
Focusing on the improvement of health outcomes for PLWH, the situation is again somewhat different 
for low- and high-resource settings. Whereas broader access to ART and other treatment options 
should substantially improve health outcomes for PLWH in low-resource settings, this no longer 
seems possible for high-resource settings. In western and central Europe, for example, long-term 
treatment is already provided to 90-100% of PLWH and the initial drops in mortality and morbidity 
have been sustained [3, 4]. In those settings, though, long-term treatment experiences have shown that 
treatment comes at a price for PLWH. Since ART therapy demands a constant level of medication to 
suppress viral replication, once started it has to continue without interruption. Compelling evidence 
has linked treatment interruptions, including medical guided ones, with poorer clinical outcomes 
compared to continuous treatment (i.e., near-perfect adherence) [5]. Further, it has been shown that 
even newer and more potent regimens have to be taken very regularly in order to prevent or delay drug 
resistance, which is closely associated with treatment failure [20, 43, 44]. Despite the risks of non-
adherence, though, many PLWH find it difficult to keep to their medication regimens for long periods. 
Estimates of prescribed doses taken range from 60%-70% for PLWH in Western Europe and Northern 
America, while various barriers have been shown to complicate PLWH’s cART adherence patterns [6-
8].  
Further, more than half of PLWH receiving ART experience some medication side effects [12, 54]. 
While some of these are minor and diminish over time, others can be very distressing or even life 
threatening. A high number and distressing symptoms have been shown to complicate adherence to 
ART [9, 21]. To complicate matters still further, HIV-related immune suppression is associated with a 
range of life threatening, debilitating, or otherwise distressing opportunistic infections [55]. In 
addition, PLWH frequently suffer from other chronic health conditions (e.g., tuberculosis, liver 
disease, heart disease and cancer), any of which can complicate HIV treatment and care [56, 57]. In 
sum, due to the adverse effects of cART, opportunistic infection and comorbidities symptoms 
prevalence is consistently high for many PLWH, averaging 8-14 symptoms per person [9-12]. 
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Regarding the stabilization of health outcomes for the aging and treatment-experienced population of 
PLWH in affluent settings, major advances are no longer possible based solely on treatment access. It 
is clearly necessary to formulate new management strategies that consider multiple aspects of this 
chronic condition, including the medical complexity of the condition, the skills of healthcare 
providers, patients and the close support persons who manage the condition in their homes, and the 
need for long-term collaboration between and follow-up of patients and healthcare providers. Where 
accessibility to cART is high, then further improvement of health outcomes for PLWH will demand 
comprehensive healthcare services meeting these needs. In the long run, as accessibility issues are 
resolved in developing areas, such strategies, adapted to specific contexts, will become a global 
priority. 
The management of chronic conditions 
Through advances in treatment, HIV/AIDS is now widely accepted as a chronic condition. Healthcare 
needs of PLWH have become comparable to those of patients with other chronic conditions such as 
cardiovascular disease, cancer or diabetes, which also require comprehensive health support [58]. 
However, most healthcare systems in affluent countries were originally designed to respond to acute 
episodic illness. As a result, they often have difficulty focusing on the goals of containing a disease, 
slowing its progression, and supporting patients to deal with its challenges [14, 41]. A survey of 
chronically ill adults in eight high-income countries (Australia, Canada, France, Germany, the 
Netherlands, New Zealand, the United Kingdom, and the United states) found major differences 
between countries regarding access, safety, and care efficiency, indicating that the characteristics of 
national healthcare systems significantly influence the actions of persons with chronic conditions. 
Still, certain deficits were noted across all countries, particularly inadequate coordination regarding 
patients seen by multiple clinicians and weak efforts to engage or support patients to manage their 
conditions [14]. Focusing on institutional/organizational factors, Handford et al. examined the 
association between the organization of care at individual healthcare institutions and outcomes for 
PLWH across a range of studies (28 studies, 39,776 subjects). The results linked institutions treating 
higher volumes of HIV patients, especially those incorporating case management approaches, i.e., 
patient-centered care, with increased provision of cART and with lower mortality rates [13].  
In order to improve healthcare and outcomes for patients with chronic conditions, Handford et al. 
indicate a need for fundamental changes to all of the studied healthcare systems. Historically this need 
was highlighted by researchers’ observations that patients had changing needs depending on the 
phases of their illness [59]. In the late nineties Wagner et al. evaluated the efficacy of interventions 
across a range of programs, leading to their widely-adopted Chronic Care Model (CCM), which was 
later developed further by the WHO [15, 60, 61]. The WHO publication ‘Innovative Care for Chronic 
Conditions’, structures chronic care management areas requiring changes into micro, meso, and macro 
levels, with each level interacting with and dynamically influencing the others. At the micro level, i.e., 
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the level of patient interaction, improvements require a primary focus on patient and close support 
persons’ behaviors, and on the information they receive from their healthcare providers. The meso 
level refers to healthcare organizations and communities. At this level, care coordination requires 
evidence-based practice. This means integrating community resources, including information tracking 
systems, to plan, establish, implement and coordinate preventive interventions and long-term care 
processes. At the macro level, policy makers, i.e., government officials, rely on input from the micro 
and meso levels to inform their decisions and help them set standards and incentives for quality care in 
chronically ill populations [15].  
While none of the various comprehensive approaches proposed to improve chronic care have yet been 
directly acknowledged as superior, the CCM is among the most widely applied. Several studies have 
investigated the impact of single or multiple elements of the CCM. For example, a meta-analysis by 
Tsai et al. found that no single element of it was essential for improving outcomes, but that changing 
the design of healthcare delivery systems based on the CCM framework significantly improved 
process outcomes, as did self-management [62]. A more recent structured qualitative review on the 
effectiveness of the CCM came to a similar conclusion: studies applying most elements of the model 
in ambulatory settings showed improved patient care and health outcomes [63]. However, much of the 
evidence supporting the CCM is still observational and causal inferences are difficult. Trials and 
reviews have mostly focused on specific areas of the model, such as patient self-management 
programs [64]. This is particularly true in the context of HIV/AIDS, where most trials have been 
conducted in fragmented areas of PLWH’s self-management, such as adherence to ART or 
transmission prevention [23, 65]. 
However incomplete, the available evidence strongly suggests that a chronic care approach would 
improve current HIV/AIDS management strategies. Importantly, the CCM and related approaches 
provide only a framework for changes at diverse levels of the healthcare system: meeting the specific 
challenges of any chronic condition requires strategies tailored to fit the context and needs of each 
patient. The research presented in this thesis provides evidence to better answer the question of how 
and where to improve care for PLWH on the micro level (patient), by providing a fuller understanding 
of PLWH’s self-management and collaboration with CSPs and HCPs within the process. 
The two aspects of the chronic care mode – self-management and collaboration – will be discussed 
below. 
Self-management: a collaborative endeavor 
In the context of chronic disease management, “self-management” has become a widely used term, 
encompassing the day-to-day activities a chronic illness patient performs to minimize the 
consequences of his or her condition. Such actions vary based on the person’s perceptions, experiences 
and expertise, but share the focus of optimizing health outcomes, whether by retarding deterioration, 
maintaining a given level of health, or improving overall wellness [16-18]. Lorig and Holman 
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conceptualize the essence of these processes more succinctly: they incorporate diverse tasks and 
required skills [17]. In their 2003 study, based on an earlier investigation by Corbin and Strauss, three 
self-management tasks were observed across a range of chronic conditions: medical management, role 
management and emotional management [66]. Medical management included, for example, 
medication taking, or adhering to a special diet; role management included maintaining, changing and 
creating new life roles according to the challenges of the condition; and emotional management 
involved dealing with such emotions as anger, fear, and frustration, all of which are commonly 
experienced during chronic illness trajectories. Regarding these tasks, five self-management skills 
were described: 1) problem solving: isolating problems, gathering information, implementing 
solutions, and evaluating results; 2) decision making: applying information and training to distinguish 
medically serious symptoms from less serious problems and reacting appropriately; 3) resource 
utilization: navigating through health information sources and identifying the most relevant material; 
4) formation of provider partnerships: appropriately discussing developments regarding the course of 
illness with healthcare providers to allow informed decisions; and, 5) action planning and self-
tailoring: developing and implementing short-term action plans [17]. 
As suggested in the CCM, self-management should be viewed not as an isolated theory but rather in 
the contexts of broader systems (e.g., policy, healthcare organizations, communities and families). In 
these contexts, self-management is increasingly recognized as a dynamic process that includes active 
collaboration with others, especially close support persons (e.g., partners, friends, family) and 
healthcare providers [19].  
The term “collaboration” is widely used but often misunderstood to signify any form of teamwork. A 
more useful definition is ‘a recursive process where two or more people or organizations work 
together in an intersection of common goals by sharing knowledge, learning and building consensus. 
Collaboration does not require leadership and can sometimes bring better results through 
decentralization and egalitarianism’ [67]. In the context of chronic care models it is proposed that 
collaboration of the different players is most effective when every member of the team is informed, 
motivated, prepared and able to communicate and manage the chronic condition [15, 61, 68]. It can 
therefore be proposed that effective self-management collaboration requires special skills not only of 
patients but also of the other key players. Yet the skills that enable healthcare providers and close 
support persons to work with PLWH’s self-management have only been vaguely described. Existing 
evidence is summarized in ‘Collaboration in medication and symptom management’. Given the 
importance of the types of collaboration described in the CCM, developing them will require a deeper 
understanding of the specific collaborative processes, tasks and skills demanded of each player [15, 
61, 68].  
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Self-management of PLWH 
Patient self-management shows similarities across a range of chronic conditions, particularly the tasks 
of medical, role, and emotional management. Nevertheless, every chronic condition has special 
challenges, and self-management tasks can be described most usefully with reference to their specific 
characteristics. 
In order to provide an overview of HIV specific self-management tasks and to position the two aspects 
of self-management at the focus of this thesis, i.e., medication and symptom management, within the 
broader context of HIV self-management, a literature review was conducted on themes described 
under the umbrella of HIV self-management. Based on this review and combined with the broader 
self-management conceptualization described by Lorig and Holman [17].  
HIV self-management tasks have been divided into eight categories: medication management, 
symptom management, substance use management, lifestyle management, emotional management, 
role management, transmission management, and disclosure management. A short description of each 
task is provided in Box 2 (below). 
Box 2: HIV Self-management Tasks 
Medication management 
Decisions related to initiating or changing cART regimens often require collaboration with healthcare providers. 
Once started, the new or changed regimens have to be integrated into daily life and adherence maintained over 
time. Eventually, this also entails the management of adherence related obstacles, which often requires the 
support of others. Additionally opportunistic diseases and/or comorbidities often require medication 
management.[7, 25, 27, 30, 69] 
Symptom management 
The diverse symptoms that can occur throughout the illness trajectory have to be recognized, evaluated and 
monitored. Decisions are necessary on how to deal with symptoms, such as when to contact healthcare providers, 
whether or not to alter exercise or diet, and when to take — or not take — certain medications.[16, 28, 70-72] 
Substance use management 
The use of substances including tobacco, alcohol and diverse illicit drugs can interfere with health either directly 
or by hindering the management and treatment of HIV. Treatment strategies have to take substance use into 
account, and harmful behaviors have to be changed or reduced. Such behavioral change sometimes requires 
collaboration with healthcare providers.[73-77] 
Lifestyle management  
HIV infection generally requires lifestyle changes. Initiation of health promoting activities may be perceived as 
needed and helpful. Often-cited changes include eating healthier food, using food supplements (e.g., vitamins) 
and special precautions against food-related infections. Many PLWH also take steps to reduce stress and increase 
their physical fitness. [18, 70, 78, 79] 
Emotional management 
Awareness of HIV infection alters ones view of the future, often leading to emotions such as anger, fear, 
frustration and depression. Learning to manage those emotions is part of the process of managing the condition. 
[17, 80-84] 
Role management 
The trajectory of HIV may involve diverse changes in health. Despite such changes, important life roles have to 
be maintained or adapted and meaningful new roles and behaviors developed. For example, a woman suffering 
severe fatigue might need to reduce household tasks in order to be able to take care of her child. [17, 85-87] 
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Transmission management 
Prevention of virus transmission is complex and particularly influences sexuality and reproduction. Knowledge 
about prevention of transmission has to be gained and strategies have to be implemented into daily life. This 
often requires discussion with others (partners, families, friends, healthcare providers) and evaluation of risks 
taken. Own worries and fears and feelings of shame have to be managed. [65, 88-91] 
Disclosure (social) management 
To prevent stigmatization and other negative consequences, pros and cons of disclosure have to be constantly 
evaluated. This includes consideration of consequences for close persons such as children or partners. Once the 
decision is made, disclosure often involves educating others about HIV. Further decisions are also required 
regarding active participation in political and advocacy work. [17, 92-96] 
 
The self-management tasks outlined here are distinct but mutually influential: the management of one 
task, such as medication management, can be influenced by the way other tasks such as disclosure or 
symptoms are managed. Still, the four tasks of medication, symptom, substance use, and lifestyle 
management are closely related to improvement of health and could therefore be categorized more 
broadly, as Lorig and Holman suggest, as “medical management”. Likewise, based on Lorig and 
Holman’s conceptualization, the two tasks of emotional and role management have not been further 
refined. These terms summarize much descriptive HIV research very well, requiring no further 
differentiation. However, both transmission risk management and disclosure management represent 
newly defined task categories. The tasks they describe fit poorly alongside any of the previously 
existing general self-management tasks (medical, emotional, and role management). For use across 
diverse chronic conditions, a more general term such as ‘social management’ might be useful, under 
which disclosure management and other aspects specific to the respective conditions could be 
summarized.  
From a medical perspective, with a focus on improvement of health outcomes, medication and 
symptom management may be regarded as the core tasks of HIV self-management. After all, a 
person’s experience of symptoms is closely related to adherence to cART, and adherence is closely 
related to treatment success [9, 20, 21, 91]. From the patient’s perspective, however, medication and 
symptom management might not always be the main focus. For example, if problems arise from illicit 
drug use or the stress involved in disclosing one’s HIV infection to a new partner, medication or 
symptom management might fade at least temporarily into the background. Nevertheless, it can be 
assumed that, over the trajectory of the disease, every PLWH will have to deal with symptoms, 
medication intake or both and both tasks will inevitably require self-management strategies. 
Additionally, the self-management tasks described thus far demand specific skills. Figure 1 (below) 
provides an overview on HIV self-managment tasks and skills. The set of core skills described by 
Lorig and Holman (for description see last chapter) was added to the HIV specific self-management 
tasks [17]. In figure 1, these skills surround the self-management tasks, reflecting their importance 
regarding the described tasks. The skills are drawn as cogs of a gear, which, if complete, can mesh 
smoothly with other gears to achieve a desired outcome, thus illustrating that active, successful self-
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management always includes and is influenced by collaboration with others, such as close support 
persons or healthcare providers.  
 
 
Figure 1: HIV self-managment tasks and skills 
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Collaboration in medication and symptom management 
In the current literature, medication management and symptom management – the two self-
management tasks upon which this thesis focuses – have mainly been described in a fragmented way, 
with close attention paid only to one or the other, despite the fact that several studies have linked them 
closely [9, 17, 21, 22]. The two tasks will therefore be introduced separately before their associations 
and the collaborations within the management process are further elaborated. 
Medication and symptom management 
Medication management for PLWH includes decision making related to starting or changing medical 
treatments such as cART or medication to treat opportunistic diseases or co-morbidities [24-26, 97]. 
Once a decision is made, medication intake has to be integrated into daily life, where adherence 
choices will be made on a dose-by dose basis [22, 69]. Most studies of HIV medication management 
have focused on cART adherence, often broadly defined as the extent to which a patient’s medication 
taking behavior corresponds with the agreed recommendations of the healthcare provider [98].  
Even though this definition implies collaboration, the current concept of adherence has been criticized 
for maintaining a paternalistic and provider oriented perspective on medication management [99]. If 
cART initiation, for example, is determined not by consensus but by guidelines. The start of cART is 
recommended with the decline of immune functions, as reflected by the prevalence of T-cells, 
especially the CD4 cell count. Current guidelines recommend a treatment initiation threshold of 350 
CD4 cells/µ L; later starts have been associated with worse health outcomes [50]. Additionally, it is 
recommended that symptomatic patients start cART regardless of their CD4 cell counts. On the other 
hand, even for those feeling absolutely healthy, cART is recommended if CD4 cell counts are near the 
threshold, although treatment can be associated with diverse adverse effects. This may mean that some 
patients are pressured to initiate cART before they are convinced of the need for it. 
For timely treatment starts, however, PLWH’s readiness, i.e., the affected individual’s awareness that 
a particular change will be beneficial, is an important issue. Since the patient is ultimately responsible 
for taking the medication, potential barriers to adherence have to be identified, and the patient has to 
accept responsibility for initiation of the behaviour. Finally, the individual must retain a sense of 
control and impending action [26]. There is evidence that readiness and adherence to cART are 
distinct concepts. More specifically, readiness is viewed as a distinct factor that influences adherence, 
and therefore treatment outcomes, and should be examined as a subcategory of self-management 
support related to medication management [97]. Additionally, readiness to ART has been shown to be 
influenced by the PLWH - HCP collaboration [25]. 
Once the decision is made to initiate cART, the treatment’s success is profoundly influenced by each 
person’s ability to ingest the complete regimen, every day at exact times, over a long period of time 
[100]. Early studies showed that 95% of the prescribed doses had to be taken as prescribed; more 
recent results illustrate that some combinations of drugs allow less stringent adherence to achieve viral 
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suppression [43, 44]. Nevertheless, irregularities can lead to insufficient plasma drug levels, increasing 
the risk of drug resistant mutations, cross-resistance to other medications, which can ultimately lead to 
ineffectiveness of the medication.  
Further, multi resistant virus strains can be transmitted through the community [20]. As a result, a 
combined sense of public and individual responsibility motivates or even forces PLWH to develop 
medication management strategies to integrate their regimens into their lives [99].  
Still, problems with adherence to cART are widespread. Across Europe and North America cross 
sectional studies have determined that, on average, only 60%-70% of doses prescribed are actually 
taken [23, 101]. In a study incorporating long term follow-ups (median 8.3 years IQR 3.13-9.30), only 
32.78% of patients (n=540) achieved and maintained continuous adherence [102].  
Not surprisingly, qualitative and quantitative research shows that adherence can be complicated by 
multiple factors. These cover five dimensions: 1) Socioeconomic factors, e.g., age, gender, and 
income; 2) therapy related factors, e.g., the number of daily doses, pill counts and side effects; 3) 
condition related factors, e.g., viral load, time since diagnosis and HIV related symptoms; 4) patient 
related factors, e.g., low self-efficacy, treatment beliefs and depression; 5) healthcare team and system 
related factors, e.g., medication distribution, reimbursement, and support of healthcare providers [6, 
27]. However, few factors have demonstrated a consistent negative influence on adherence. The issue 
of why people fail to manage their medication sufficiently, even when lapses may shorten their lives, 
belies simple explanations of influencing factors [103].  
The task of symptom management is important for PLWH throughout the course of HIV infection. In 
the early stages, acute HIV infection can be associated with mild influenza- like symptoms lasting 
several days. After this comes a so-called asymptomatic phase, where a strong immune response 
controls viral replication, often for years, and opportunistic infections are rare [104]. Nevertheless, 
PLWH can still experience symptoms during this phase. For example, depression, fatigue and anxiety 
have been reported throughout the course of HIV [21, 104].  
When the function of the immune system declines and cART is started, whether in symptomatic or 
asymptomatic patients, it can be associated with a range of adverse effects. For example, among 
PLWH who changed therapy regimens, clear therapy associated reasons included diarrhea, nausea, 
vomiting, myalgias, paresthesias, and body fat redistribution [12]. Additional symptoms might occur 
in the context of opportunistic infections or comorbidities [105].  
Given such a range of reasons for symptoms, it is unsurprisingly that, across a range of studies, the 
symptom prevalence has remained high through the pre- and post-cART eras [11, 12, 21, 105, 106]. 
Two studies conducted after the advent of cART documented an overall symptom prevalence of 
around 70%. More specifically, Newshan et al. reported that 68% of an outpatient cohort sample 
(n=484) reported at least one symptom, whereas, of those, 96% reported multiple symptoms [107]. 
The second study investigated symptom prevalence in a sample of HIV-positive women (n=1256). In 
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that case, 67% of the women not receiving therapy and 69% of women receiving therapy showed at 
least one symptom [12]. These results indicate that symptom prevalence has not been reduced in the 
context of cART.  
Congruent with the findings of the study of women, a study of men (n=374) reported a higher number 
of symptoms in the men receiving cART (n=210, 56%). The cART group displayed an average of 14 
symptoms, compared to an average of 10 among the non-cART group (p=0.001) [10].  
Across a range of more recent studies, averages of 8 to 14 symptoms per PLWH have been described, 
depending on the scales used [9-12, 105]. Yet not only the prevalence of symptoms but also their 
intensity and the distress they cause have shown severe influences on PLWH’s adherence to cART 
and their health related quality of life [10, 106, 108, 109].  
Effective symptom management is therefore crucial, encompassing day-to-day decisions about dealing 
with symptoms, such as when to contact healthcare providers, whether or not to alter exercise or diet, 
and when to take—or not take—certain medications [16, 28].  
One line of research provides further descriptions of the different types of activities PLWH perform to 
self-manage symptoms. These include distraction techniques, dietary measures, complementary 
therapies, medications, exercise, and substances such as alcohol and marijuana [70, 82, 110, 111].  
Additionally, symptom management can be disrupted by various factors, most of which are 
summarized or described in different models of HIV symptom management [28, 71, 112, 113]. As 
described for barriers to adherence, these factors can be grouped into 4 dimensions: 1) socioeconomic 
factors, e.g., age, gender, literacy and social support; 2) condition related factors, e.g., co-morbidities, 
immune status and treatment success; 3) patient related factors, e.g., illness representations, loss of 
control or self-efficacy; 4) healthcare team and system related factors, e.g., sources of information, 
self-management programs and collaboration with healthcare providers [28, 71, 112, 113]. 
For PLWH the two self-management tasks of medication and symptom management appear closely 
related and similarly important to health outcomes [22]. In particular, insufficient symptom 
management can negatively affect a person’s health seeking behaviors, quality of life and adherence to 
cART [21]. Across a range of studies, patients with more symptoms scored lower in health related 
quality of life [45, 46, 114-118]. More specifically, in a study investigating changes in virological 
markers, quality of life, and symptom profiles over time, quality of life was less sensitive to 
immunological or virological changes than it was to responsiveness to symptoms [119].  
Further, prevalence of symptoms has also been linked, across diverse studies, to PLWH’s adherence to 
ART. For example in a cross sectional multi-center study (n=358), non-adherent patients had higher 
mean scores both for overall symptoms (12.3 +/- 9.2 versus 8.1 +/- 6.6; p<.001) and for medication’s 
adverse effects (2.9 +/- 2.7 versus 1.9 +/- 1.9; p<.001) when compared with adherent patients [9]. 
Another study, showing similar results, also highlighted a negative association related to collaboration 
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with healthcare providers: PLWH (n=420) with higher symptom scores were also less likely to adhere 
to medications, follow providers’ advice, or attend scheduled medical visits [120]. 
PLWH’s collaboration with close support persons and healthcare providers 
Collaboration appears integral to HIV self-management processes, since PLWH must continually 
make decisions such as whether to seek support or with whom they will interact in order to achieve 
positive health outcomes [18]. Primarily, they collaborate with two other groups regarding medication 
and symptom management: healthcare providers and close support persons.  
Close support persons are individuals who share deep personal connections with PLWH and provide 
various forms of support in times of need [33, 121], whether as family members, life partners or 
friends [33]. However, such support can by no means be expected: even the closest relationships show 
the influence of persistent social stigmatization of HIV/AIDS and those affected by it [33, 93, 96]. In a 
qualitative investigation in Switzerland, for example, only a small subgroup of family members of 
PLWH actually provided support for them. They did this very privately to avoid rejection and moral 
judgement of others [33].  
Nevertheless, the presence of at least one close and informed support person is clearly beneficial to 
PLWH’s health. A prospective cohort study demonstrated that stable partnerships have been 
associated with slower rates of disease progression in PLWH receiving cART [122]. More 
specifically, high levels of social support have been associated with fewer depressive symptoms and 
enhanced treatment adherence [123-125].  
Narratives of close support persons show that they consistently provide both instrumental support, 
such as preparing medications, and emotional support, such as listening or conversing [31]. However, 
for persons with chronic conditions, collaboration with CSPs is generally described as unidirectional, 
with the CSP assuming the role of caregiver [126]. Still, in the post-cART era, with declining HIV 
related morbidity allowing many PLWH to maintain active work and social lives, such collaboration 
has been researched only marginally, leaving significant knowledge gaps, such as that regarding how 
PLWH and their CSPs collaborate on the health-inflluencing tasks of medication and symptom 
management. 
Healthcare providers monitor symptoms, prescribe medications, and support PLWH’s self-
management efforts. Nevertheless, nurses and physicians typically demonstrate little skill at predicting 
patients’ symptom experiences, readiness for cART or adherence to cART [30, 127-129]. Therefore, 
mutual patient-provider communication is crucial element of effective support, beginning with the 
accurate assessment of symptoms and adherence. Beach and colleagues, for example found a single 
item — the patient’s perception of “being known as a person”— significantly and independently 
associated with receiving appropriate cART, adhering to cART, and having undetectable serum HIV 
RNA [36]. Qualitative data also confirm that for patients, healthcare providers are an important source 
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of information and  decision making assistance, as long as they are able to acknowledge the patient’s 
expertise and judgement [25].  
Results of adherence and symptom management intervention studies show that while healthcare 
professionals are able to provide effective support, most intervention programs have been conducted 
outside routine clinical care [23, 65, 72, 130]. Additionally, focusing on the triad of PLWH, CSP and 
healthcare provider, details of collaborative activities between CSPs and healthcare providers 
regarding self-management processes remain unclear.  
Role of Self-management programs for PLWH 
Self-management is increasingly recognized as an active process linking the social systems of PLWH 
with healthcare providers [19, 64]. The dynamics of this process have been applied to self-
management of diverse other chronically ill populations, in group or individual based programs, by 
educated peers, lay workers, nurses, psychologists, pharmacists and physicians [16, 23, 130].  
Yet, while multiple studies have confirmed the positive association between social support and health-
related outcomes such as adherence [123, 124, 131], few HIV self-management interventions have 
focused on the roles of close support persons. One exception was a study by Remien et al., who 
demonstrated the effectiveness of a couple based adherence-promoting intervention. Although, in most 
cases, effects diminished with time, the intervention group showed very significantly higher mean 
cART adherence (proportion of doses taken) than controls (76 % vs. 60%) [132].  
HIV specific self-management programs’ have generally been directed toward specific self-
management tasks, such as transmission risk management, symptom management or medication 
management (focusing on adherence). A meta-analytic review on the efficacy of adherence 
interventions, for example, indicated that across studies, participants in intervention groups were more 
likely than those in control groups to achieve 95% adherence (OR 1.50, 95% CI:1.16-1.94) [23]. And 
while Gifford et al. developed a comprehensive HIV self-management program, their main outcome 
measure was symptom status. Their randomized controlled trial illustrated a decrease in the 
experimental group’s symptom severity index (i.e., the number of symptoms with moderate or greater 
severity), alongside an increase in that of the control group (-0.9 versus +0.5; p<.03) [16].  
Many symptom management intervention programs focus on individual symptoms such as diarrhea or 
depressive symptoms [133, 134]. Some smaller studies of interventions focusing on overall symptom 
management measured adherence, quality of life, emotional distress and perception of health as 
outcomes. All showed a tendency for improvements in their intervention groups’ measured outcomes 
[130, 135]. A recent randomized controlled trial testing the effectiveness of a symptom management 
manual (compared to a Nutrition Manual) illustrated in a mixed model growth analysis significantly 
greater declines in symptom frequency and intensity scores for the intervention group compared to 
controls (t=2.36, P=0.018) [72]. 
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Such programs illustrate the possibility to improve individual self-management behaviors in 
chronically ill populations in general and among PLWH in particular. Likewise, in the field of HIV-
self-management, the majority of self-management interventions limit their focus to very specific  
tasks. Unfortunately, such specificity fails to reflect the life situations of PLWH, who, as illustrated by 
the close connection of symptom and medication management, often find themselves managing 
multiple tasks simultaneously. Additionally, self-management behavior is complex and changing. And 
while interventions often show short-term improvements, long term programmatic efforts are 
necessary to maintain those effects. This is supported by recent evidence that not every person profits 
from stand alone programs, while long term benefits may require ongoing collaborative processes 
between PLWH, CSPs and HCPs [23, 136]. 
HIV self-management in the Swiss context 
The chronic condition management, especially self-management, is strongly context-dependent. Since 
the research summarized in this thesis was conducted in Switzerland, a broad overview of Swiss 
national conditions is provided below. 
The Swiss healthcare system is well developed, with a mandatory health insurance system covering 
ambulatory care, laboratory testing, and prescription medications offered at specialized clinics – in this 
case, HIV outpatient clinics. For patients unable to pay standard premiums or deductible amounts, the 
Swiss social insurance system provides subsidized coverage. In theory, this means that the 
approximately 25’000 PLWH in Switzerland, including migrants and asylum seekers, have full access 
to specialized HIV care and treatment [3].  
The seven ambulatory centers of the Swiss HIV Cohort Study (SHCS) provide the majority of 
specialized HIV outpatient treatment, caring for about 70% of PLWH in Switzerland [137]. In 2008, 
86% of Swiss PLWH were male and 82% were caucasian. Transmission paths broke down as follows: 
men having sex with men (MSM), 37%; heterosexual contact, 39%; and intravenous drug use (IDU), 
20.9% (SHCS, 2008). The centers provide highly individualized treatment and care. Over 20 approved 
antiretroviral agents from four drug classes are prescribed according to the international guidelines 
[50, 138]. Five of these clinics are part of University hospitals; the remaining two belong to Cantonal 
hospitals.  
In high level practice and educational settings such as these, physicians tend to change frequently, 
while nurses usually work many years in the same setting. Since the Swiss system of academic nursing 
education is a fairly recent development, most nurses working in such settings are educated at the 
diploma level. 
All of the SHCS outpatient clinics use the SHCS Adherence Questionnaire (SHCS-AQ) to assess 
patient self-reported adherence at least every 6 months [139]. In a recent survey of 3607 SHCS 
participants, 31.1% reported missing doses over the preceding 4 weeks, with individual clinics’ non-
adherence scores averaging from 26.1% to 41.5% [101]. One explanation of the broad variability of 
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adherence rates between centers is that some provide structured adherence interventions whereas 
others do not. Symptoms and medication side effects are regularly assessed and treated in regular 
medical consultations by healthcare providers. To date, though, no structured or standardized patient 
education has been implemented regarding symptom management. Such education is generally 
provided during one-to-one consultations, and therefore depends largely on individual providers’ 
perceptions and skills. Additionally, CSPs have not been systematically integrated into clinical care or 
self-management support, depending instead on the priorities of individual centers and providers. 
To summarize, limited and highly fragmented information is available about PLWH’s collaboration 
experiences regarding medication and symptom management. In fact, the available evidence suggests 
that healthcare providers do not sufficiently recognize or address this population’s symptom and 
medication management processes [10, 128]. The Swiss healthcare system provides near-universal 
access to very individualized HIV-specific treatment at specialized outpatient clinics. However, 
regarding symptom and medication management support for both PLWH’s and their CSPs, 
interventions are less structured, depending instead on center- and provider-specific variables. 
Nevertheless, medication and symptom management activities are key predictors of non-adherence to 
cART, a known risk factor for poor outcomes in HIV populations. PLWH’s and their CSPs’ 
descriptions of such activities, including their collaborative efforts to develop effective self-
management skills and strategies, are important resources for healthcare providers concerned with 
offering the best possible care. 
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Aims of the research program 
In countries with broad access to antiretroviral therapy, mortality and morbidity rates among PLWH 
have fallen significantly, with HIV/AIDS now generally accepted as a treatable chronic condition[2]. 
Recent evidence further suggests that improvements in health outcomes require an approach based not 
on traditional acute care models but on modern comprehensive chronic illness management [14]. 
Across diverse chronic conditions, such services have proved successful with changes at the levels of 
policy, healthcare organization and the individual patient [15].  
At the patient level, self-management and collaboration between patients, close support persons and 
healthcare organizations are now seen as the most important aspects related to health outcomes [19]. 
In HIV/AIDS, medication and symptom management tasks are key to successful self-management, but 
have been described mainly in fragmented ways, with most research focusing either on symptoms or 
on cART adherence, despite the fact that PLWH’s symptom experiences are closely associated with 
adherence to cART [19, 22, 23, 28].  
For PLWH, the formulation and adoption of many medication and symptom management strategies 
involves collaboration with their HCPs and CSPs; yet, despite the seemingly obvious benefits of such 
collaboration, the related processes are only vaguely understood. Since self-management activities 
regarding both medications and symptoms are closely associated with health outcomes, a fuller 
understanding of such activities is necessary to improve related services.  
The overall aim of this exploratory research program was to describe PLWH’s symptom and 
medication management activities, focusing on collaboration between PLWH, CSPs and HCPs, from 
the perspectives of all three groups. This involved focusing on the specific aims outlined below: 
• to present a clinical case report from the HCP’s perspective, with individualized evidence based 
medication and symptom management interventions (based on literature review); 
• to review the evidence on adherence support interventions for PLWH (based on literature review); 
• to describe the experiences of PLWH regarding medication and symptom management, with 
reference to collaboration with HCPs and CSPs (based on qualitative results); and 
• to explore the collaborative activities between PLWH and their CSPs within the process of 
symptom management, including the concordance between both players’ symptom reports (based 
on qualitative and quantitative results). 
This study was conducted according to an exploratory mixed methods design [47]. In a first step, the 
goal was to gain a clearer understanding of PLWH’s and CSPs’ medication and symptom management 
experiences, including their collaboration with each other and HCPs. Therefore, in-depth interviews 
were conducted with PLWH and CSPs and qualitatively analyzed. In the second phase, based on the 
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findings of the first, questions related to the concordance of PLWH’s and HCPs’ symptom reports 
were formulated and tested quantitatively in a larger sample.  
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Abstract  
Adherence to antiretroviral therapy is key for successful treatment in HIV-infected persons. In order to 
enhance adherence, multilevel interventions are necessary. This is often a challenge as this case of an 
HIV-infected man with a history of poor adherence and multiple virological failures demonstrates.  
With a multidisciplinary approach, comprehensive intervention strategies were used to facilitate the 
patient’s adherence to an enfurvirtide-based regimen. The interventions are described in detail and 
include adherence support with modified daily observed therapy, support regarding symptom 
management, and social relationships. The patient’s clinical progress was monitored using indicators 
such as clinical surrogate markers, adherence to ART and HIV-related symptom and depression 
scores. 
The case illustrates how interventions that were individualized, culturally sensitive, and provided by a 
team of health care providers enabled a patient to optimize his adherence which led to significant 
improvement in his clinical surrogate markers and subjective quality of life. 
Chapter 3 
43 
Introduction 
Potent antiretroviral therapy (ART) for HIV-infection requires nearly perfect adherence1 on a long-
term basis, since non-adherence by HIV-infected patients has been associated with incomplete viral 
suppression, the development of drug resistance, disease progression, and mortality (Bangsberg et al. 
2003). Unfortunately, recommended levels of adherence to medication are not often achieved. In 
clinical practice, non-adherence rates in the HIV-infected population fall somewhere between 20% 
and 50% depending on operational definitions and methods of measurement (WHO, 2003). Adherence 
is complex and influenced by multiple factors including: (1) the complexity of the regimen; (2) 
frequency and severity of side effects and symptoms; (3) social and psychological factors such as 
depression; (4) treatment and health beliefs; (5) social and provider support; and (6) personal attributes 
such as clinical status, sex, age and substance use (Fogarty et al. 2002). Thus, multileveled adherence 
support is crucial.  
In order to integrate medical, psychosocial, and behavioral interventions in patients with HIV, a 
chronic illness management approach is recommended. Patients need to become invested and 
knowledgeable partners in managing their chronic condition in daily life (Bodenheimer, Lorig, 
Holman & Grumbach, 2002). Within that context, patient’s health outcomes are optimized by state-of-
the-art medical therapy and interventions related to adherence and symptom management. The 
interventions should be performed over time and include combinations of educational, behavioral and 
social support approaches (Yeni et al. 2004; Reynolds 2004). 
Incorporating multilevel approaches that meet an individual patient’s needs in clinical practice is often 
a challenge. Strategies need to flex and adapt to the ever changing physical and psychosocial states of 
a patient who struggles with the management of ART. Providers need time and expertise to provide a 
safe and therapeutic environment for change to occur. Yet they are often less skilled at enabling 
behavioral change than they are at educating and advising. The practice setting also creates barriers to 
comprehensive intervention strategies in terms of time allotted for short visits with an emphasis on 
physiological rather than psychological outcomes. 
The following case report offers an opportunity to analyze comprehensive evidence-based clinical 
interventions to facilitate adherence to a complex antiretroviral treatment regimen for an HIV-infected 
man who had a history of long term non-adherence and multiple virological failures, intravenous drug 
use, and clinical depression. After the case presentation, the evidence-based theoretical background of 
the selected intervention strategies will be described, before the implementation of interventions and 
the patient’s clinical progress are illustrated. 
                                                     
1
 Adherence to ART is understood as the extent to which a patient’s behavior, regarding taking 
medication corresponds with the agreed recommendations that were collaboratively developed with the health 
care provider (WHO, 2003). 
Chapter 3 
44 
Presentation of the case study 
Mr. Angeli2 was a 44 year old man attending an HIV Outpatient Clinic in a Swiss city for monitoring 
and treatment of his HIV Infection. The Clinic is one of the seven centres participating in the Swiss 
HIV Cohort Study (SHCS). Within the SHCS, standardized collection of socio-demographic, clinical, 
and laboratory data are integrated into the care of patients living with HIV (www.shcs.ch). Due to 
mandatory health insurance, all persons living with HIV in Switzerland (including migrants) have 
equal access to care and ART whether participating in the SCHS or not.  
Mr. Angeli’s primary care provider was a physician with a specialty in infectious disease. The 
patient’s clinic visits had been infrequent and erratic. With interruptions, he had been taking various 
combinations of antiretroviral medications for the last 3 years. At the time of this case study, he 
presented to the clinic with therapy failure and multiple drug resistant mutations. Since his problems 
with adherence to ART had been documented numerous times, he was referred to a nurse-led 
adherence counseling program, funded in part by a nursing practice development grant. 
Medical History 
Mr. Angeli’s HIV Infection (CDC C3) was first diagnosed in 1992. He had experienced opportunistic 
infections that included candida esoghagitis and herpes zoster, both in 1999. Additional comorbidities 
included hepatitis C infection, chronic obstructive lung disease, and peripheral polyneuropathy. Mr. 
Angeli had been an intravenous drug user from 1978-1987. Substance use had been routinely assessed 
within the SHCS every six months. Over the past 3 years Mr. Angeli had reported three instances of 
sporadic cocaine use. In the same time period, many episodes of high alcohol consumption, mostly 
during weekends, had been reported in his chart. However the patient did not meet the criteria for 
alcohol use disorder (ICD10). 
Mr. Angeli presented to our clinic in April 2005 because of bloody diarrhea without abdominal pain or 
fever. In addition, he complained about dyspnea, generalized muscle pain, severe fatigue and 
depressed mood. CD4-T-count was 5 cells/µL and a viral load of 462991 copies/mL on ART with 
Didanosine, Tenofovir, and Nevirapine. Genotypic and phenotypic resistance testing showed broad 
resistance to protease inhibitors (M46IL, L90M), NNRTI (Y181I) and NRTI (M184V, K70KR). Due 
to his condition, the patient was hospitalized. 
Social History 
Born and raised in a little village in southern Italy, Mr. Angeli came to live and work in Switzerland 3 
years prior. He moved to Switzerland because of a relationship with his girlfriend, but he stated that 
they had broken up a few months prior to this assessment. His ex-girlfriend was the only person who 
                                                     
2
 Name and information about the patient’s changed to maintain his privacy.  
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knew about his HIV status. Mr. Angeli had a few friends with whom he socialized occasionally, but he 
could not name a close support person. He had been working in a large bakery and had recently lost 
his job due to long unexplained absences from work. Mr. Angeli complained about severe fatigue and 
weakness and was not always able to cope with the heavy work and the night shifts at the bakery. Still, 
he did not want his physician to provide documentation to his boss, because he feared disclosure of his 
HIV status at work.  
Even though he had been working in a German speaking Swiss town for 3 years, he was not able to 
understand, read, write or speak German. At work he spoke Italian; he stated he did not have the 
energy to go to German classes because he was exhausted from work. His ex-girlfriend had handled 
all his paperwork and financial affairs for him until they separated. Mr. Angeli explained that he was 
now overwhelmed by the papers and bills due to his health problems and did not feel that he could 
cope anymore.  
Treatment and Adherence History 
Mr. Angeli was treated with Zidovudine, Lamivudine, and Nelfinavir from 1999 to 2003. Several 
treatment interruptions were reported in his chart, most of them because of fear of drug interactions 
and concomitant use of alcohol and cocaine. Due to cumulative drug resistance, he was treated in 2003 
with a new experimental regimen with Indinavir and Lopinavir/Ritonavir administered once a day. Mr. 
Angeli complained of the high pill burden and interrupted the treatment. A few months later, in 2004, 
a simpler regimen with Didanosine, Tenofovir, and Nevirapine was started. Reduction of the daily pill 
count from 10 to 4 was achieved. Other possible adherence influencing factors were frequently 
documented such as high alcohol consumption, depression, unstable work situation, and relationship 
problems. 
A present assessment of adherence, based on the motivation to change medication taking behavior 
(Highstein, Willey & Mundy 2006) and on barriers and facilitators to adherence (WHO, 2003) 
revealed that Mr. Angeli was motivated to try another antiretroviral regimen in order to feel better. 
The conversation about his former medication taking behavior revealed additional barriers such as: 
having a hard time maintaining a daily schedule; fear of HIV disclosure; not wanting to be reminded 
of his HIV status; and loneliness. 
Since the high alcohol consumption reported in the chart represented a risk factor for adherence 
problems, Mr. Angeli’s alcohol consumption was assessed with the Alcohol Use Disorders 
Identification Test (AUDIT). The AUDIT is a questionnaire that helps practitioners identify a 
potentially harmful drinking pattern or dependence (WHO 2001). Mr. Angeli’s AUDIT Score 
represented a medium-level alcohol problem and indicated that brief counseling and continued 
monitoring were appropriate interventions. The first counselling session was held immediately after 
the assessment. Monitoring was integrated in the assessment of the SHCS every six months. 
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Background of the intervention strategies 
Mr. Angeli is a complex patient with diverse interrelated problems. In order to optimize health 
outcomes, individualized evidence-based intervention strategies had to be implemented. Therefore a 
trusting relationship between Mr. Angeli and his health care providers (nurse/physician) had to be 
established. This was especially important because of language barriers and his former negative 
experiences with the health care system. Further, Mr. Angeli had to be included in the decision-
making process related to treatment and support interventions, since his active participation was 
needed. On the basis of a trusting relationship and the process of shared decisions, Mr. Angeli needed 
support in the areas of adherence, symptom management and social support. A modified daily 
observed therapy program (mDOT) seemed an appropriate adherence intervention for Mr. Angeli: it 
would help him to structure his days and provide support in the administration of medication. Further, 
the regular visits would permit nurse-led counseling for a longer time in the areas of adherence, 
symptom management, and social support.  
Shared Decision Making 
Participation by chronically ill patients in the process of treatment decision making has demonstrated a 
positive influence on patient satisfaction and motivation for treatment (Bodenheimer et al. 2002). In 
HIV care, good patient-provider communication and a shared process of treatment decision making 
has been shown to influence a patient’s readiness for ART (Fehr et al. 2005). Further, a positive 
patient provider relationship has been shown to have a significant influence on an HIV-infected 
patient’s adherence to ART (Fogarty et al. 2002). Schneider et al. (2004) found that multiple 
dimensions such as communication, HIV specific information, participatory decision making, trust, 
and the quality of dialogue regarding adherence were significantly associated with adherence to ART. 
Decision making regarding symptom management involves a collaborative process aimed at making 
changes in medication and health behavior (Spirig, Moody, Battegay & De Geest, 2005). Thus, 
patient-provider interaction plays an important role related to interventions and health care outcomes.  
Modified Daily Observed Therapy and Adherence Counselling 
A growing body of evidence has demonstrated that directly observed therapy (DOT) can be a 
successful approach to enhance adherence to ART in patients who are hard to reach or have been 
unsuccessful in previous attempts of ART (Altice et al. 2004). To date, the existing programs have 
been conducted in structured institutional settings such as methadone maintenance clinics, HIV clinics, 
skilled nursing facilities or prisons, or communities and resource-poor countries (Mitty & Flanigan 
2004). The strategies used differ depending on the population they planned to reach. Few programs 
use DOT strategies and observe every dose of medication taken. The majority use modified daily 
observed therapy strategies (mDOT), which includes, for example, the observation of one dose of a 
twice daily regimen for five days of the week. Additionally many DOT/mDOT programs include 
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enhanced services such as adherence counselling and linkages to community and health care resources 
(Mitty et al. 2004).  
To date experience with DOT/mDOT (for ART) is limited to pilot studies, preliminary results of 
randomized clinical trials or observational (comparative) studies (Altice et al. 2004). Even with these 
limited data, results for DOT and mDOT are promising, as Macalino et al. (2004) found in their pilot 
study: 25 individuals with active substance use disorders and documented history of non-adherence 
received a 6 month DOT intervention. Full viral suppression (less than 50 copies/mL) was achieved by 
47% of patients after 2 to 3 months and 70% after 3 to 6 months. However, DOT alone will not 
eliminate non-adherence and successful programs include the following additional characteristics: (1) 
be highly individualized and flexible; (2) build a trusting relationship with patient; (3) address 
facilitators and barriers of adherence; (4) include enhanced services; (5) have good communication of 
different providers (Mitty et al. 2004; Frederick et al. 2004). Programs that include those components 
have shown to be well accepted by patients and have been an important link for comprehensive health 
care services for hard to reach patients when addressing the above mentioned clinical outcomes.  
Further DOT/mDOT programs might be one of many different useful strategies to support patients 
with a history of long term non-adherence who have developed multiple resistant mutations and could 
profit from complex regimens including Enfurvirtide (ENF). ENF has to be administered twice daily 
by subcutaneous injection; it typically takes approximately 20 minutes for ENF to dissolve fully. 
Trials have found that injection site reactions were the most common adverse event and nearly all 
patients reported at least one reaction. In clinical trials, acceptance of ENF by patients is reported to be 
high. However some barriers such as subjective acceptance by patients, readiness for treatment, and 
adoption in daily clinical practice have been observed (Clotet et al. 2004). In the Swiss HIV Cohort 
Study, about 40% of patients starting ENF discontinued the treatment after a median time of 6 months 
(Elzi et al. 2005). Many factors may be involved in the high rate of stopping ENF. Former IV drug 
users objected to the use of ENF as the subcutaneous administration revived negative experiences 
associated with their substance dependence. Reactions at the injection site were rarely found to be 
treatment limiting – however they may have also contributed to the psychological barriers of adoption 
and administration of ENF therapy. Complexity of ENF adoption and administration can be further 
increased by the high psychosocial and behavioral risk profiles of these patients. Patient education 
materials alone have proved not to be sufficient to support some of the patients on ENF in their self- 
management (Kempner, 2005). For the “typical” ENF patient, injection site reactions, HIV-related 
symptoms, changing therapy because of optimal background, and pill- and injection-fatigue may 
converge to create a complex clinical scenario. This impacts patients’ self-management and adherence 
behaviors necessitating a much more individualized approach than would have been expected based 
on the findings of the trials establishing efficacy of treatment.  
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Support in the Management of Symptoms and Side Effects  
Symptom management encompasses how a person living with HIV makes day-to-day decisions about 
dealing with symptoms, such as when to contact the health care provider, whether to take certain 
medications, and whether or not to alter exercise or diet (Gifford, Laurent, Gonzales, Chesney & Lorig 
1998; Spirig et al. 2005). When symptoms are poorly managed, adherence becomes a problem 
resulting in rapid disease progression and negative effects on quality of life (Bastardo & Kimberlin 
2000). Effective symptom management therefore is imperative. Providers have to be sensitive to the 
broad range of physiological and psychological symptoms and side effects that might occur and assess 
them systematically and regularly. Patients typically experience multiple signs and symptoms. 
Mathews and colleagues (2000) recently found that only 9.1% of the HIV-infected patients in their 
study (N = 4042) reported no signs and symptoms during a 6 month period. Frequently reported 
symptoms include: (1) fatigue (between 20%—85%); (2) sadness (82%); (3) diarrhea (40%—75%); 
and (4) pain (76%) (Vogl et al. 1999; Matthews et al. 2000). A patient’s active self-management of 
symptoms is important and involves teaching for monitoring and managing symptoms by providers. 
Gifford and colleagues discovered, for example, that after receiving a self management program HIV 
patients improved their attitudes and abilities to deal with their symptoms and reduced unscheduled 
hospital visits (1998). Chou and colleagues (2004) tested a symptom management program that 
emphasized self care education related to medication side effects. They also reported significant 
differences in unscheduled hospital visits between groups but no differences in self esteem. 
Social Support and Stabilization of Living Conditions 
Reports from studies of patients living with chronic illnesses show that the availability of social 
support from a social network, especially a primary support person, is an important determinant of 
well-being (DiMatteo, 2004). A longitudinal descriptive study using the data from the Swiss HIV 
Cohort Study (N = 5350) demonstrated that the presence of a stable partnership was a significant 
predictor of slower progression of disease (Young et al. 2003). More specifically, effective self-
management of HIV-infected persons, including adherence to ART, is enhanced when there is a social 
network and the presence of one primary support person (DiMatteo, 2004). Providers should assess a 
HIV-infected person’s social network and also provide primary support persons with information and 
guidance or use a systemic approach that focuses interventions on families. This might be important 
since qualitative data show, that patient and support persons are often very close, live withdrawn lives, 
and provide important support to each other but do not exchange much with others outside of their 
close circle (Spirig, 2002). Additionally, health care providers can provide links to other sources of 
social support. DOT/mDOT programs provided social support by enhancing conncetions to existing 
community-based resources (Mitty et al.2004).  
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Implementation of interventions and clinical progress 
Mr. Angeli’s primary physician had known him for 6 months. She was a cultural match for him as she 
was a native Italian speaker and thus able to converse with Mr. Angeli, which allowed them to 
establish a trusting relationship. During the week of Mr. Angeli’s hospitalization, the physician 
introduced him to the Advanced Practice Nurse (APN) who had  expertise in adherence counselling. 
The physician and nurse met with Mr. Angeli for short visits on the hospital unit, listening to his 
worries and problems and conveying to him  prospects for future support. The visits gave the nurse the 
opportunity to establish and strengthen their relationship. This facilitated conducting the adherence-
related assessment at the first outpatient clinic visit after discharge from the hospital. 
Due to Mr. Angeli’s multiple drug resistances, possible future treatment options were discussed in an 
interdisciplinary team of HIV-experienced physicians and nurses. A salvage regimen with Enfurvitide 
(ENF) and Tenofovir, Efavirenz, Lamivudine, Zidovudine, and Didanosine was proposed. 
Additionally, antidepressant treatment with Paroxetine was suggested since the patient screened 
positive for depression and anxiety scores as assessed by the Hospital Anxiety and Depression Scale 
(HADS) (Bjelland, Dahl, Haug & Neckelmann 2002). 
In a joint session the patient, physician, and nurse discussed the proposed therapy options. Thorough 
discussion ensured that Mr. Angeli was able to express his worries, hopes, and former experiences 
with medications and adherence. For example, he said that he was afraid of needles and even though 
he had injected intravenous drugs, he never had injected his drugs himself. The physician brought 
issues of drug effectiveness and side effects of the proposed regimen into the discussion whereas the 
nurse brought in possible individualized adherence support strategies. In a process of shared decision 
making, they agreed that Mr. Angeli would start the proposed antiretroviral regimen with the support 
of a mDOT program as well as financial and housekeeping assistance. They decided not to start the 
antidepressant treatment, as Mr. Angeli believed that his mood would improve once he started feeling 
better with the ART. Ongoing nurse and physician consultations were planned with a comprehensive 
evaluation after 6 months. At that time, they had the option to stop or change the ART regimen if 
needed. This timeline was very important for the patient since he felt able to adhere to the plan for a 
period of 6 months if no adverse events occurred.  
His twice daily regimen with Enfuvirtide and Tenofovir, Efavirenz, Lamivudine, Zidovudine included 
subcutaneous injections and oral medication intake every 12 hours. The individualized mDOT 
program included visits to the HIV outpatient clinic every morning during the week (20 minutes). 
Once a week Mr. Angeli had an individualized 25 minute counseling session with the APN. 
Community care nurses went to his home in the evening and on the weekends to administer the 
injections and oral medication. All services were covered by his health insurance. The community 
nurses were given background information by the APN at the HIV outpatient clinic. Consultations 
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with the physician were scheduled at the outpatient clinic 2 weeks after start of treatment, at 1 month 
and then every 3 months. 
Mr. Angeli kept his appointment at the outpatient clinic every day, even though he spent the rest of the 
day in bed during the early weeks of treatment. Within a few weeks his symptoms of fatigue and 
muscle pain were better controlled due to ART and effective pain management. By self-report on a 
Likert scale from 1 to 10 (1 = none, 10 = worst) his fatigue score decreased from 8 at baseline 
assessment to 5 after 4 weeks and his pain score decreased from 6 to 2. He began asking questions 
about HIV-infection and treatment. Counseling sessions included making drawings about his health 
beliefs and educational materials about biomedical issues as verbal communication was limited due to 
the language barrier.  
After 3 months of treatment, Mr. Angeli showed a slight interest in the process of administering ENF 
by injection. He began to observe the nurse doing the injection when previously he had turned his head 
away. The nurse explained what she was doing and further counseling sessions included education 
regarding preparation of the vials and later, injection of medications. Educational material in Italian 
was used for this purpose. A few weeks later the patient was ready to do the ENF-injections by 
himself. He rated his self efficacy (perceived capabilities to perform the task) with administration of 
ENF as 7 on a 1-10 scale with 1 indicating not at all confident and 10 totally confident (Schwarzer, 
Bässler, Kwiatek, Schröder & Zhang, 1997). Community nursing service was stopped and Mr. Angeli 
did the evening and weekend injections himself. Even so, he still wanted to come to the outpatient 
clinic for his morning injections but he administered the medication himself. One of the nurses always 
checked how he was doing and gave assistance if needed. They called him when he did not arrive at 
the clinic, but this only happened a few times.  
Mr. Angeli’s viral load decreased from 462991 copies/mL below 400 copies within a year after 
treatment change. Accordingly his CD4 count slowly increased from 5 cells/µL to 106 cells/µL after 3 
months, 101 after 6 months, and 127 after 24 months. 
Counseling sessions after the patient began the injections himself focused on issues around injection 
site reactions, side effects, and symptom management. With the help of the nurse, Mr. Angeli 
developed an injection schema which made injection site reactions, such as painful indurations, 
manageable. He learned to palpate the indurations and change injection site carefully, since he had 
limited sites for injection.  
During the first 6 months of treatment Mr. Angeli suffered several episodes of a fever or cough. This 
frightened him so his counseling included education to differentiate between symptoms where he 
needed the assistance of professionals and those that he could manage himself. Discussion also 
included a differentiation of symptoms connected to HIV-infection and those probably as a result of 
depression. After education about depression related symptoms and treatment possibilities, Mr. Angeli 
decided to start antidepressant treatment, 5 months after the initiation of ART. Mr. Angeli’s subjective 
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quality of life increased while the depression score (measured by HADS) decreased to a negative score 
(see Table 1) (Bjelland et al. 2002). 
Table 1: Anxiety and Depression Scores according to the HADS  
 Depression Score Anxiety Score 
Baseline 14 positive 12 positive 
3 months after mDOT start 14 positive 9 questionable 
6 months after mDOT start * 9 questionable 5 negative 
12 months after mDOT start 5 negative 7 negative 
Score: negative 0-7 / questionable 8-10 / positive >10 
*3 month after start with antidepressant  
 
Mr. Angeli’s alcohol and drug consumption was been assessed at 3, 6 and 12 months with the 
assessing consumption/amount of consumption questionnaire routinely used at the  SCHS. At every 
assessment, he indicated that he had stopped alcohol and drug use completely. His aspartate and 
alanine aminotransferases were within the normal range thus no additional laboratory tests were done. 
Asked about his reasons of stopping, Mr. Angeli described a trigger event: A few days after starting 
with the new regimen he had 2 glasses of wine there after he fainted in the bathroom. That was the 
moment when he realized this was his last treatment option and he did not want to ruin this chance.   
At the beginning of the ENF treatment, Mr. Angeli had been referred to the local HIV Agency for help 
with his paperwork and financial issues. He also received community services for cleaning because he 
was too weak to do it himself. The HIV Agency paid for both services. After his HIV-infection and 
depression were better controlled he took over both tasks independently.  
Issues during counseling shifted to disclosure of his HIV-positive status. During this time Mr. Angeli 
disclosed his HIV-positive status to two close friends and brought them to the outpatient clinic. In an 
interactive session they received information about HIV infection from Mr. Angeli and the nurse. 
During the conversation, Mr. Angeli demonstrated how much he had learned and that he had become 
quite knowledgeable about his HIV infection. His friends were very touched and willing to give 
support where needed. 
The nurse and physician met regularly to discuss the Mr. Angeli’s progress and upcoming problems. 
The joint brief sessions with him after 3 and 6 months demonstrated that the initial plan with 
interventions related to adherence symptom management and social support had been successful. 
While Mr. Angeli enhanced his self management skills, his clinical markers (CD4/VL) improved, his 
symptoms were controlled and his subjective quality of life increased significantly. The 
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interdisciplinary approach and shared process with him allowed adaptation of the interventions to the 
ever-changing clinical situation. 
Discussion and implications for practice 
This case illustrates how a patient with many adherence-related barriers and multiple genotypic drug 
resistances was able to adhere to a complex ART regimen, which led to a significant improvement in 
his health status. Former adherence related interventions during the patient’s outpatient clinic visits 
had failed. Those interventions had predominantly focused on acute problems: for example a high pill 
burden from the patient’s perspective or a failing regimen from the provider’s perspective. Clinical 
strategies used had been based on advice and education by different providers without structured 
follow-ups. Mr. Angeli’s outcomes demonstrated that this approach was not sufficient. We suggest 
that in our case, the highly structured multilevel approach over time, with culturally relevant 
information and skill building strategies, was pivotal for the improvements his in health outcomes. 
This is in accordance with the existing literature, which concludes that knowledge of ART is a 
necessary component of adherence, yet educational strategies alone are not sufficient in promoting 
adherence. In addition, motivational, cognitive, behavioural, and affective strategies have to be 
included in repetitive interventions (Reynolds, 2004). We propose that such interventions should be 
included early in the treatment process in order to prevent treatment failure due to adherence 
problems. 
Planning and implementation of the above described multilevel approaches in clinical practice is 
demanding, as many issues have to be assessed and different providers have to coordinate their 
interventions. We used the Self Regulatory HIV Symptom Management Model (SSMM-HIV) to 
understand the relationships between key factors influencing adherence to ART and HIV-related 
management. The SSMM-HIV, developed by our team and described elsewhere (Spirig et al. 2005), 
provided a framework for assessment of key factors influencing Mr. Angeli’s symptom management 
and adherence. Whereas the SSMM-HIV helped to identify problem areas, for example medication 
management, interventions had to be further individualized. In the case of Mr. Angeli’s problems with 
medication management, the mDOT approach was selected. Other patients might need different 
approaches. A patient’s needs and feasibility of interventions related to different health care settings 
have to be carefully considered. To date there is limited evidence showing which intervention strategy 
is most effective related to diverse problem behaviors or different groups of HIV-infected patients. 
More specific research in this area is needed. Meanwhile clinical expertise and good patient-provider 
communication seem to be essential for successful interventions. A DOT strategy may be viewed as 
intrusive and controlling by patients and thought of as paternalistic by professionals (Mitty et al. 
2004). However, we chose the treatment regimen and adherence supportive intervention in 
collaboration with the patient. This enabled him to benefit from the structure of regular visits and 
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counselling without feeling controlled. Less structural help was needed as he developed his self 
management skills and actively took over his medication management. 
According to Bodenheimer et al. (2002), optimal chronic care is achieved when an informed, activated 
patient interacts with a prepared, proactive practice team. Further, the support of a larger network of 
health professionals has been identified as an adherence supporting factor (Reynolds, 2004). In our 
case an adherence specialization nurse and a physician at the HIV outpatient clinic, different 
community care nurses, and a social worker in town interacted with the patient. We suggest that not 
only the support of the different health care providers was important but also their collaboration and 
the coordination of interventions. In our case, it was the nurse’s role to coordinate interventions and to 
educate non-HIV specialized providers about key issues related to interaction with the patient. In 
complex clinical cases, orchestrated teamwork with broad HIV- and adherence-related knowledge and 
expertise are important issues for successful interventions. Further, teams need to be able to constantly 
evaluate and adapt their interventions to the clinical situation, since ART regimens have to be 
monitored closely. Adherence is being recognized as a dynamic behavior influenced by interrelated 
factors that change over time (Reynolds, 2004). For that, cases like Mr. Angeli’s are important 
because knowledge generated from reflection and critical review enhances the understanding of 
providers about adherence, adherence intervention, symptom management, and multidisciplinary 
collaboration. It is especially important that teams analyze such cases carefully in order to better 
understand patient behavior and provider support. 
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Zusammenfassung 
Durch die Entwicklung einer hochwirksamen antiretroviralen Kombinationstherapie der HIV Infektion 
konnte die Lebenserwartung und die Lebensqualität vieler HIV positiver Menschen im Vergleich zu 
vor 10 Jahren massgeblich verbessert werden. Diese positive Entwicklung wird dadurch 
beeinträchtigt, dass viele Betroffene nicht best möglich von der Therapie profitieren können, da eine 
Vielzahl von Faktoren dazu beitragen, dass ihre Adhärenzrate nicht im optimalen Bereich liegt. Dies 
kann unter anderem zu therapieresistenten Mutationen des Virus führen. Sowohl Ärzte und Ärztinnen, 
wie auch das Pflegefachpersonal sind deshalb gefordert, eine angepasste und wirkungsvolle 
Unterstützung mit dem Ziel einer Adhärenzverbesserung zu bieten. Evidenzbasierte Empfehlungen, 
wie solche Interventionsprogramme für die Praxis konkret aussehen sollen fehlen bislang. Diese 
Literaturzusammenfassung geht ausgehend von randomisierten kontrollierten Studien der Frage nach, 
wie Interventionsprogramme aufgebaut und welche Elemente darin enthalten sein sollen, damit die 
Adhärenz der Patienten best möglich unterstützt und gesteigert werden kann. Es zeigt sich, dass 
Interventionsprogramme wirkungsvoller sind, wenn sie verschiedene methodische Ansätze 
kombinieren und theoriebasiert sind. Für die Praxis kann empfohlen werden, den Patienten zusätzlich 
zu generalisierten Kurzinterventionen eine kontinuierliche und auf ihre jeweilige individuelle Situation 
angepasste Betreuung zukommen zu lassen.  
Abstract 
The introduction of potent antiretroviral therapy led to a reduction of HIV associated mortality and 
morbidity in industrial countries. HIV infection has changed from a lethal disease to a chronic illness 
that can be treated effectively. It can be assumed, that people who receive correct treatment now have 
a normal life expectancy. However one of the most crucial predictors to ensure the effectiveness of 
ART is a nearly perfect adherence to the medication regime. Evidence based guidelines on adherence 
intervention programs are missing so far. This literature review summarizes the evidence resulting of 
randomised controlled trials which were conducted to enhance medication adherence to antiretroviral 
therapy. It shows that effective programs need to combine several methods. Generalized short term 
interventions are easier to be tested by randomized controlled trials. However, for nursing guidelines 
we suggest long term programs which are tailored to the need of the patient.  
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Einleitung 
Die Immunschwächekrankheit HIV / AIDS war lange Zeit eine Krankheit, welche nicht effektiv 
therapiert werden konnte. Seit der Entwicklung der hochaktiven antiretroviralen 
Kombinationstherapien (Highly Active Antiretroviral Therapy [ART]) Mitte der 1990er Jahren konnte 
in Industrieländern die Mortalität bis ins Jahr 2004 um 86% gesenkt werden [1]. Unter der Behandlung 
von ART können die Betroffenen ein Absinken der Viruslast und ein Anstieg der CD4 Zellzahl 
erfahren; verbunden mit weniger Hospitalisationen und einem langsameren Fortschreiten der 
Krankheit hin zu AIDS [140, 141]. HIV / AIDS hat sich damit zu einer behandelbaren chronisch 
verlaufenden Krankheit gewandelt, mit deren Symptomen und Anforderungen die Betroffenen und 
ihre Bezugspersonen umgehen und leben lernen müssen.  
Der Erfolg der Therapie ist jedoch nicht ohne Vorbehalte garantiert und kann z.B. durch 
Medikamentenresistenzen limitiert werden. Diese entstehen durch ungenügende Wirkstoffspiegel, 
welche unter anderem durch Interaktionen und Malabsorptionen der Medikamente verursacht werden 
und deshalb von Patient zu Patient3 variieren. Einer der wichtigsten Einflussfaktoren auf den 
Wirkstoffspiegel stellt die Therapietreue der Patienten (im Folgenden Adhärenz4 genannt) dar, indem 
dieser schon durch die kleinste Abweichung vom verordneten Regime absinken kann [44, 141, 143, 
144]. Eine ungenügende Adhärenzrate hat damit aber nicht nur negative Auswirkungen auf das 
Individuum, sondern ebenso auf die Epidemie als Ganzes, da vermehrt Übertragungen mit 
teilresistenten HIV Viren stattfinden.  
Trotz der ernst zu nehmenden Auswirkungen einer mangelhaften Therapiebefolgung, ist der   Anteil 
von Patienten, welche eine Adhärenzrate von 95% nicht erreichen in der HIV Population hoch. Je 
nach Definition und Messmethode liegt er zwischen 20% und 50% [142]. In der Schweiz konnte 
mittels einer Erhebung mit einem Fragebogen gezeigt werden, dass 31.1% der Patienten mindestens 
eine Medikamenteneinnahme im Monat vergessen [145].  
Die Gründe für eine mangelhafte Adhärenz sind mannigfaltig. Eine grosse Anzahl Studien untersuchte 
im Verlauf der letzten Jahre Faktoren, die Einfluss auf das Adhärenzverhalten der HIV Patienten 
ausüben [6, 146, 147]. Analog dem WHO Schema [142] finden sich verschiedene patienten-, sowie 
therapie- und krankheitsbezogene Faktoren, welche stark negativ mit der Adhärenz korrelieren, wie 
z.B. ein fehlender Glaube in die Therapie, Depression, aktiver Drogen- und Alkoholkonsum, die 
Komplexität der Therapie oder unerwünschte kurz- und langfristige Arzneimittelwirkungen [120, 140, 
148-154]. Positiv mit der Adhärenzrate korrelieren ein gutes Verhältnis zwischen dem Patienten und 
                                                     
3
 Im Text wird die männliche Form ‚Patient’ stellvertretend für beide Geschlechter verwendet. 
4
 Die World Health Organisation 142. WHO, Adherence to long-term therapies. Evidence for 
action. 2003. definiert Adhärenz als „das Ausmass, mit welchem das Verhalten eines Patienten mit den 
Empfehlungen übereinstimmt, die er von einer Person aus dem Gesundheitsbereich erhalten und mit denen er 
sich einverstanden erklärt hat.“ (WHO 2003). 
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dem Arzt / dem Betreuungsteam, sowie regelmässige Nachkontrollen. Klare Instruktionen zur 
Verwaltung der Medikamente und Wissen zur Krankheit und zum Zusammenspiel von Adhärenz und 
Krankheitsverlauf sind ebenfalls Faktoren, welche signifikant  positiv mit der Adhärenz korrelieren 
[155, 156]. Sozioökonomische Faktoren, wie z.B. Alter, Geschlecht, Einkommen oder Bildungsstand 
zeigen dagegen in den verschiedenen Studien keine konstante Korrelation mit der Adhärenz [6, 155]. 
Heute, 10 Jahre nach der Entwicklung von ART, liegt der Fokus vieler Beteiligten weniger auf der 
Untersuchung der Einflussfaktoren als vielmehr auf der Entwicklung wirkungsvoller 
Interventionsprogramme, welche zum Ziel haben, die Patienten bei der regelmässigen und korrekten 
Einnahme der Medikamente zu unterstützen und so eine hohe Adhärenzrate zu gewährleisten. Viele 
dieser Programme sind dabei explizit auf die oben beschriebenen Einflussfaktoren der Adhärenz 
ausgerichtet. Im Verlauf der letzten Jahre wurden mittels experimenteller randomisierter Studien 
diverse Interventionsprogramme wissenschaftlich getestet. Diese Literaturzusammenfassung will eine 
Übersicht über die Ergebnisse solcher publizierter Interventionsprogramme und deren Implikationen 
für die Praxis geben. Die Frage, welcher dabei nachgegangen wird, lautet: „Welche Interventionen 
bewirken eine Verbesserung der Adhärenz von HIV Patienten unter ART?“  
Literatursuche 
Um diese Suchfrage beantworten zu können, wurde von April bis August 2005 die nachfolgend 
beschriebene Literatursuche durchgeführt. Die Artikel wurden anhand folgender Einschlusskriterien 
ausgewählt: 
 Die Probanden sind erwachsene HIV Patienten, die mit ART therapiert werden 
 Der Publikationstyp ist entweder eine kontrollierte experimentelle Interventionsstudie 
(randomized controlled trial [RCT]) mit dem Ziel einer Adhärenz- Steigerung 
(Primärliteratur) oder eine Literaturzusammenfassung (Review) solcher 
Interventionsstudien.  
Der Grund für die Einschlusskriterien liegt darin, dass bei diesen das höchste Evidenzniveau erwartet 
werden kann. Metaanalysen sind bezüglich der formulierten Zielfrage keine vorhanden. 
Ausgeschlossen wurden Machbarkeitsstudien und Pilotstudien. 
Die Literatur-Suche wurde auf den Suchmaschinen PubMed / MEDLINE, PsychINFO und der 
Cochrane Library durchgeführt, wobei sich auf PsychINFO keine Artikel fanden und die Cochrane 
Library nur eine Review als Ergebnis lieferte. Als Suchbegriffe verwendet wurde HIV, 
ADHERENCE, COMPLIANCE und INTERVENTION. Die Suche mit den Stichworten HIV + 
INTERVENTION + ADHERENCE OR COMPLIANCE auf PubMed ergab 65558 Resultate, weshalb 
die Suche in Kombination mit Compliance rsp. Adherence einzeln durchgeführt wurde: HIV + 
INTERVENTION + COMPLIANCE ergab 175 Resultate, wobei bei inhaltlicher Durchsicht 
festgestellt wurde, dass es sich fast nur um unerwünschte Titel handelte, da sie sich vor allem auf die 
Wirksamkeit von Wirkstoffen konzentrierten. Die Suche nach HIV + INTERVENTION + 
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ADHERENCE dagegen zeigte 151 Resultate, welche  gemäss der oben genannten Einschlusskriterien 
gesichtet wurden. Insgesamt fanden sich in der Literatursuche 13 RCTs und vier Reviews. 
Da die Autorinnen in einem Verb und von Interessenten betreffend der Problematik der Adhärenz von 
HIV Patienten sind, wurden sie auf eine weitere Literaturzusammenfassung von Simoni, Frick, 
Pantalone und Turner [157] aufmerksam gemacht, welche in Form eines Buchkapitels veröffentlicht 
worden ist. In dieser Review haben Simoni et al. ihre  vorhergehende Literaturzusammenfassung vom 
Jahr 2003 bis zum Januar 2005 aufdatierten. Da diese Review ebenfalls den Suchkriterien entsprach, 
wurde sie zusätzlich in die Ergebnisse mit einbezogen. Es zeigte sich, dass die von uns gefundenen 
RCTs bis auf einer später erschienenen Studie alle in dieser Review aufgeführt wurden.  
Beschreibung der Studien 
Nachfolgend werden die Resultate aus der Literatur-Suche beschrieben, welche in ausführlicherer 
Form in der Tabelle 1 dargestellt sind.  
Die fünf Reviews und die darin beschriebenen Interventionsprogramme werden in chronologischer 
Abfolge dargestellt und anschliessend  durch die aktuellere Interventionsstudie ergänzt. Nebst dem 
gesuchten Effekt auf die Adhärenz wird jeweils auch angegeben, ob gleichzeitig eine signifikante 
Verbesserung der klinischen Werte, wie z.B. eine Reduktion der Viruslast oder ein Anstieg der CD4+ 
Zellzahl vermerkt werden konnte. Diese klinischen Parameter wurden in den meisten Studien nebst 
der Adhärenzrate als zweite Outcome-Variabel erhoben.  
Haddad, Inch, Glazier, Wilkins, Urbshott, Bayoumi & Rourke [158] beschreiben nebst sechs 
Kurzbeschreibungen als einzige publizierte Studie diejenige von Knobel, Carmona, Lopez, Gimeno, 
Saballs, Gonzalez, Guelar & Diez [159]. Dabei wurde in einem durch Pharmazeuten geleiteten RCT 
versucht, mittels Schulungen und telefonischer Nachbetreuung die Adhärenz der Patienten zu steigern. 
Die Adhärenzrate unterschied sich signifikant zwischen den beiden Gruppen, während aber die 
Unterschiede in der Viruslast nicht signifikant waren. Die Literaturzusammenfassung von Fogarty et 
al. [146] stellt 16 Interventionsprogramme vor, von welchen die einzigen vier publizierten RCTs erst 
als Pilotstudien vorlagen. Lediglich eine dieser Pilotstudien wies einen signifikanten Effekt auf die 
Adhärenz auf, welcher allerdings nur temporär anhaltend war [160]. Eine weitere 
Literaturzusammenfassung beschreibt RCTs, welche bis 2002 publiziert oder an der internationalen 
AIDS Konferenz in Barcelona im Juli 2002 vorgestellt worden waren [161]. Darin werden die drei 
publizierten Artikel  von Knobel et al. (1999), Tuldra, Fumaz, Ferrer, Bayes, Arno, Balague, Bonjoch, 
Jou, Negredo, Paredes, Ruiz, Romeu, Sirera, Tural, Burger & Clotet et al. [162]  und Rigsby, Rosen, 
Beauvais, Cramer, Rainey, O'Malley, Dieckhaus & Rounsaville [163], sowie vier RCTs aus der 
Konferenz vorgestellt. Die Intervention in der Studie von Tuldra et al. (2000) war psychoedukativer 
Art und bestand aus vier Behandlungen. Nach 48 Wochen erreichten 94% der Teilnehmer der 
Interventionsgruppe eine Adhärenzrate von mindestens 95%, während dies in der Kontrollgruppe nur 
69% waren. Die Teilnehmer der Interventionsgruppe zeigten auch eine tiefere Viruslast. Die 
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Unterschiede in der Adhärenz erreichten jedoch nicht statistische Signifikanz. Rigsby et al., (2000) 
führten eine Intervention durch, bei welcher die Patienten angeleitet wurden, ihre Medikamente an 
eine fixe Aktivität zu koppeln (cue dose training), mit dem Ziel weniger Einnahmen zu vergessen. 
Dabei erhielt eine Gruppe zusätzlich eine monetäre Entlöhnung, wenn die Adhärenzrate zufrieden 
stellend war. Resultat: Nur die Gruppe mit der zusätzlichen Entlöhnung zeigte eine signifikant erhöhte 
Adhärenz, welche in einer späteren Kontrollmessung ebenfalls nicht mehr nachgewiesen werden 
konnte. 
Die aktuellsten Reviews sind diejenigen von Simoni, Frick, Pantalone & Turner [164] und (2005), 
welche die vorhergehenden Reviews bis zum Januar 2005 aufdatieren und auch nach laufenden 
Studien suchen, welche durch den amerikanischen Nationalfonds unterstützt werden. In der 
Literaturzusammenfassung von 2003 finden sie nebst den bereits erwähnten drei Reviews 21 
publizierte Studien und 39 laufende Studien. Unter den publizierten Studien  befinden sich eine 
Pilotstudie und vier weitere RCTs: Das Kurzinterventionsprogramm von Safren, Otto, Worth, 
Salomon, Johnson, Mayer & Boswell [165] enthielt lediglich eine Einzellektion,  basierend auf 
kognitiver und verhaltensorientierter Therapie und auf Techniken der motivierenden 
Gesprächsführung. Die Interventionsgruppe erfuhr einen anhaltenden, signifikanten Adhärenzanstieg. 
In einer weiteren Studie wurden die Probanden der Interventionsgruppe häufiger über ihre HIV-1 
RNA Werte informiert als diejenigen der Kontrollgruppe [166]. Diese Intervention zeigte keinen 
Effekt auf das Adhärenz Verhalten. Mann [167] wählte für seine Interventionsstudie einen 
gefühlsorientierten Ansatz: die Teilnehmer wurden aufgefordert, zwei Mal pro Tag positive Gedanken 
bezüglich der Zukunft und ihrer Therapie aufzuschreiben. Diese Studie zeigte ebenfalls keine 
signifikanten Ergebnisse. 
In der aufdatierten Review von Simoni et al. [157] finden sich bereits 15 RCTs, darunter drei 
Pilotstudien, und 51 laufende Studien, was deutlich aufzeigt, wie stark das Interesse an dieser Frage 
innerhalb  dieses Zeitraumes zugenommen hatte. Smith, Rublein, Marcus, Brock und Chesney [168] 
führten mit 43 Probanden eine kontrollierte randomisierte Intervention durch, welche eine 
Entwicklung von Fertigkeiten in den Bereichen Zielsetzung, Selbstkontrolle, Selbstbelohnung und 
soziale Unterstützung enthielt und während drei Monaten je eine Visite beinhaltete. Die Intervention 
zeigte zwar, dass die Probanden im Vergleich zur Kontrollgruppe eine höhere Selbstwirksamkeit5 
entwickeln konnten und eine signifikant höhere Adhärenzrate hatten; die beiden Gruppen 
unterschieden sich in der Viruslast jedoch nicht signifikant. Die Studie ist unter anderem auch deshalb 
interessant und wegweisend, weil die Entwicklung des Interventionsprogrammes theoriebasiert 
erfolgte indem sie sich auf die ‚social cognitive theory’ stützt [170]. Goujard, Bernard, Sohier, 
                                                     
5
  Mit dem Begriff der Selbstwirksamkeit (self-efficacy) bezeichnet man die individuelle Überzeugung,  
dass man in einer bestimmten Situation die angemessene Leistung erbringen kann 169. Bandura, A., Social 
foundations of thougt and action: A social cognitive theory. 1986, NJ: Prentice Hall: Englewood Cliffs.. 
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Peyramond, Lancon, Chwalow, Arnould & Delfraissy [171] führten ein Schulungsprogramm durch, 
welches auf das Wissen der Patienten und den organisatorischen Umgang mit der Therapie 
(Erinnerungshilfen, Medikamentendispenser,...) gerichtet war. Die Resultate zeigten eine 
Verbesserung der Adhärenz und der Gesundheitssituation, nicht jedoch einen signifikanten 
Unterschied in den klinischen Werten zwischen Interventions- und Kontrollgruppe. Rawlings, 
Thompson, Farthing, Brown, Racine, Scott, Crawford, Goodwin, Tolson, Williams & Shaefer [172] 
beschreiben eine aufwändige Schulung mit 11 Modulen, die sowohl die Patienten, wie auch deren 
Bezugspersonen besuchten (Bestärkung zur Zielerreichung mit Wissensvermittlung und Vermittlung 
von Fähigkeiten zur Verbesserung von Selbstpflege, Adhärenz, Lebensqualität und Zufriedenheit). Die 
Studie konnte keinen Unterschied zwischen Interventions- und Kontrollgruppe aufzeigen, weder in der 
Adhärenzrate noch in den klinischen Werten. Auch in der Studie von Pradier, Bentz, Spire, Tourette-
Turgis, Morin, Souville, Rebillon, Fuzibet, Pesce, Dellamonica & Moatti [173] wurde der 
Interventionsgruppe empathische individuelle Beratung und Schulung zuteil, die das Gefühl der 
Selbstwirksamkeit stärken sollte. Die Interventionsgruppe zeigte in der Nachkontrolle einen anhaltend 
höheren Anteil an adhärenten Patienten und eine signifikante Abnahme der Viruslast. In einer anderen 
Studie wurde ein Pager als Erinnerungshilfe für die Medikamenteneinnahem eingesetzt. Auch hier 
zeigte sich eine signifikante Adhärenz Steigerung in der Interventionsgruppe [174]. In zehn 
Gruppenlektionen wurde in der Studie von Jones, Ishii, LaPerriere, Stanley, Antoni, Ironson, 
Schneiderman, Van Splunteren, Cassells, Alexander, Gousse, Vaughn, Brondolo, Tobin & Weiss 
[175] durch Therapeuten Stressmanagement und Ausdruckstherapie vermittelt. Die Kontrollgruppe 
erhielt eine ähnliche Schulung mittels Video-Lektionen. Es konnten keine signifikanten 
Gruppenunterschiede erkannt werden. 
Ergänzend wird noch die Studie von Remien, Stirratt, Dolezal, Dognin, Wagner, Carballo-Dieguez, 
El-Bassel & Jung [132] beschrieben, die wir in unserer Literatursuche zusätzlich gefunden haben. 
Diese führten eine paarfokussierte Intervention durch und verwendete das von ihnen entwickelte 
SMART Programm (sharing medical Adherence Responsibility together), welches auf der social 
action theory von Ewart, (1991) basiert. Es beinhaltet Schulungen zum Wissen über die Krankheit und 
die Therapie und soll dazu dienen, Schwierigkeiten in der Befolgung der Therapie aufzudecken und 
Strategien zur Problemlösung und Kommunikation zwischen dem Patienten und seiner Bezugsperson 
zu entwickeln, mit dem Ziel einer optimierten Unterstützung durch den Partner und einem erhöhten 
Vertrauen in die Selbstwirksamkeit. Es konnte zwar eine Adhärenz-Steigerung ausgemacht werden, 
die Adhärenzrate lag aber weiterhin im suboptimalen Bereich und fiel in den Nachkontrollen nach drei 
und sechs Monaten wieder ab.  
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Stichprobe Intervention Resultate 
Knobel et al., 
1999 
Patienten aus Barcelona mit einer 
Viruslast >5'000 und CD4 Zahl < 200 
N=170 
Gruppe 1: Eine Einzellektion mit einem Pharmazeuten welcher ein 
individuelles Assessment durchführte und Ratschläge abgab und 
telefonische Unterstützung anbot n=60 
Gruppe 2: Kontrollgruppe mit Standardbetreuung n=110 
Nachkontrolle nach 24 Wochen: 
- Adhärenzrate über 90% bei 77% der Teilnehmer 
von Gruppe 1 gegenüber 53% in Gruppe 2 p<.002 
- Keine Gruppenunterschiede bezüglich einer 
nicht nachweisbaren Viruslast 
Tuldra et al., 
2000 
Konsekutive Patienten, welche die 
erste oder zweite antiretrovirale 
Behandlung begonnen 
N=116 
Gruppe 1: eine Einzellektion durch einen Psychologen über die 
Wichtigkeit von Adhärenz und darüber, wie ausgehend von der 
Selbstwirksamkeits- Theorie mit Problemen bezüglich der Adhärenz 
umgegangen werden kann. Bei den nachfolgenden Sitzungen nach 4, 24 
und 48 Wochen wurde die Adhärenz erneut betont und es wurden 
spezifische Probleme angegangen n=55 
Gruppe 2: Kontrollgruppe mit Standardbetreuung n=61 
Nachkontrolle nach 48 Wochen (N=70): 
- 94% der Gruppe 1 erreichten eine selbst 
rapportierte Adhärenz Rate von mindestens 95%, 
gegenüber 69% in der Gruppe 2 
- 89% der Gruppe 1 zeigten HIV-1 RNA Levels 
von höchstens 400 Stk/ml, gegenüber 66% in der 
Gruppe 2 
Rigsby et al., 
2000 
Hauptsächlich männliche Afro 
Amerikaner mit vorgängigem 
Drogenkonsum aus West Haven und 
Hartford, CT 
N=55 
Während einem Monat jede Woche eine Lektion über: 
Gruppe 1: Durch einen Berater geführte cue dose Trainings (Patienten 
stellten tägliche Hilfestellungen auf, die sie an die 
Medikamenteneinnahme erinnern) und Rückmeldungen der EEM6 
Messung n=22 
Gruppe 2: Dasselbe plus eine wöchentliche monetäre Belohnung für 
zeitlich korrekte Medikamentenflaschenöffnungen 
Gruppe 3: Kontrollgruppe, mit Ermutigung bezüglich der Adhärenz.  
- Während der Intervention (Woche 0 bis 4) zeigte 
nur die Gruppe 2 eine höhere Adhärenz im 
Vergleich zur Kontrollgruppe 
- In den Nachkontrollen (Woche 5 bis 12) zeigte 
die Gruppe 2 einen signifikanten Adhärenz 
Rückgang im Vergleich zur Kontrollgruppe 
(Gruppe 1 nicht) 
Haubrich et 
al., 2001 
Vorwiegend Patienten mit geringem 
Einkommen von fünf der Universität 
angegliederten HIV Kliniken in 
Kalifornien 
N=206 
Gruppe 1: während einem Jahr alle zwei Monate Rückmeldung zu den 
HIV-1 RNA Werten 
Gruppe 2: halbjährliche Rückmeldungen dazu 
- Es konnten keine signifikanten Unterschiede in 
der selbst rapportierten Adhärenz und der CD4 
Zahl zwischen den Gruppen beobachtet werden 
- Gruppe 1 wies im Vergleich mit der Gruppe 2 
eine signifikant grössere Reduktion der Viruslast 
auf (p=.003) 
                                                     
6
 electronic event monitoring (EEM) ist eine Messmethode der Adhärenz 
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Stichprobe Intervention Resultate 
Mann, 2001 Multiethnische Frauen mit tiefem 
sozioökonomischem Status (40% 
Afro Amerikanerinnen, 35% 
Hispanic) 
N=44 
Gruppe 1: Pro Tag mindestens zwei Mal je 10 Minuten über das Thema 
„eine positive Zukunft, in welcher ich zur Behandlung von HIV täglich 
nur eine Tablette einnehmen muss“ schreiben n=21 
Gruppe 2: Keine Schreibübung n=23 
Nachkontrolle nach 4 Wochen:  
- diejenigen Probanden mit tiefer Adhärenz 
zeigten einen (nicht signifikanten) Trend Richtung 
einer höheren Adhärenz, während die Probanden 
mit hoher Ausgangsadhärenz eine 
Verschlechterung der Adhärenzrate zeigten. 
Safren et al., 
2001 
Patienten aus der Gemeindepflege in 
Boston, welche als gefährdet 
angesehen werden für eine Non-
Adhärenz weil sie entweder einen 
Therapiestart oder eine  
–änderung erlebten oder in der Visite 
in den letzten zwei Wochen vor dem 
Einschluss eine Adhärenz von 
weniger als 100% rapportierten N=56  
Gruppe 1: Eine Einzellektion durch einen Arzt oder via Videoband 
basierend auf kognitiver und verhaltensorientierter Therapie, 
Problemlösungsstrategien und Techniken aus der motivierenden 
Gesprächsführung und einer telefonischen Nachbetreuung nach einer 
Woche n=30 
Gruppe 2: Minimaler Kontakt während zwei Wochen und Selbstkontrolle 
durch ein Medikamententagebuch n=26 
Nachkontrolle nach zwei Wochen: 
- Gruppe 1 rapportierte einen signifikanten 
Anstieg der Adhärenz seit den Ausgangsdaten 
(von 74% auf 95%), während in der Gruppe 2 eine 
minimale Zunahme von 84% auf 90% stattfand. 
Nachkontrolle nach 12 Wochen: 
Die Adhärenzraten waren konstant gegenüber 
Woche 2 
Goujard et 
al., 2003 
 
Patienten aus verschiedene Kliniken 
in Frankreich,  
N=367 
Gruppe 1: Ärzte und Pflegefachpersonal mit speziellem 
Vorbereitungstraining entwickeln eine individuellen Schulungsplan, 
basierend auf den persönlichen Schwierigkeiten bezüglich der Adhärenz, 
bestehend aus einer Zeitplanung mit Aufkleber, drei einstündigen 
Schulungslektionen und einem Medikamentendispenser. N=188 
Gruppe 2: Kontrollgruppe n=179 
Nachkontrolle nach 6 Monaten: 
Die Teilnehmer der Interventionsgruppe zeigten 
eine signifikante Zunahme der Adhärenz zwischen 
Ausgangsmessung und sechs Monaten, welche 
nach 12 und 18 Monaten beibehalten wurde. 
- Keine direkte Auswirkung auf die Viruslast oder 
CD4 Zahl. 
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Stichprobe Intervention Resultate 
Jones et al., 
2003 
Multiethnische Teilnehmerinnen 
(54% Afro Amerikaner, 18% 
Hispanics) aus Florida, New York und 
New Yersey 
N= 174 
Gruppe 1: Zehn Gruppen-Lektionen mit Therapeuten über kognitives und 
verhaltensorientiertes Stressmanagement und unterstützende 
Ausdruckstherapie n=92 
Gruppe 2: Video-Lektionen mit ähnlichem Inhalt, aufgeteilt in  10 
Lektionen à 45 Minuten Schulung und 75 Minuten Unterhaltung n=82 
Nachkontrolle nach 15 Monaten: 
- keine signifikante Unterschiede in der Adhärenz 
zwischen den Gruppen 
- Diejenigen mit sehr tiefer Adhärenz zeigten in 
beiden Gruppen nach der Intervention eine 
Adhärenz-Zunahme von 0-40% (Gruppe 1 p<.001 
und Gruppe 2 p<.01) 
Pradier et al., 
2003 
Patienten unter HAART welche in 
eine medizinische Nachkontrolle am 
Universitätsspital von Nizza kamen. 
N=246 
Gruppe 1: dreimalige Einzellektion mit einer Pflegefachperson mit 
individueller Beratung und Schulung basierend auf motivierender 
Psychologie und patientenzentrierte emphatische Therapie mit dem Ziel, 
das Gefühl der Selbstwirksamkeit und weitere Fähigkeiten zu steigern 
n=124 
Gruppe 2: Kontrollgruppe mit Standardbetreuung n=122 
Nachkontrolle nach 6 Monaten: 
- Gruppe 1 zeigte einen signifikant höheren Anteil 
an adhärenten Patienten und eine signifikante 
Abnahme der Viruslast 
- Zwischen den Gruppen zeigte sich kein 
Unterschied in der nicht nachweisbaren Viruslast 
Rawlings et 
al., 2003 
HIV positive Frauen mit einer 
nachweisbaren Viruslast, rekrutiert 
aus 25 Kliniken 
N=195 
Gruppe 1: Vier vorgegebene Module zu Schulung und Beratung mit 
Patientinnen und deren persönlichen Bezugspersonen plus 
Standardberatung betreffend Adhärenz durch einen 
Gesundheitsfachperson (health care provider)  n=96 
Gruppe 2: einfache Standardberatung betreffend Adhärenz n=99 
Nachkontrolle nach 20 Wochen: 
- Kein Unterschied zwischen den beiden Gruppen 
zu keinem Zeitpunkt, weder in der selbst 
rapportierten noch in der durch EEM erhobenen 
Messung 
- Keine Unterschiede in virologischen Indikatoren 
beobachtet 
Smith et al., 
2003 
Patienten einer Klinik in North 
Carolina, welche einen Therapiestart 
oder –wechsel erlebten 
N=43 
Gruppe 1: Individuell gestaltetes Schulungsprogramm und Training von 
Fähigkeiten, durch eine Pflegefachperson oder einen Pharmazeuten in 
vier Sitzungen. Das Programm enthielt Informationenaustausch , 
Entwicklung von Fähigkeiten, Selbstkontrolle, Setzen von Zielen und 
soziale Unterstützung und Selbstbelohnungen n=22 
Gruppe 2: Kontrollgruppe mit Standardtherapie n=21 
Nachkontrolle nach 12 Wochen: 
- Gruppe 1 zeigte erhöhte und höhere 
Adhärenzwerte an als die Kontrollgruppe 
(p<.0017) 
- Bezüglich der virologischen Indikatoren konnten 
keine Gruppenunterschiede festgestellt werden 
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Stichprobe Intervention Resultate 
Safren et al., 
2003 
Patienten aus der Gemeindepflege in 
Boston, USA, welche in der 
zweiwöchigen Adhärenz-Messung mit 
EEM eine Adhärenzrate von weniger 
als 90% aufwiesen 
N=44 
Gruppe 1: Nachrichtensystem via Pager als Erinnerungshilfe für die 
Medikamenteneinnahme, die Mahlzeiten und die Arzttermine und EEM 
Messung ohne Rückmeldung n=34 
Gruppe 2: Nur EEM Messung n=36 
Am Ende der 12 wöchigen Intervention zeigte die 
Gruppe 1 eine signifikant höhere Verbesserung in 
der durch EEM gemessenen Adhärenz als die 
Gruppe 2 (p<.004) 
Remien et al., 
2005 
Patienten von zwei ambulanten 
Kliniken in NY mit weniger als 80% 
Adhärenz und ihre Partner 
N=215 
Gruppe 1: Vier Lektionen à 45-60 min innerhalb von 5 Wochen durch 
eine Pflegende mit dem selbst entwickelten Programm „sharing medical 
Adherence Responsibilities together” (SMART), basierend auf Ewart’s 
social action theory. Das Programm beinhaltete Schulung über Therapie 
und Adhärenz, das Finden von Hindernissen bezügl. dem Erreichen einer 
guten Adhärenz, das Entwickeln von Kommunikations- und 
Problemlösungsstrategien, die Optimierung der Unterstützung durch den 
Partner und der Aufbau einer Zuversicht in das Erreichen einer optimalen 
Adhärenz 
n=106 
Gruppe 2: Kontrollgruppe mit Standardtherapie 
n=109 
Nachkontrolle nach 8 Wochen (zwei Wochen 
nach Intervention):  
- signifikant höhere Adhärenz in Gruppe 1,sowohl 
bezüglich der eingenommenen Dosen wie auch 
der zeitlichen Adhärenz, jedoch immer noch im 
suboptimalen Bereich 
Nachkontrollen nach drei und sechs Monaten: 
- kein nachweisbarer Effekt mehr  
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Zusammenfassung der Resultate 
Die oben aufgeführten Interventionsprogramme werden nachfolgend bezüglich Methodologie,  
Interventionslänge und –ansatz (Einzel-, Paar-, Gruppensitzung) und dem Inhalt des 
Interventionsprogramms vergleichend dargestellt. 
Methodologie 
Die Zahl der Probanden in den Interventionsgruppen ist durchschnittlich 67, mit 21 als kleinste und 
188 als grösste Anzahl. Sie ist vor allem in den früheren Studien häufig kleiner als 60 Personen, was 
die Erreichung einer statistisch genügend grossen Teststärke erschwert.  
Die angewendeten Messmethoden zur Erhebung der Adhärenz sind je nach Studien unterschiedlich. 
Die Adhärenz wird sowohl elektronisch gemessen, was zurzeit als zuverlässigste Messmethode 
angesehen wird, wie auch durch Zählung der verbliebenen Anzahl Tablette bei der Arztvisite oder 
durch Fragebogen, welche sich wiederum im Umfang und dem Inhalt der Fragen stark unterscheiden. 
Der unterschiedliche Validitätsgrad der verschiedenen Messmethoden, welcher sich in verschieden 
hoher Sensitivität und Spezifität äussert, hat eine erhebliche Auswirkung auf die erhobene 
Adhärenzrate. Eine Vergleichbarkeit der Studien wird dadurch erschwert. Positiv ist zu vermerken, 
dass mit Ausnahme von Safren et al., 2003 bei allen Interventionsstudien regelmässige Nachkontrollen  
bis zu einem Jahr nach der Intervention statt fanden. Von den Studien, welche signifikante Effekte 
nachweisen konnten, waren die Nachkontrollen frühestens nach drei Monaten erfolgt. Bei dieser 
Zeitspanne kann man davon ausgehen, dass der Effekt längerfristig anhaltend ist. 
Anzahl Sitzungen 
Die Interventionsdauer unterscheidet sich in den verschiedenen Studien mit einer Spannbreite von 
einer bis zu mehr als 10 Sitzungen erheblich. Signifikante Erfolge verzeichneten dabei sowohl 
Kurzinterventionsprogramme von nur einer Sitzung, wie auch Programme mit zwei bis fünf 
Sitzungen. Von den drei Studien, welche mehr als fünf Sitzungen beinhalteten, wies allerdings keine 
einen signifikanten Effekt auf. Dies steht möglicherweise mit den Interventionsprogrammen in 
Zusammenhang: Die eine Intervention ist rein kognitiver Art; die anderen basieren auf  
standardisierten Schulungsprogrammen, in welchen kaum individuell angepasste Inhalte vermittelt 
werden können (Jones et al., 2003; Haubrich et al., 2001).  
Ansatz der Intervention 
Bei 10 der 13 Studien wurde das Programm einzig mit dem Patienten selbst durchgeführt; davon 
konnte in sieben eine signifikante Adhärenz-Steigerung nachgewiesen werden. Die beiden 
Programme, in welchen die Partner mit einbezogen wurden, wie auch die Gruppenintervention zeigten 
keinen, rsp nur einen kurzfristigen Erfolg. Dies kann wiederum damit zusammen hängen, dass bei 
zwei Studien ein generalisiertes Programm angeboten wurde, wodurch möglicherweise nicht 
genügend auf die jeweiligen Bedürfnisse der Probanden oder der Paare eingegangen werden konnte 
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(Jones et al., 2003; Remien et al., 2005). Darüber hinaus kann der Erfolg des Programms auch davon 
abhängen, wie gut die Intervention auf die spezifischen Charakteristika der jeweiligen Population der 
Probanden abgestimmt ist  (Rawlings et al., 2003).  
Art der Intervention 
Insgesamt sind nur zwei der 13 Studien umfassend theoriegeleitet ausgearbeitet worden. Bei den 
anderen ist die Entwicklung der Intervention mangelhaft bis gar nicht beschrieben, obwohl diese 
häufig Elemente aus verschiedenen Modellen verwenden, wie z.B. die Selbstwirksamkeit oder die 
motivierende Gesprächsführung.  
Bezüglich der Inhalte der Interventionsprogramme lässt sich die Entwicklungstendenz der letzen Jahre 
folgendermassen beschreiben: Während von den ersten Interventionsprogrammen bis 2001 die Hälfte 
relativ einfach konzipiert waren und beispielsweise ausschliesslich auf kognitiven oder emotionalen 
Inhalten basierten, weisen die neueren Programme ab 2001 in fünf von sieben Programmen einen 
breiten Ansatz auf, indem sie kognitive und verhaltensorientierte Schulung kombinierten. Es fällt auf, 
dass Interventionen, die verschiedene Ansätze kombinierten und auf eine Verhaltensänderung 
hinzielten häufiger zu einer signifikanten Adhärenz-Steigerung führten. Im weiteren lassen sich die 
Studien hinsichtlich dem Kriterium vergleichen, ob das Interventionsprogramm standardisiert oder 
individuell konzipiert ist: Von den acht Studien, welche ein individuell angepasstes Programm allein 
oder kombiniert mit standardisierten Inhalten anboten, zeigten sechs signifikante Erfolge bezüglich 
eines Adhärenz-Anstieges, während bei den standardisierten Programmen nur eines von fünf einen 
signifikanten Effekt aufweisen konnte.   
Schlussfolgerung und Empfehlung 
Die Adhärenz ist einer der wesentlichsten Einflussfaktoren einer erfolgreichen antiretroviralen 
Therapie. Die Pflegefachpersonen und Ärzte sind deshalb gefordert, den Patienten eine angepasste und 
wirkungsvolle Unterstützung mit dem Ziel einer Adhärenz Verbesserung zu bieten. Eine 
evidenzbasierte Empfehlung, wie solche Interventionsprogramme konkret aussehen sollen, fehlt 
jedoch bislang. Die hier beschriebenen randomisierten kontrollierten Studien zeigen  Tendenzen auf, 
welche wichtige Hinweise für die Planung zukünftiger Praxisprogramme liefern. Der Nutzen der 
RCTs in Bezug auf die klinische Umsetzung, wie auch deren Limiten werden nachfolgend diskutiert. 
Wie eingangs dargestellt wurde, handelt es sich bei der Adhärenz um ein komplexes Phänomen, 
welches vielen Einflussfaktoren unterliegt. Die Entwicklung der letzten Jahre zeigt, dass die ersten 
Interventionsprogramme dieser Komplexität zu wenig Rechnung trugen, indem sie sich primär auf den 
Patienten und kaum auf sein Umfeld konzentrierten und vor allem Interventionen im psychologischen 
und kognitiv-verhaltensorientierten Bereich anwendeten, wobei die Ansätze selten kombiniert wurden. 
In den letzten Jahren wurden die Interventionsprogramme zunehmend komplexer: Es wurden vermehrt 
individuell angepasste Programme angeboten, die kognitive und verhaltensorientierte Schulung 
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kombinieren. Sie sind jedoch nach wie vor stark auf den Patienten ausgerichtet und kaum auf die 
weiteren Einflussfaktoren der Adhärenz wie sie die WHO (2003) formuliert hat. Angesichts der 
wichtigen Rolle, welche die soziale Unterstützung in einer effektiven Adhärenz-Erhaltung spielt, sollte 
bei zukünftigen Studien insbesondere vermehrt Augenmerk auf die fachliche Betreuung durch das 
Gesundheitspersonal und die soziale Unterstützung durch private Bezugspersonen gelegt werden.  
In den Resultaten zeigt sich die Tendenz, dass Studien, die auf einem Modell basieren der 
Multidimensionalität besser Rechnung tragen und auch erfolgsversprechende Resultate 
zeigen. Dies kommt daher, weil die Adhärenz hierbei als Verhaltensänderung verstanden 
wird, die in engem Zusammenspiel mit Aspekten wie z.B. der Selbstwirksamkeit und 
Motivation steht, welche entsprechend ins Interventionsprogramm integriert werden. Bei der 
Mehrzahl der oben beschriebenen Studien liegt dem Interventionsprogramm aber kein 
theoretisches Modell zu Grunde, was als deutliches Manko bezeichnet werden kann und bei 
der Planung zukünftigen Studien beachtet werden soll. 
Bezüglich der Interventionsdauer ist auffallend, dass komplexe Programme nicht nur bei 
Interventionen über einen längeren Zeitraum hinweg, sondern bereits in Form von Einzellektionen 
signifikante Effekte auslösen können. Ausgehend von den Resultaten könnte vermutet werden, dass 
Kurzinterventionen durchaus wirkungsvoll sein können, wenn sie in Form von generalisierten 
Programmen durchgeführt werden (Schulungen im Plenum, etc), während längerfristige 
Interventionen gezielt auf den individuellen Patienten zugeschnitten sein müssen, um seinen 
Bedürfnissen gerecht zu werden und ihn in seiner Verhaltensänderung angepasst und best möglich 
begleiten zu können. 
Die beschriebene Tendenz in Richtung breit angelegter und individualisierter Programme die sich 
nach Sichtung der Studien zeigt, stimmt mit Schlussfolgerungen aus allgemeiner Literatur zu 
Adhärenz überein: Haynes, Montague, Oliver, McKibbon, Brouwers & Kanani  [176] beschreiben in 
einer umfassenden Review, dass Wissensvermittlung zwar ein notwendiger Bestandteil eines 
erfolgreichen Adhärenz-Programms ist, die Schulungen alleine jedoch nicht genügen, um eine 
anhaltende Verhaltensänderung herbei zu führen. Er kommt zum Schluss, dass umfassende 
multidimensionale Interventionen effektiver zu sein scheinen. Diese zeichneten sich durch eine 
komplexe Kombination von Information, Erinnerungshilfen, Beratung, Selbstüberwachung, 
Bestärkung, Familientherapie und weitere Formen von supervisorischer Hilfe durch Fachpersonen aus.  
Programme, die eine solche Komplexität aufweisen sind jedoch schwieriger zu testen, da sie den 
Anforderungen einer randomisierten kontrollierten Interventionsstudie kaum entsprechen können. Es 
gelingt zudem selten, grossen Gruppen von Patienten ein einheitliches Interventionsprogramm 
zukommen zu lassen, das bei allen Probanden unabhängig ihrer individuellen Situation eine 
gleichermassen effektive Wirkung zeigt. Dies kann als Limitation dafür verstanden werden, 
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Interventionsprogramme mit dem Ziel einer Adhärenz-Steigerung  mittels RCTs zu testen und mag 
nebst den methodologischen Mängeln ein Grund dafür sein, dass in den beschriebenen Studien oft nur 
kleine Interventionseffekte gemessen werden konnten. Insofern ist die Aussagekraft von RCTs 
bezüglich der Testung idealer Interventionsprogramme beschränkt. Trotzdem ist die Durchführung 
solcher Studien unumgänglich, da sie im Vergleich zu den deskriptiven Studien ein höheres 
Evidenzniveau aufweisen und ihre Resultate wegweisend für die Entwicklung von zukünftigen 
Praxisprogrammen sind.  
Für die klinische Pflegepraxis bedeuten die obigen Schlussfolgerungen, dass die Praxisprogramme 
theoriebasiert erstellt werden sollen und verschiedene Methodenansätze beinhalten sollen. 
Optimistisch stimmt dabei der Umstand, dass auch standardisierte Kurzinterventionen gute Wirkung 
zeigen können, was angesichts der beschränkten Ressourcen ein wichtiger Aspekt für das klinische 
Arbeitsfeld darstellt. Hingegen bietet sich in der klinischen Pflegepraxis zudem die Möglichkeit, die 
Patienten kontinuierlich und auf ihre individuelle Situation angepasst zu betreuen, wodurch die 
Adhärenz noch wirkungsvoller unterstützt werden kann.  
Bei der Implementation aller Praxisprogramme muss allerdings beachtet werden, dass auch hier eine 
vorausgehende Einschätzung der Adhärenz zentral ist und die mit der Intervention beauftragten 
Personen bezüglich der verschiedenen  Programmelemente speziell geschult werden, damit sie über 
die für die Intervention notwendigen Kompetenzen verfügen. 
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Abstract 
Objectives: the purpose of this study was to gain an understanding of the experiences of persons living 
with HIV and their medication and symptom management in light of collaboration with close support 
persons and healthcare providers. 
Design/Methods: Open ended interviews were conducted with adult participants on antiretroviral 
therapy who were receiving care at four different HIV outpatient clinics in Switzerland. Data were 
analyzed using a critical hermeneutical approach.  
Results: Narratives revealed that already small changes in health and treatment could change 
participant’s impression of “having a grip” on HIV or “losing it.” To keep a grip, participants 
constantly monitored their condition, developed expertise in care and symptom management, and 
included healthcare providers and close support persons in their management. 
Conclusions: Patients’ impressions of their abilities to manage their condition appeared to be a 
phenomenon that could guide future support. Collaboration with healthcare providers and close 
support persons enabled or hindered a patient’s management. Suggestions to improve support are 
made. 
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Introduction 
Over the past several decades, developments in the treatment and monitoring of HIV have radically 
improved the prospects of those living with the disease. In countries with broad access to long-term 
combined antiretroviral therapy (cART), usually monitored through outpatient services, the morbidity 
and mortality of people living with HIV (PLWH) have been sharply reduced (Sterne et al., 2005). As a 
result HIV is now considered a manageable chronic condition.  
In order to improve outcomes for patients with chronic conditions, fundamental changes across health 
care systems have been suggested (Schoen, Osborn, How, Doty, & Peugh, 2009). The WHO 
publication ‘Innovative Care for Chronic Conditions’, structures chronic care management areas 
requiring changes into macro, meso, and micro levels, with each level interacting with and 
dynamically influencing the others (WHO, 2002). The macro level refers to policy decisions and 
standards, the meso level to health care organization and the community and finally the micro level to 
patient interactions. On the micro level, patient’s self management and the patient-provider 
collaboration have been described as key issues influencing health outcomes (Epping-Jordan, Pruitt, 
Bengoa, & Wagner, 2004; Schoen et al., 2009). 
Patient self-management includes diverse tasks, such as dealing with emotions related to the condition, 
maintaining meaningful behaviors despite fluctuation in health, and most notably, handling medical 
management on a daily basis (Corbin & Strauss, 1988). For PLWH this medical management includes 
two main components: the management of medications and the management of symptoms (Spirig, 
Moody, Battegay, & De Geest, 2005).  
Both aspects are closely related and are important for optimal health outcomes. Symptom prevalence 
remains high for many PLWH and insufficient symptom management can negatively influence 
medication adherence and quality of life (Ammassari et al., 2001; Badia, Podzamczer, Casado, Lopez-
Lavid, & Garcia, 2000). Lack of medication adherence has been linked with the development of drug 
resistant mutations along with the loss of viral suppression and immune functions (Bangsberg, Kroetz, 
& Deeks, 2007; King, Brun, & Kempf, 2005). Additionally, qualitative research has highlighted the 
interface between symptom management and medication adherence choices (Wilson, Hutchinson, & 
Holzemer, 2002). Research and clinical practice further show that, for day-to-day management of 
medications and symptoms, collaboration with supportive others and with healthcare providers is vital 
(Thorne, Paterson, & Russell, 2003). In the current literature, PLWH’s medication and symptom 
management has been described in a very fragmented way, focusing either symptom management or 
medication adherence. Necessary collaborations within those processes have been largely neglected. 
Traditionally medication and symptom management were considered the territory of healthcare 
providers, conducted in a rather paternalistic way without an emphasis on a patient’s illness, work, or 
educational needs (Bodenheimer, Wagner, & Grumbach, 2002a). Nevertheless the benefits of 
collaborative approaches have been discussed in the literature and it can be assumed that these 
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approaches have made their way into clinical practice (Joosten et al., 2008). In order to reflect and 
improve current practice, it is important to focus on the patient’s perspective. The aim of this 
investigation was therefore to gain understanding of PLWH’s experiences with medication and 
symptom management in light of collaboration with healthcare providers and close support persons.  
Methodology and Methods 
This study is part of a larger mixed method research project investigating the perceptions of PLWH, 
their close support persons and healthcare providers, regarding symptom and medication management. 
This particular report describes PLWH experiences within medication and symptom management 
including their perspectives on collaborations with close support persons and healthcare providers.  
The study is rooted in critical hermeneutics (Allen, 1995). By employing the principles of critical 
hermeneutics, this study focused on language and understanding in the interviews with participants 
and in the study of texts, in relation to wider socio-cultural aspects (Allen, 1995; Koch, 1996).  
Socio-cultural Setting 
The study has been conducted in HIV outpatient clinics in the Swiss healthcare system. Ambulatory 
care prescription medications are covered with a mandatory health insurance system. For patients 
unable to pay standard premiums or deductible amounts, the Swiss social insurance system provides 
subsidized coverage.  
Seven ambulatory centers of the Swiss HIV Cohort Study (SHCS) provide the majority of specialized 
HIV outpatient treatment, caring for around 70% of PLWH in Switzerland (Gebhardt, Rickenbach, & 
Egger, 1998). This study has been conducted in four SHCS centers, three located within University 
hospitals and one within Cantonal hospitals. In high level practice and educational settings such as 
these, physicians tend to change frequently. In contrast, nurses usually work many years in the same 
setting.  
Data Collection 
Over a six month period, nurses at the SHCS centers offered adult HIV patients, coming for medical 
consultations, the opportunity to participate in this study. Ethics review boards of all study centers had 
approved the investigation. To be eligible for inclusion, participants had to be German speaking, on 
antiretroviral therapy and have a close support person. A close support person was defined as someone 
who, by birth, marriage, friendship or declared commitment, shared deep personal connections with 
the participant and provided various forms of support in times of need (Levine, 1990). Participants 
(PLWH) from the convenience sample in the larger study had been asked whether they would be 
willing to participate in qualitative interviews. From the group who had consented to this, a sample of 
13 PLWH was purposefully selected based on center, gender and transmission group. Written 
informed consent was given prior to the interviews. 
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The critical hermeneutic experience is characterized by open dialogue (Koch, 1996). A broad 
interview guide with open questions to facilitate the dialogue on medication- and symptom 
management and the collaboration with others was used. Interviews, which lasted 50 to 90 minutes, 
were recorded and later transcribed verbatim. In critical hermeneutics it is argued that the 
conversations are influenced by social and political norms that shape the involved relationships and 
interviewers are not perceived as neutral observers (Allen, 1995). In this study three nurses with a 
Masters Degree and experience in HIV research and clinical care were involved in the process of data 
collection. None of them were involved in clinical care of participants. All had received extensive 
interview training and the process was reflected after every interview in the research team. 
Data Analysis 
The interview analysis was started after the first three interviews and it influenced further data 
collection. After ten interviews themes seemed to be repeating and no new aspects were considered. 
Three more interviews were conducted to ensure this observation. To analyze and interpret data, the 
hermeneutic approach suggested by Diekelmann and Allen (1989) was used. It involves multiple steps 
such as a) developing an overall understanding of the texts; b) defining categories for each interview; 
c) developing relational themes (themes that cut across all texts); and d) building constitutive patterns 
(patterns present in all documents, expressing the relationships of the relational themes). Atlas 
software supported this process (Atlas.ti 5.2 Scientific Software Development, Berlin, Germany). Two 
researchers with expertise in HIV care and research were involved in each step of the data analysis, 
building of categories and relational themes involved consensus discussions. To ensure the quality of 
data analysis, the process itself and the relational themes were regularly discussed in the research 
group and with two PLWH that were not study participants. The data analysis was undertaken in 
German, the language in which the interviews were conducted. The final description of the findings 
was written in English, quotes were back worth translated.  
Results 
Five women and seven men between 27 and 50 years of age (mean: 41.2) participated in the 
interviews. Their living circumstances in rural and urban areas of Switzerland were diverse: some 
lived in homo- or heterosexual partnerships, others in families with children or by themselves with 
close contact with friends or family members. Five of them had a history of illicit drug use. 
Participants’ stories revealed a broad experience of living with HIV and managing cART and 
symptoms within diverse relationships in the Swiss healthcare context. 
The constitutive pattern generated from the interview data and illustrated in figure 1 “I have a grip on 
HIV—HIV has a grip on me” describes the participants’ ongoing evaluation of their own condition 
with respect to their medication and symptom management. Four relational themes influenced this 
process. They illustrated the participants’ continuous work in relation to medication and symptom 
management. Two themes “generate images” and “generate expertise,” revealed processes conducted 
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by participants in order to keep up a meaningful daily life despite changes in their health. The other 
two themes, oriented toward the same goal, were “work with healthcare providers” and “navigate 
relationships”, which showed interactive processes with others.  
Figure 1: “Keeping a grip on HIV” 
 
I Have a Grip on HIV—HIV Has a Grip on Me 
Participants reported that developments in antiretroviral treatment options increased their prospects of 
a long and relatively healthy life. Yet, living with HIV/AIDS left them prone to multifaceted health 
problems throughout the course of the condition. If not sufficiently managed, even small changes in 
health or treatment were reported to severely impact daily life. A woman commented on this situation, 
I can talk like this, because I am alright at the moment. If something comes up and the 
whole situation could change quickly. 
Related to this management, participants described two interchanging conditions. At one pole they felt 
fully able to manage the difficulties of their chronic disease and keep up a meaningful life. At the 
other they felt overwhelmed by difficulties and unable to manage. The two conditions reflected in “I 
have a grip on HIV” and “HIV has a grip on me,” and the dynamics between them, experienced by all 
participants irrespective of their years of experience with HIV, will be further explored.  
“I have a grip on HIV” reflects the condition where participants felt able to master the challenges of 
living with HIV. In their stories, issues of everyday life were more present than those of illness 
management. Many negated having any disease or medication related symptoms. Still, some explained 
that, although they experienced symptoms such as diarrhea or fatigue, they were untroubled by them, 
because they had successfully integrated their management into daily life. Additionally, they had 
integrated the intake of antiretroviral regimens into their daily routines. Participants were able to take 
their medications on a regular basis without difficulty or even much awareness. Significant others 
were often part of this routine. Even in exceptional situations, such as vacations, medication intake 
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could be handled without difficulty and was not a key issue. A woman with children typified this 
condition with this comment:  
For us it’s a normal life. I don’t have any troubles and don’t even think about 
it. The only thing is to take my meds. I just do it every day at lunch. Otherwise 
it’s not a topic anymore. 
If changes in health and treatment were not sufficiently manageable, participants described an 
incremental process of radical changes that influenced the perception of their condition. Such changes 
could occur throughout the illness course. 
“HIV has a grip on me” reflects this more daunting condition, where participants felt driven by their 
HIV infection itself. Issues of the illness management, such as uncontrolled symptoms or problems 
with the medical regimen, could become all-dominant and threaten their ability to keep up the 
normality of their daily lives. Reflecting on this change, a male participant said,  
I had a huge combination of medications, but I felt fine for years. Even though 
I had this fatigue, I was able to do everything, like going out or exercising. But 
two years ago the body aches and the loss of energy really started. Now, I have 
to say this can not be it! Some days before getting up, I feel like I can’t handle 
daily life and work. 
Various other participants recounted stories about their “most difficult symptoms,” including for 
example almost unbearable skin itching, changes in body fat distribution, or warts. In particular, 
changes in body fat and warts negatively impacted a participant’s body image. They also feared 
stigmatization due to forced disclosure of their HIV status because of visible symptoms. 
Visible symptoms are more difficult. Every time others look at you, they will 
think, something is wrong with her. That forces you to explain yourself and is 
very stressful, besides the fact that you don’t like yourself looking like this. 
Diverse difficulties involving their antiretroviral regimens seemed to further complicate their everyday 
lives. For some, the medications were a constant reminder of their HIV infection, which was still 
painful. Others talked about problems integrating medication intake into their routines, or experienced 
distressing side effects. One man shared such an experience: 
Often it is very difficult to open the medication box. Especially if we have 
relatives visiting, it is difficult. They do know about it, but then my wife acts 
extraordinarily and puts the box on the table right in front of me. I am 
completely stressed in those situations. 
If those difficulties could not be resolved over time, people reported a sense of losing their “grip” on 
HIV. This could lead to uncertainty, fear, and loss of morale. In order to get back the “grip on HIV” 
again, participants described various strategies, revealed by following four themes: generate an image, 
generating expertise, working with providers, and navigating relationships. 
Chapter 5 
81 
Generate an image 
Participants seemed to be aware that health changes could occur any time and influence their ability to 
have a “grip on HIV”. To minimize the impact of such changes on their everyday life, they talked 
about constantly monitoring their own state of health and related behavior. Along with the effect of 
medical treatment or their current adherence behavior, they kept a close watch for any new or 
changing symptoms. In order to create an overall image of their situation, participants talked about 
evaluating their observations, which helped them to make management decisions. Generating an 
image was an important, but often difficult task to keep a grip on HIV as this example illustrates:  
If I can isolate something (symptom) concretely, the situation is simply 
different from when I don’t know where it’s coming from. That makes it 
possible to get a grip on it. It’s positioning something, not even what you can 
do about it that makes the difference.  
To generate an image, participants seemed to base their interpretations on frames of reference they had 
developed for themselves regarding their knowledge of symptoms, their bodies, their labs, and their 
personal adherence requirements. These frames which will be further described. 
Participants’ knowledge of medication side effects or their experiences of diverse symptoms allowed 
them to distinguish between known and unknown symptoms. 
By now I know my symptoms. They repeat themselves, I can differentiate 
between the ones I know and those I don’t, then I watch more carefully. 
They further stated that compared to the beginning of their chronic condition, over time they had built 
up a keen sense for their individual body changes, recognizing, for example, small sensations before 
trouble arose.  
With time, you really get the feeling for your body, a lot more than any healthy 
person does that is for sure. 
All participants knew the courses and current states of their surrogate markers; some used this to 
combine and interpret their current parameters with occurring symptoms or the effect of medical 
regimens, whereas others combined it with their body feelings only. 
Additionally over time participants had defined what level of adherence was sufficient for them. With 
this in mind, they could monitor their adherence behavior regarding timing, doses, and dietary 
restrictions. Such personal perception of adherence requirements seemed not always in concordance 
with provider recommendations, but with their lab parameters or body feeling.  
I take them regularly. I only forget them two or three times a month. But I 
never eat with them, as I am supposed to. It just did not work out while 
working. Anyway my lab is always fine, I am doing alright. 
Participants seemed to link all of these reference points to form an overall picture of their condition 
and to arrive at management decisions. For some, the monitoring processes were so well integrated 
into their daily routines they almost did not notice them. For others, these processes demanded more 
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attention and energy, especially if they had not yet developed expertise in managing symptoms and 
medications.  
Generate expertise 
Participants revealed that they developed expertise in handling the challenges of medication and 
symptom management. Many described a difficult learning process at the beginning, with many trials 
and errors before they were able to solve the problems. Such situations could lead to the impression of 
loosing ‘the grip on HIV’. Nevertheless diverse experiences and increases in knowledge made 
management easier. Yet, participants were aware that irrespective of their current knowledge new 
health challenges could always occur. In order to ‘keep a grip on HIV’ they continuously and actively 
developed their expertise. This included learning processes related to making decisions, finding out 
what works, organizing medications, and understanding HIV that will be further described.  
Skills seemed to grow as participants built up their knowledge to make decisions related to symptoms 
and medications, observing, for example, the criteria healthcare providers used to make such 
decisions. Many also sought information on the Internet or other media sources. Even negative 
experiences yielded knowledge for future decisions: 
I have problems with my eyes and it’s my fault: I waited too long (to seek 
treatment). Because it was at the beginning of the disease, at that time you 
don’t know how to handle it. I would recommend a newly infected person to 
see the doctor for every bloody thing. They should really see about what’s 
important and what’s not. It’s a real advantage when you know how to manage 
the disease. 
Participants shared, that they had to work out personal strategies to manage their symptoms, based on 
recommendations from different sources such as providers, diverse media and peer support. To 
manage diarrhea, for example, one woman describes how she used prescribed medications, changed 
her diet and tried over the counter medications until she found a working strategies for herself.  
I have this diarrhea and the doc gave me Imodium (loperamid). But with time I 
learned to better manage it. I used Bioflorin which rebuilds the intestinal 
mucosa, it works out for me now. I have also tried with food, for a while I ate 
bananas. 
Participants also seemed to develop systems that allowed them to take their antiretroviral regimen 
according to the perception of their own adherence requirements. For example, they used diverse 
technical reminder systems, adjusted times, and experimented with food until they had found a system 
that worked for them. Such a working system often needed time to be developed. One woman talked 
about this: 
I organized myself over time. Now I have these boxes for fourteen days. Every 
other Sunday I fill them up, and then I take the medication every morning and 
every evening. I am accurate; I take them pill by pill in the same order. First 
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before breakfast I take the thyroid medication and then after breakfast with a 
sip of coffee, the HIV medication.  
All participants seemed to have developed broader perspectives on HIV and related issues, including 
opportunistic diseases and possible symptoms, functions of the immune system, interpretation of lab 
parameters, and the benefits and side effects of antiretroviral agents. Information from diverse media, 
supportive others, and, in particular, healthcare providers served as a basis for knowledge and 
understanding. A woman describes this process. 
I ask her (physician) many questions and she explains a lot.  And every time it 
is like little bridges you cross to connect things. Knowing and understanding 
really helps. 
Work with providers 
To manage symptoms and medications effectively, participants emphasized the importance of a close, 
participatory relationship with HIV specialized healthcare providers. This was particularly important 
to strengthen unsatisfactory self-evaluation and management strategies. And therefore to change from 
the condition of ‘HIV has a grip on me’ to ‘I have a grip on HIV’. The process of working with 
healthcare providers involves selecting the place to go for support, ones own contribution to the 
collaboration and dealing with provider relations.  
Independent of their relationships with individual providers, participants experienced their HIV 
outpatient clinics as important institutions. A clinic was the place “where people really know me.” 
They were welcomed familiarly by nurses, their health histories were known and they did not have to 
repeat their case details at every visit. Additionally, many appreciated that, they had long term 
relations with nurses and that in their clinics, they could talk freely about their HIV infections and 
associated topics.  
HIV is a topic there at the clinic. Well I somehow always feel I can talk about 
it there. The staff takes it seriously and I can discuss with them. 
Finally, if problems in symptom and medication management arose, the clinic was a place to call and 
where they were confident of receiving competent, HIV focused care. 
Active participation was perceived as important for participants in their collaboration with individual 
healthcare providers, especially with physicians. One woman stated: 
I think you have to work with them (physicians); if you don’t, the outcome is no 
good for both parties. I always prepare myself, I look things up and I tell them 
about my symptoms and my opinion.  
Participants stated that they could not expect to be asked about every symptom. It was therefore 
important to know about possible symptoms and clearly and actively communicate observations or 
even emotions. Further, textbook recommendations were often not experienced as sufficient to solve 
problems regarding symptom or medication management. Individualized solutions had to be worked 
out collaboratively to ‘keep a grip on HIV’. Participants prepared suggestions for symptom 
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management strategies or therapy options to be discussed with their providers. They also intended to 
have an active exchange of expertise with their providers. While they actively sought information 
from experienced providers, they also educated newer ones about important experiences they had had 
in the past, including, for example, unusual side effects not yet described in the available literature. 
Finally, they coordinated general healthcare providers with their HIV specialized providers. When 
necessary, they also called to check about medication interactions. Some insisted on being treated by 
their HIV providers for general health problems. They questioned competence of non HIV specialized 
providers and feared to loose ‘grip on HIV’ with a less competent partners. 
Relationships with providers were sometimes experienced as positive and supportive, other times as 
difficult and non-supportive. If the latter was the case, participants missed the active partner they 
needed to optimally manage the situation. Two women, with severe skin itching, shared two very 
different experiences. One was positive: 
At one point I had this awful itching; I was really stressed about it. But I got 
the impression they really took it seriously, even though from an objective 
perspective it’s not such a bad thing. I definitely liked that. 
The other woman experienced a non-supportive interaction: 
I had very dry skin and awful itching, but absolutely no one took it seriously 
there (at the clinic). Especially during winter time, I had bleeding legs. As 
soon as the physician changed, he told me medications could do that. But 
before that, I told them many times and no one reacted to it. 
Participants talked about being deeply affected by such differences in relationships since it was very 
relevant for ‘keeping a grip on HIV’. When mentioning providers with whom they experienced 
positive interactions, for example, they used inclusive language with phrases such as “we need to 
solve this” or “we will do this.” In those cases, providers knew to listen carefully before acting and to 
focus on the patient comprehensively, as a person. Such providers educated and enabled participants to 
deal with difficulties, for example, by preparing them for medication intake. Such relationships 
fostered a sense in the participants that they could bring in their own perspectives—that they and their 
providers were genuine partners. This gave them a feeling of security, even if problems could not be 
solved immediately.  
In contrast, some participants had the impression that their providers were not actually listening to 
their input, but simply pursuing their own agendas. To the participants, such providers seemed either 
uninterested or simply did not believe them. In particular, symptoms involving fatigue, neurological or 
cognitive problems, where a quick solution was not possible, appeared extremely difficult to discuss. 
The statement of a man with fatigue reflects this situation: 
All went well for years. I had the impression they (physicians) appreciated how 
well I managed besides a full time job. Now I have this fatigue and everything 
changed. I sometimes think my lab results are still to good to be taken 
seriously. My last physician for example, in every consultation told me, that he 
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wants to take me of the antibiotics and go back to work. He really scared me, I 
almost panicked. I always wanted to work that’s not it, but now I think they 
don’t take my problems seriously.  
Participants also occasionally questioned the competence of less communicative providers— for 
example, when they had not prepared them for possible side effects, or seemed not to react 
appropriately to symptoms. In such cases, participants felt they had not been taken seriously, and 
expressed difficulties speaking about their experiences. Some withdrew from the relationship and 
withheld information about symptoms. Others used more active strategies and insisted that their 
perspectives be acknowledged. “I fight for my rights and well being,” as one patient put it. Others 
considered changing providers. 
For participants who had the feeling of having a grip on HIV, close collaboration was appreciated, but 
not essential. However, in cases where they felt HIV had a grip on them (also indicating that their own 
strategies were insufficient), full collaboration was indispensable. If it was absent, such participants 
expressed feelings of insecurity, distress, and even desperation. 
Navigate relationships 
Relationships with family members, partners, friends, colleagues at work and others were an important 
part of participants’ everyday lives. With a focus on their illness management and in order to ‘keep a 
grip on HIV’, participants therefore carefully navigated relationships with significant others. This 
process included following issues that will be further described: the management of disclosure, things 
PLWH and the persons close to them did for one another and how they kept the balance. 
Management of HIV disclosure was an important issue. All participants seemed to handle the 
disclosure of their HIV status with great care. Whereas some restrictively informed only the most 
important persons in their lives, others informed a broader group. Participants decided against 
disclosure to certain close relatives, including children or parents, to protect them from stigmatization 
or negative feelings. Their disclosure decisions seemed to be closely linked to issues of symptom and 
medication management. Participants informed others in order to receive support or at least to 
minimize disturbances in their management. For example, they informed others if symptoms became 
noticeable, began to hinder daily activities or work performance, or if they simply wanted to talk. 
They also informed others in order to take their antiretroviral medication openly, as the example of 
one participant illustrates: 
Being HIV positive is not so important for me. But before I spend my vacation 
with someone, I usually tell them about it. I don’t want to hide the medication 
intake or even lie about it. Usually I feel close to people I spend my vacation 
with. So it’s not to bad, but you need to prepare them. 
The moment to disclose HIV status appeared to be chosen carefully, since it always demanded energy 
and time to talk. Even though some participants informed others very easily and openly, they had to 
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take the reaction of the others into account. For others, the disclosure process was very distressing, 
especially if they felt forced to do so, for example by visible or bothersome symptoms. 
To share issues surrounding symptom and medication management, it was important for participants 
that the people who supported them were informed about their HIV diagnosis and that they be 
trustworthy and understanding. Participants often shared all aspects of their daily lives and activities 
with such close support persons. Merged into these daily activities were diverse forms of mutual 
caregiving that reflected not only their close relationships but also various issues involving symptoms 
and medications. Participants explained, for example, that their close others were there for them to talk 
to or offered to drive or accompany them to clinic visits if those tasks were difficult or distressing. 
One woman talked about how her sister assumed certain household chores: 
We don’t have to talk about it. My sister recognizes if I’m tired or feeling down 
and helps me with little everyday tasks. She vacuums the house or helps me to 
feed the animals. 
On the other hand participants also explained that they provided similar support for their significant 
others. They might have taken over household tasks, because the support person had a heavy workload 
and were there to talk if any problems occurred. Additionally, close support persons, especially 
children and partners, were perceived as persons for whom it was important to live, and, in fact, to 
actively manage their chronic condition. 
Close support persons were described as co-affected by the disease and its related challenges. Changes 
also obviously influenced their daily lives: they had to deal with the diagnoses of their loved ones and 
to keep abreast of issues of symptom and medication management . Sometimes they were able to 
provide support, other times, as one participant described, they struggled with difficult situations: 
This fatigue came slowly, but it is very disturbing for us. My partner just can’t 
handle it, he is completely stressed about it. We often argue about it, discussed 
it back and forth but I don’t see a way out so far. 
In order to “keep a grip” on their own illness management and to reduce the burden on their close 
support persons, participants seemed to carefully balance their relationships according to their specific 
circumstances. Sometimes, for example, this would involve discussing symptom management 
decisions with them, whereas other times they might not even mention the symptoms they 
experienced. One woman, not wishing to disturb her husband before an important business meeting, 
did not talk to him about her symptoms, but went to see her doctor. Even after learning that she had to 
be hospitalized, she called her husband only after everything was set and his important meeting was 
concluded. Additionally, to allay the fears of those closest to them, participants provided HIV related 
knowledge and informed them about their conditions on an ongoing basis.  
Discussion 
Findings reflect medication and symptom management experiences of a group of PLWH receiving 
care at Swiss HIV outpatient clinics. The constitutive pattern “I have a grip on HIV—HIV has a grip 
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on me” sheds light on the importance for PLWH to gain or maintain the feeling of being able to 
manage medications and symptoms. This stands in accordance with former qualitative investigations, 
where the decision of persons with a chronic condition to control the disease rather than being 
controlled by it has been described (Lorig & Holman, 2003; Thorne et al., 2003). In contrast to former 
research our results not only describe a one time decision but highlight a dynamic process of changes 
in the perception of “having a grip” across the course of the condition. This leads to the assumption 
that time-limited self management interventions as usually planned and tested in study programs might 
not sufficiently meet PLWH’s needs. Ongoing screening of needs and provision of support should be 
integrated into clinical care. Additionally the phenomena of “keeping a grip or controlling HIV” 
should be further investigated. This is in particular important, since a limitation of this study was the 
mainly white population with a western cultural background. However a qualitative investigation in 
Australia revealed differences for an English- and an Arabic speaking group of diabetes patients: 
whereas the English speaking group emphasized the need to control the condition, the Arabic speaking 
group emphasized the need to reduce stress caused by the condition (Furler et al., 2008). 
The ongoing and active self-management of PLWH to “keep a grip on HIV” can also be influenced by 
social aspects. In Switzerland, health and related productivity are become important values. Health, 
understood as an expression of an individual’s well being, has become desirable and achievable for 
everyone. With that awareness, social expectations grew, such that individuals, including chronically 
ill persons, actively maintain their health (Kickbush, 2006). Nevertheless, some highly challenging 
illness related work, such as described by PLWH and other chronically ill populations, does not seem 
to be well recognized in society nor in the healthcare community (Lorig & Holman, 2003; Wiener, 
1989). For PLWH in particular, the underrecognition of their contribution to health by society could 
be increased because of fear from stigmatization only a close circle of persons is informed about the 
chronic condition (Spirig, 2002). The underrecognition of PLWH’s daily work by healthcare providers 
could be explained by the traditional stronger focus on biomedical issues, compared to behavioral 
aspects such as self management (Bodenheimer et al., 2002b). Managing a still stigmatized chronic 
condition, in a social context where individuals are expected to maintain optimal health, combined 
with underrecognition of self management support needs by professionals could put PLWH’s at risk 
for negative health outcomes. 
The results of this study clearly showed that interactions with healthcare providers and close support 
persons assisted or hindered PLWH’s continuous management of medications and symptoms. 
However, independent of the experiences with individual providers, PLWH’s connected their HIV 
outpatient clinics in two important respects. First, they described it as a place where they could talk 
about HIV freely. Even today fear of stigmatization and experiences of stigmatization by PLWH are 
described in diverse settings (Peretti-Watel, Spire, Pierret, Lert, & Obadia, 2006; Schuster et al., 
2005). An investigation in a large teaching hospital in the UK for example illustrated that 
professionals working on units that regularly provided HIV-care, appeared to be more positive and 
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less pejorative against PLWH than others (Hodgson, 2006). In such contexts, HIV specialized 
institutions with a less pejorative caring culture and attitudes seem to be important recourses for 
PLWH’s. Second study participants described the clinics as places where they were known as a person 
and health history was familiar to providers. Interestingly in particular nurses were associated with the 
feeling of familiarity and being known. This supports recent discussions on the importance of high 
care continuity for persons with a chronic condition highlights the role nurses can play within 
continuity of care (Guthrie, Saultz, Freeman, & Haggerty, 2008). Both aspects, the non pejorative 
environment and care continuity, seem to be important conditions for patient-provider partnerships in 
HIV care. 
The need of PLWH’s to establish working partnerships with their healthcare providers as reflected in 
this research project, is described in studies across diverse chronically ill populations (Thorne et al., 
2003). These findings provide insight into the details that constitute such partnerships with a focus on 
managing medications and symptoms. On one hand, the need for providers to use a patient centered 
approach, including recognizing each person as a unique human being, is described and has already 
been found to be important in a broad range of studies (Beach et al., 2006; McCoy, 2005; Schneider, 
Kaplan, Greenfield, Li, & Wilson, 2004). On the other hand, these findings highlight the importance 
of the need for HIV-specific competence on the part of healthcare providers. Next to a medical 
competence, this includes the ability to assess a patient’s symptom experience in a non judgmental 
manner, to develop medication and symptom management strategies collaboratively with patients, to 
provide ongoing education within those topics, and finally to assist patients in decision making and in 
the coordination of different health problems. In PLWH’s narratives physicians played a key role 
related to such needs. However meeting all of those needs can be a challenge for an individual 
physician in specialized outpatient clinics situated in academic hospitals. A team approach with an 
optimal mix of individual provider’s skills seems to be needed. Nurses, who have traditionally strong 
focus on self management education, could probably expand their role in self management education. 
Consistent with the literature, close support persons provided diverse forms of support and a reciprocal 
process of giving and taking support was described (Bischofberger & Spirig, 2004). In contrast former 
studies, PLWH seemed to manage relationships with the clear goal to ‘keep a grip on HIV’. This gave 
them a leadership role in their collaboration with close support persons. For example, participants 
seemed to educate their close support persons about HIV related knowledge and their actual condition 
to allay their fears. Since they themselves often did rely on information and education of healthcare 
providers, they had to transfer the gained understanding to their close support person. PLWH who 
were having difficulties in medication and symptom management and who had a fearful support 
person, seemed, at times, to be overburdened with this work. This highlights the need for not only for 
patient but also for support person focused interventions. So far the Swiss healthcare and insurance 
system is strongly focused on and reimburses services at the individual patient level. As a result, 
healthcare providers have focused the individual patient as the center of care. Family focused 
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interventions have rarely been integrated in the education curricula of nurses and physicians. For 
example nurses (n = 580) in a Swiss university hospital, who were directly engaged in patient care, 
rated their professional competences over seven dimensions. The dimension of “education for patients 
and families” received the lowest ratings with a median of 80% (1=not competent; 100=absolutely 
competent) (Martin et al., in press, 2009).  
Conclusion 
The sometimes hardly visible illness work of PLWH around medication and symptom management 
has to be recognized as such and adequately supported by healthcare providers in particular nurses 
need to expand self management support. Patients’ own perceptions of their ability to control their 
disease management could be one important marker of the needed support and should be further 
investigated. Since PLWH need active partners in their medication and symptom management, their 
close support persons should be included in support interventions. The process of supporting PLWH 
and their close support persons in medication and symptom management requires good 
communication, caring, respect and high medical competence by their healthcare providers. These 
needs might be best met by a chronic illness approach with well orchestrated teamwork by different 
healthcare providers. 
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Abstract 
For persons living with HIV (PLWH) effective symptom management, on a daily basis, is crucial for 
good health outcomes and usually involves close support persons (CSP). This sequential exploratory 
mixed methods study investigated the collaboration of PLWH and their CSP within the process of 
symptom management, including symptom experience reports of the two players. Qualitative results 
revealed that collaboration is constituted by distinct but integrative positions of manager and partner 
which are reflected in diverse themes of daily symptom management and confirmed in the 
quantitatively assessed symptom experience reports. In conclusion the collaboration of the two 
players, in particular symptom communication in specific areas, such as neurocognitive problems, 
should be further supported by better integrating CSP into clinical services. 
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Introduction 
Despite significantly improved survival prospects due to long term antiretroviral therapy, many 
persons living with HIV (PLWH) continue to experience a wide range of symptoms related to the 
disease as well as comorbidities, opportunistic infections, and medication side effects [1, 10-12]. 
Effective symptom management is essential for such people and usually involves collaborating with 
others, in particular close support persons (CSPs), since the chronic condition is mainly managed in 
the home setting with hospital care services provided in outpatient settings mainly. Symptom 
management is important since a high number of symptoms have been shown to negatively impact 
health-related quality of life and antiretroviral treatment adherence [9, 116, 177]. A high antiretroviral 
treatment adherence is key as even small irregularities can lead to insufficient plasma drug levels, 
which increases the risk of drug resistant mutations, cross-resistance, and ultimately, ineffectiveness of 
the medications used for treatment [20]. Despite this, PLWH conducted daily adherence decisions 
based on their symptom management [22]. 
PLWH symptom management is complex. It encompasses day-to-day decisions about dealing with 
symptoms, such as when to contact a health care provider, whether or not to alter exercise or diet, and 
when or when not to take certain medications [16]. These processes are likely to be influenced by the 
social contexts in which they take place. PLWH are part of diverse families, partnerships and 
friendships. In Switzerland, it has been shown that these diverse relations are influenced by the 
continuing social stigmatization of the condition and those affected by it. In a qualitative investigation, 
only a small subgroup of family members were willing to assume caregiving tasks for PLWH. They 
performed these very privately in order to prevent being rejected or judged by others. Nevertheless the 
presence of at least one close and informed support person seemed to be important for a PLWH’s 
health [33]. A prospective cohort study demonstrated that stable partnerships were associated with 
slower rates of disease progression in PLWH receiving antiretroviral therapy [122]. Other 
investigations found that for PLWH, high levels of social support were associated with fewer 
depressive symptoms and enhanced treatment adherence [124, 125]. In sum, research clearly 
demonstrates the importance of relationships with close support persons for PLWH health. Yet the 
collaboration process between PLWH and CSPs for symptom management remains unclear, even 
though a better understanding of this is important if health care providers are to guide tailored 
symptom management interventions.  
The first step in the process of symptom management is the symptom experience of PLWH. This 
process involves a cognitive component, where the frequency and severity of a symptom is 
recognized, and an emotional component, where the distress caused by the symptom is felt [28]. The 
negative influence of high symptom frequency, severity and in particular of high distress levels on 
health outcomes such as adherence and quality of life has been documented [28, 71]. Taking the 
PLWH symptom experience as the starting point for symptom management, it would seem that 
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concordance between symptom reports by PLWH and CSPs is crucial if they are to collaborate in the 
symptom management process. Insufficiently managed symptoms have been shown to cause distress 
not only for patients with chronic conditions but also for their CSPs. Furthermore, such distress seems 
to hinder effective symptom communication between the two players [178]. To our knowledge, 
concordance in symptom experience has not been investigated in the HIV population. In cancer 
patients, Kurth and colleagues found a high agreement of 71% in symptom reports between patients 
and their CSPs [34]. However, in a more recent study of cancer patients and their CSPs, agreement 
levels for single symptoms were diverse and ranged from poor to excellent with a general trend for 
CSPs to overestimate symptom experience [35]. An understanding of the concordance or discordance 
in the perception of symptoms between PLWH and their CSPs and the role this plays in the overall 
symptom management process would appear to be important for health care providers. For example, 
they might need to educate patients and support persons about symptom communication or educate 
support persons in symptom distress presentation, in order to improve health outcomes for PLWH. 
The purpose of this mixed methods research study was therefore to explore the collaboration between 
PLWH and their CSPs within the process of symptom management, including the concordance of 
symptom reports of the two players. 
The first phase of the study involved a qualitative exploration of how PLWH and their CSPs 
experienced collaboration on symptom management. The second phase analyzed participants’ 
narratives recorded during the first qualitative phase to construct three hypotheses for a quantitative 
exploration about concordance of symptom reports: 1) PLWH report on more symptoms than their 
CSPs do; 2) There are specific symptoms that are more often reported by CSPs; and 3) In the case of 
symptoms being reported as very distressing by PLWH, symptom reports by PLWH and CSPs do not 
differ. 
Methodology and Methods 
A mixed methods approach featuring a combination of qualitative and quantitative investigations was 
chosen to expand existing knowledge about how PLWH and their CSPs collaborate on the 
management of symptoms. More specifically, a sequential exploratory design was used with a greater 
emphasis on the qualitative investigation [47]. The project started with a qualitative phase designed to 
explore the phenomena of collaboration in symptom management. The data gathered during this phase 
were used to form hypotheses which were then tested with data drawn from a larger sample (Figure 1). 
The quantitative follow-up study was used to complement, validate, and extend the qualitative 
findings. 
From a methodological point of view, the study was guided by a critical hermeneutical approach. This 
thinking tradition is grounded in critical theory and oriented toward critiquing and changing society, in 
contrast to traditional theories which are oriented only toward understanding or explaining phenomena 
[179]. A major critique within critical theory has been that scientific knowledge can not only be 
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generated by the careful testing of clearly observable propositions, but also through understanding 
revealed by conversations. Therefore both approaches to knowledge generation - that is, qualitative 
and quantitative approaches -  can be viewed as equally relevant and valid ways of exploring specific 
questions, as long as the results are reflected upon with respect to the social contexts in which they 
exist and in light of power issues [180]. At the method level, the process included shifting between the 
qualitative and subjective data and the use of inductive reasoning and quantitative numeric data using 
deductive reasoning [181]. This process is further depicted in an overview shown in Figure 1. The 
studies were conducted by a team of researchers with complementary expertise in qualitative and 
quantitative research. 
Figure 1: Overview of Exploratory Sequential Design 
Setting and Sample 
This study was conducted within the framework of a larger multicenter investigation exploring the 
relationships between symptom experience, symptom manageability, adherence, health related quality 
of life, and disease progression in PLWH from the perspective of patients and their CSPs (Spirig 
2002b). The investigation was implemented in collaboration with the Swiss HIV Cohort Study 
(SHCS) in four of their seven centers. The relevant ethics committees granted approval.  
PLWH and their CSPs were consecutively recruited for this study at medical appointments. To be 
eligible for study participation, PLWH had to be on antiretroviral therapy, over eighteen years of age, 
able to read and speak German and able to participate together with a CSP. A CSP was defined as an 
individual who by birth, marriage, friendship or declared commitment shared deep and personal 
connections with the PLWH and provided various types of support in times of need [121]. PLWH 
decided whether or not they had someone who met this definition. With the consent of the PLWH, 
their CSP was then contacted and asked to participate in the study. From this final sample, a smaller 
sample was purposefully selected for interviews, in order to achieve variation according to centers, 
gender of the PLWH, and diversity in relationships with CSPs.  
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Data collection and measurement 
Data collection of quantitative and qualitative data occurred independently of each other, since the 
granting agency required the completion of data collection within a specific timeframe. 
Participants who consented to this study were given a set of structured study questionnaires, which 
they completed and returned by mail. Demographics were assessed with the SHCS Questionnaire. The 
HIV Symptom Experience Assessment Scale (HIV-SEAS) was used to assess occurrence and distress 
of symptoms. This consists of 73 items (symptoms) to be rated across three dimensions: frequency and 
severity (representing symptom occurrence) and distress. PLWH filled in the questionnaire for 
themselves, whereas their CSPs rated the PLWH symptom experience from their perspective. 
Participants were asked to indicate if a symptom had occurred during the past week (yes/no). If it had 
occured, they were asked to rate how often it had occured on a 4-point Likert scale (1 = rarely, 2 = 
occasionally, 3 = frequently, 4 = almost constantly), how severe it usually was (1 = slight, 2 = 
moderate, 3 = severe, 4 = very severe) and how much it distressed or bothered the PLWH (0 = not at 
all, 1 = a little bit, 2 = quite a bit, 3 = very much). The HIV-SEAS was developed and tested by within 
the larger study (Vincenzi, Moody, Spirig, 2009). 
For this study, qualitative interviews took place in the participants’ homes or in a private room of the 
HIV outpatient clinic, according to preference. PLWH and CSPs were interviewed separately. An 
interview guide suggesting open-ended questions was used to facilitate dialogues on participants’ 
perspectives of symptom management and their collaboration. Interviews lasted between 50 and 90 
minutes. They were recorded and later transcribed verbatim. 
Data analysis 
The mixed method analysis was done in a sequential but integrated fashion with periodic exchange 
between the preliminary results of the two parts of the study. We began by analyzing qualitative data, 
using the critical hermeneutic approach suggested by Diekelmann and Allen [182]. This involves 
multiple steps such as a) developing an overall understanding of the texts; b) defining categories for 
each interview; c) developing relational themes (themes that cut across all texts); and d) building 
constitutive patterns (patterns present in all documents expressing the relationships of the relational 
themes). Atlas software was used to support this process (Atlas.ti 5.2 Scientific Software 
Development, Berlin, Germany). Finalized descriptions of results were translated into English. 
After the first two steps of the qualitative analysis (a and b above) were carried out, the preliminary 
results were discussed by the research team. Based on three themes that cut across all narratives, 
tentative hypotheses for the quantitative analysis were built and tested. Descriptive data were 
calculated for demographic variables as follows: medians for non-normally distributed data and 
frequencies for categorical data. To test the differences in the numbers of reported symptoms between 
PLWH and CSPs (H1), the Wilcoxon signed rank test was used. To explore discordant and concordant 
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symptom reports (H2 and H3), the Mc Nemar paired samples test was employed. To account for 
multiple testing, q-values were calculated as suggested by Benjamini and Hochberg: i.e., the expected 
number of type Ι - errors was kept below 5% [108]. The adapted p-values were denoted as q-values. 
Symptom distress across the PLWH sample was defined by averaging individual symptom distress 
ratings. The presence of the twenty most ‘distressing’ recorded symptoms by PLWH was compared 
against those given by CSPs. All analyses were performed using SPSS® version 16.0 (SPSS Inc., 
Chicago, IL, USA). 
The final steps of the qualitative analysis (c and d) were conducted concurrently with the quantitative 
analysis. After qualitative and quantitative analysis, data combination occurred at the level of data 
interpretation with a critical social perspective that is outlined in the discussion section. 
Results  
At medical consultation, 220 PLWH agreed to participate. Subsequently, 34 of their CSPs did not 
agree to participate. Of the remaining 184 dyads, 64 were lost to follow-up, mainly due to unreturned 
questionnaires. The final sample consisted of 122 PLWH and their 122 CSPs.  
Description of samples and participants  
The characteristics of the overall sample (CSPs and PLWH), those not included due to CSP refusal, 
and those lost to follow-up are shown in Table 1. On average the sample was middle-aged with almost 
no age differences between PLWH and CSPs. Participants were predominantly white Swiss men, with 
males accounting for 75% of PLWH and 59% of CSPs. Whereas the PLWH mostly only had a basic 
education, many CSPs had a higher level of education: 20% of PLWH and 40% of CSP had a 
bachelor’s degree or higher. The median plasma CD4 cell count for the PLWH was 455 (IQR 294-
590) cells/mm3 and the majority (90%) had plasma HIV-1 RNA below 400 copies/mL. 
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Table 1: Characteristics of participating PLWH and CSP and non participating PLWH 
Variable PLWH  CSP PLWH lost to follow-
up 
PLWH whose CSPs 
refused participation 
Total – N 122 122 64 34 
Male gender - %     75.4 59.2 84.4 76.5 
Age – median (IQR)                       44.5 (40-51) 45 (39-55) 43.0 (39-48) 44 (40-52) 
Highest completed educational degree -%      
No completed school or educational degree 1.6 0.8 4.7 - 
Mandatory schooling (9 years)  11.5 11.6 9.4 23.5 
Completed apprenticeship  63.1 43.8 54.7 55.9 
Bachelor degree / higher professional education 9.9 15.7 7.8 8.8 
Graduate degree  10.7 24 15.6 5.9 
No information / other 3.3 4.1 7.8 5.9 
Swiss nationality - % 92.6 87.3 No information 75.8 
White ethnicity - % 97.5 95.9 No information 97 
Transmission group - %     
MSM1 50.8  42.2 35.3 
MSF / FSM2 27  26.6 20.6 
IV drug use 8.2  18.8 26.5 
Other 14  12.5 17.6 
AIDS - % 27  29.7 38.2 
CD 4 cell count (mmol/L) - median (IQR) 454.5 (305.5-630.0)  369.5 (299.3-634.5) 440 (255.0-601.0) 
HIV-1 RNA (copies/ml)  - %     
<50  77.9  67.2 85.3 
50 – 399  13.1  17.2 8.8 
≥400  9  15.6 5.9 
IQR = interquartile range 
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The qualitative sample derived from the larger sample consisted of 26 participants - 13 PLWH and 
their 13 CSPs. Compared to the larger sample, there were no major differences in age, CD4 cell count, 
HIV-1 RNA copies/mL or median of prevalent symptoms. The group of PLWH consisted of 7 males 
and 5 females, four of whom had a history of intravenous drug use. Their CSPs were made up of 10 
males and 3 females. All the PLWH had been living with HIV for many years and their narratives 
revealed a broad range of experiences in managing symptoms. Their living circumstances in rural and 
urban areas of Switzerland were diverse: some lived in homo- or heterosexual partnerships, others in 
families with children, others by themselves with close contact to friends and family members. 
Reflecting this diversity, the CSPs consisted of partners, close friends, brothers, or sisters. All of the 
CSPs had had a close relationship with the PLWH for more than 2 years. The broad experiences of 
participants of collaboratively managing symptoms are described below. 
Collaboration on Symptom Management 
Narratives revealed that even small changes in the symptom experience of PLWH could severely 
impact their daily lives. In order to handle these changes, both PLWH and CSPs reported participating 
actively in the symptom management process. Constitutive across all interviews were the two distinct 
positions of the two players. PLWH seemed to be the managers taking a clear leadership role, whereas 
their CSPs appeared to be their companions who supported them in specific areas of symptom 
management. The positions of ‘being a manager’ and ‘being a companion’ were closely connected, 
which is portrayed by the theme ‘keeping in touch.’ Two other themes, ‘putting symptoms into place’ 
and ‘working things out’, each with diverse sub themes, further reveal the collaboration in symptom 
management as Figure 2 shows:  
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Figure 2: Constitutive pattern of collaboration in symptom management  
 
Being a Manager 
Interviews showed that PLWH made a clear decision to not only manage their symptoms but actively 
manage the entire chronic condition. The feeling of having a grip on HIV rather than being controlled 
by it seemed most important for them. Their narratives revealed broad medical knowledge and 
expertise related to their own health and wellbeing. PLWH seemed to purposefully integrate the 
expertise of health care providers and CSPs in their management. A female participant shared her 
experiences:  
The virus is not a problem, it is quiet. My lab parameters are fine and I don’t have 
any problems with my meds. I am so pernickety; I always take them every morning in 
the same order. But the fatigue is something I have to get a grip on again. I really 
have to discuss it with my doc next week.  
 
Being a companion  
CSPs emphasized a strong commitment to stay in the relationship despite HIV. With a strong focus on 
PLWH illness management, CSPs talked about finding their own responsibilities in the process 
according to their own resources. For instance, CSPs talked about supporting medication management, 
general health behaviors such as exercise and nutrition, and symptom management. A CSP finding his 
own responsibility in symptom management reported: 
keeping in touch Being a manager Being a companion 
Putting symptoms into place 
• learning to judge 
• feeling affected 
      Working things out 
• developing strategies 
• dealing with health care providers 
• handling burden 
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Well, if he has a cold or any kind of infection, I feel a little responsible to evaluate if 
it’s necessary for him to see his doc. You know, since I kind of have a professional 
background. 
Keeping in touch  
Despite a broad diversity in lifestyles, participants highlighted the importance of close and ongoing 
contact with one another. PLWH wanted to know about the wellbeing of their CSPs and whether they 
felt burdened by anything. This seemed important, since a struggling partner together with their own 
difficulties could make PLWH feel like they were losing their grip on HIV. They mentioned that CSPs 
made it possible for them to live meaningfully and actively manage their condition. In addition, CSPs 
wanted to know about the wellbeing of the PLWH in order to better understand behaviors and provide 
adequate support. Knowing about a PLWH’s health status seemed to help them overcome fears of 
losing their loved ones. Ongoing exchanges about clinic visits, medication scheduling, or symptoms 
were integrated into daily routines. Nevertheless both parties reported taking special efforts to enable 
exchanges, illustrated through the example of a male CSP: 
I drive her to the clinic, because I think it’s easier for her and on the way back we 
have time to talk, you know we drive for more than an hour and that’s time to talk 
about it.  
Participants also revealed that exchanges had to be carefully balanced in order not to overburden each 
other. For many of them, other discussion partners were rare or not available, since they carefully 
balanced their need to talk with others against possible negative consequences of HIV status 
disclosure.  
Putting symptoms into place 
Participants explained the importance of watching out for new or changing symptoms and putting 
them into a known frame of reference. PLWH revealed a constant monitoring of their own state of 
health and occurring symptoms, whereas their CSPs did not seem to observe the situation constantly. 
However, they were attentive and listened to PLWH in their daily exchanges. The following three sub 
themes ‘learning to judge,’ ‘feeling affected,’ and ‘not talking about it’ explore this process further. 
Learning to judge. Participants described a learning process, which made it easier for them to put 
symptoms into a known frame of reference. PLWH explained how they improved their knowledge 
about possible treatment side effects and HIV related symptoms, learned to interpret their lab 
parameters, and learned to be sensitive to small body reactions. They learned from their own 
experiences and from health care providers. Health care providers were described as important 
partners, especially at the beginning. A male PLWH said:  
Nowadays I take symptoms in a more relaxed way, if I have a rash or something like 
that, I recognize it but I am not scared anymore. In the beginning I went to see the doc 
immediately in order to get decision making support. Today I tell the doc to wait with 
examinations. I just know it could be this or that, I wait and I realize if it’s something 
more serious. In such a case I don’t put it off for long.  
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There was more variation among the CSPs’ stories. Some explained that knowing about possible 
symptoms and side effects helped them to overcome fears. They mostly learned about HIV from 
PLWH or from the media. Others favored a kind of “naive” view on symptoms. They explained that 
they did not want to learn anything about HIV since it helped them to interpret symptoms on an 
everyday level. They experienced this as complementary to PLWH symptom interpretation. Another 
group of CSPs had some sort of professional background which they used for basic knowledge. They 
mentioned how they expanded their knowledge through professional on-line searches or by asking 
knowledgeable colleagues. This group most often expressed fear of a misjudgment related to 
symptoms. One CSP revealed: 
In the case of infections, I feel responsible to help him to evaluate if he has to see the 
physician. But it is difficult sometimes, since I don’t want to blame myself for waiting 
too long or giving the wrong advice.  
Feeling affected. All participants described many similar stories about the course of certain symptoms. 
PLWH talked about the most difficult symptoms, which could not be sufficiently managed over time 
and caused uncertainty, fear and loss of morale. CSPs discussed how they recognized a PLWH’s 
suffering and expressed empathy and understanding. They stated that they were not as affected by the 
symptom as the PLWH was and did not feel stressed or bothered by the problem itself. In spite of this, 
they felt bothered by symptoms that influenced their relationship and common activities. One CSP 
said:  
I got the impression that his meds make him incredibly tired and this really troubles 
me. If we watch a movie together or we want to discuss something, after ten minutes 
he starts snoring, this really gets on my nerves. I really do not know if it is connected 
to the medications, the illness, or whether it would have been like this anyway. 
His partner with HIV explained: 
The fatigue got worse and worse. In our relationship this was a huge disturbing 
factor, since my partner just can’t handle it. I still work full time, but in the evenings I 
let go and then I fall asleep when I sit down. For him it’s very negative; for me it’s 
more positive. 
Not talking about it. Participants explained that symptoms which PLWH felt they had a grip on were 
almost never discussed in daily life. Yet there also appeared to be reasons for not talking about new 
symptoms or old ones which were still distressing. Some PLWH reported dealing with all of their 
symptoms on their own or including health care providers as primary discussion partners. Other 
PLWH explained that they tried to not overburden their CSP by carefully balancing discussions about 
distressing symptoms. They also withheld symptoms if the CSP seemed to be very fearful. One PLWH 
explained: 
There are certain things I don’t tell him. If I have headaches again, I don’t tell him, 
because otherwise he concludes it’s something because of the illness.  
CSPs mentioned situations where they felt the PLWH was suffering from symptoms but did not talk 
about them. This seemed to cause feelings of powerlessness for some of them. CSPs also revealed that 
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they sometimes observed symptoms which they did not share with the PLWH. They mentioned 
symptoms like memory loss and concentration problems, which, they assumed, might be very stressful 
for the PLWH. One CSP reported: 
Well, sometimes I realize that she stops in the middle of a sentence and then starts 
talking again about something else. She had these gaps and she doesn’t realize it. But 
I’ve never discussed it with her. I think it would be very distressing for her. 
Working things out 
Participants described how they worked out strategies with the aim of curing symptoms or integrating 
them into daily life and reducing stress. Sometimes symptoms could be dealt with quickly and easily. 
In such cases the PLWH dealt with the symptoms on their own and they did not appear as major issues 
in the corresponding CSP narratives.  
The situation was however different in the case of distressing symptoms. Here, both PLWH and CSPs 
described how they each had to handle their emotions and how they sometimes worked out strategies 
either collaboratively or on their own. This process is further described by the following sub themes: 
‘developing strategies,’ ‘dealing with health care providers’, and ‘handling burden.’ 
Developing strategies. Participants revealed that very individualized strategies had to be worked out in 
order to manage PLWH’s distressing symptoms efficiently. PLWH reported a process of testing 
different ways to deal with symptoms in which they integrated recommendations from health care 
providers, friends, and peers as well as from diverse media sources such as the internet. One female 
PLWH explained: 
I have this diarrhea and the doc gave me Imodium (Loperamide). But over time I 
learned to better manage it. I used Bioflorin which rebuilds the intestinal mucosa. It 
works for me now. I have also tried managing (the diarrhea) with food. For a while I 
ate bananas.  
There were varying accounts of the collaboration between PLWH and CSPs. Some CSPs reported 
being actively integrated in the testing of different ways to manage symptoms. Others said that they 
mainly listened to the PLWH’s stories and encouraged them to reflect on their symptoms. They also 
brought their own suggestions into these discussions. Some CSPs mentioned that they were not 
integrated into the development of strategies. In situations where PLWH were struggling with 
management, CSP often seemed to experience a sense of being excluded. As one male CSP revealed: 
I would like to be more involved with his problem solving, since it’s difficult for him. I 
still have resources and would be able to mobilize strengths to support him, in order 
to make him feel better and make both of us feel better.  
Dealing with health care providers. Participants’ narratives revealed health care providers to be 
important partners for working out symptom management strategies. PLWH emphasized the 
importance of a close participative relationship with health care providers. They actively asked 
questions and developed strategies collaboratively. Yet providers were not always experienced as 
helpful partners. PLWH talked about providers who did not seem to listen and appeared to push their 
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own agenda. If PLWH experienced such behaviors while struggling with symptoms, they expressed 
feelings of insecurity, distress, and desperation. A male PLWH reported: 
All went well for years. I had the impression they [physicians] appreciated how well I 
managed besides a full time job. Now I have this fatigue and everything has changed. 
I sometimes think my lab results are still too good to be taken seriously. My last 
physician for example, in every consultation he told me that he wants to take me off 
the antibiotics and have me go back to work. He really scared me, I almost panicked. 
I always wanted to work, that’s not it, but now I think they don’t take my problems 
seriously. 
Their CSP did not appear to be directly involved in the collaboration with health care providers even 
though some had accompanied PLWH on clinical visits. Nevertheless CSPs reported discussing 
PLWH’s clinical consultations and relationships regularly with health care providers. Accordingly 
they provided emotional or decision making support and sometimes encouraged the PLWH to contact 
a health care provider. Knowing about a positive PLWH-provider relationship seemed to relieve their 
own fears and sense of burden. As one male CSP put it:  
I’m not stressed, I know she goes to see her doc every three months and also 
goes there in between if necessary. If something comes up, I just tell her to call 
the doc and ask him if it’s something normal or not. 
Handling burden. Difficulties in the management of symptoms over time were shown to cause stress 
and be a burden for participants. PLWH emphasized that their CSP were important partners to share 
feelings of fear, sadness, and desperation related to unsuccessful symptom management. At the same 
time they revealed how they had to focus strongly on their own needs. Even though they sometimes 
talked about feeling guilty toward their CSPs, they described this process as important in stabilizing 
their situation and recovering their strength. A male PLWH explained:  
They [friends] have to accept it. I sometimes tell my partner that I can’t go out 
that day, I don’t feel well and I just can’t. For me, rest is most important, and 
over the years I have arranged my life according to the rest I need, it works 
out that way.  
CSPs seemed sometimes torn between arguing with PLWH about their own needs and being 
understanding toward PLWH. Due to the restrictive disclosure of HIV status, other support persons 
were limited. CSPs who seemed to cope well with the burden reporting escaping briefly, doing 
recreational things on their own, and organizing their needs around those of PLWH. A male CSP 
reported: 
There are situations that are how they are, one has to accept it. And I’ve now 
learned to organize my free time (space) according to her symptoms and not 
the other way around. We just have to be at home by 3 pm, in order for her to 
relax; otherwise the evening is a mess.  
Concordance in symptom experience reports  
Participants’ narratives provided an in-depth insight into their collaborative management of symptoms. 
Based on those insights we further explored their concordance in symptom experience reports. Three 
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hypotheses drawn from participants’ narratives and tested in the larger sample of 122 dyads are 
described below. 
The first hypothesis was that PLWH reported more symptoms than their CSPs did. Participants’ 
stories often circled around similar symptoms. Nevertheless PLWH used very straightforward and 
clear language whereas their CSPs use of language often reflected some insecurity about the symptom 
reports, for example: “I think he had diarrhea at that time.” There were statistically significant 
differences in symptom reports over the last week, with PLWH and CSPs reporting a median of 16 
(Q1= 9; Q3=  24) and 12 (Q1= 5; Q3= 17) symptoms respectively (p < 0.001). 
The second hypothesis was that there were specific symptoms that were more often reported by CSPs 
than by PLWH. CSPs’ stories revealed that they did not talk to the PLWH about certain symptoms 
such as memory loss or forgetfulness in order not to hurt or offend them. Results revealed significant 
differences in symptom reports for 16 out of 73 assessed symptoms as shown in Table 2. All 16 
symptoms were reported more often by PLWH. 
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  Table 2: concordance / discordance of PLWH’s and their CSPs’ reports on presence of symptoms 
  
Symptom 
(in order of appearance in 
questionnaire) 
Appraisal of symptom by PLWH 
and CSPs 
N=122 
  
   
    
Ho=1 
  
yes by 
PLWH yes by CSP Mc Nemar (paired test)   
  
n n Chi-square 
p-value 
(2-tailed)  q-value 
      
muscle cramps  18 6  0.0231 0.088 
weakness  23 13 2.25 0.1342 0.245 
painful joints 16 17 0.01 1 1 
fatigue 24 9 5.94 0.015 0.064 
muscle aches 16 7  0.0931 0.2 
fever 6 10  0.4541 0.603 
chills 11 15 0.35 0.5562 0.712 
flushing 19 18 0 1.0002 1 
night sweats 20 11 2.07 0.151 0.262 
day sweats 12 3  0.0351 0.116 
sensitivity to insect bites 7 5  0.7741 0.869 
increased sensitivity to hematoma 3 5  0.7271 0.842 
weight gain  12 9  0.6641 0.822 
weight loss 8 14  0.2861 0.426 
weight gain in stomach area 19 21 0.025 0.8742 0.967 
hump on back of neck / shoulders 2 4  0.6871 0.836 
skinny arms and legs 13 5  0.0961 0.2 
swollen feet / legs 8 3  0.2271 0.365 
prominent leg veins  17 7  0.0641 0.146 
fear / worries 30 12 6.88 0.0092 0.041 
anxious 31 12 7.54 0.0062 0.037 
decreased ability to withstand 
psychological distress 26 13 3.69 0.0552 0.146 
depressed mood 23 11 3.56 0.0592 0.146 
dizziness 25 7 9.03 0.0032 0.024 
seizures / tremors  4 3  1.0001 1 
difficulty concentrating 35 9 14.21 2.00E-42 0.003 
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memory loss 21 6 7.26 0.0072 0.039 
forgetfulness 27 10 6.92 0.0092 0.041 
insomnia / can't sleep 21 10 3.23 0.0722 0.159 
vivid dreams 21 13 1.44 0.2302 0.365 
headaches 19 13 0.78 0.3772 0.54 
nose bleeds 8 4  0.3881 0.545 
dry mouth 24 11 4.11 0.0432 0.121 
mouth ulcers 14 6  0.1151 0.221 
white patches in mouth 3 1  0.6251 0.787 
sore, bleeding gums 21 4  0.0011 0.009 
blood in spittle /sputum 3 0  0.2501 0.388 
caries / brittle teeth 15 5  0.0411 0.12 
swollen glands 14 6  0.1151 0.221 
sore throat / painful swallowing 14 5  0.0641 0.146 
tingling in head area 14 1  0.0011 0.009 
blurred vision 22 3  2.00E-41 0.003 
shortness of breath at rest 6 5  1.0001 1 
shortness of breath with activity 17 6  0.0351 0.116 
coughing 20 13 1.09 0.2962 0.432 
heart racing 13 3  0.0211 0.085 
chest pain 7 2  0.1801 0.306 
feeling of restriction in chest 18 4  0.0041 0.029 
heartburn 20 11 2.07 0.1512 0.262 
abdominal pain 16 11 0.59 0.4412 0.596 
lack of appetite 12 12  1.0001 1 
increased appetite 9 5  0.4241 0.584 
thirst 16 9  0.2301 0.365 
nausea 14 5  0.0641 0.146 
vomiting 6 4  0.7541 0.86 
gas / bloating 28 13 4.78 0.0292 0.106 
constipation 11 3  0.0571 0.146 
diarrhea 23 10 4.36 0.0372 0.117 
Rectal itching 22 0  1.00E-71 0 
Rectal bleeding 10 2  0.0391 0.119 
numbness / tingling in arms, hands, 
fingers 18 1 
 
8.00E-51 0.003 
numbness / tingling in legs, feet, toes 23 3 13.89 2.00E-42 0.003 
dry skin 25 8 7.76 0.0052 0.033 
itchy skin 20 10 2.7 0.1002 0.203 
reddening skin 10 11  1.0001 1 
increased rashes 14 10  0.5411 0.705 
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hair loss 9 4  0.2671 0.406 
splitting finger nails 15 1  0.0011 0.009 
change in body hair 5 3  0.7271 0.842 
nipple discharge 2 1  1.0001 1 
breast pain / breast changes  7 1  0.7001 0.838 
Sores or lumps on genitals 4 0  0.1251 0.234 
Burning with urination 8 0   0.0081 0.041 
1 exact significance, two-tailed; binomial distribution 
2
 asymptotic significance, two-tailed; continuity corrected 
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The third hypothesis was there was no discordance between CSPs and PLWH for symptoms reported 
as being very stressful by PLWH. When participants talked about their most distressing stories, dyads 
often used almost the same wording. From the 73 assessed symptoms, 55 were reported as being 
‘distressing’ by PLWH, with average distress levels ranging from 1.52 to 2.95 on a scale of 1 to 3. The 
20 most distressing symptoms as rated by PLWH are shown in Figure 3. Of these 20 symptoms, there 
was discordance among the reports on four of the symptoms, which were also most often named by 
PLWH: memory loss, anxious, forgetfulness, and feeling restriction in chest (symptoms shown in 
Table 2) 
Figure 3: The twenty most distressing symptoms for PLWH 
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■ Marked black: discordant reports of symptom presence by PLWH and CSP 
 
Discussion 
Participants’ narratives provided insights into a collaborative process of managing symptoms. This 
collaboration has been shown to be constituted by distinct but integrative positions. The positions, in 
particular the clear leadership of PLWH, seemed to be reflected in the descriptions of daily symptom 
management issues and also in symptom experience reports. The latter revealed that PLWH reported 
on more symptoms overall, that no symptoms were reported more often by CSPs, and that there was 
discordance among the two players’ reports for some of the most distressing symptoms for PLWH . 
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Consistent with earlier research, our results highlight a complex process of managing symptoms in 
everyday life and shed light on PLWH taking a clear position to actively manage such challenges [18, 
22]. Compared to these earlier investigations, this study highlights symptom management as a 
collaborative task between PLWH and CSPs and provides insight into this process. So far, 
involvement of CSPs into symptom management has mostly been described as ‘informal care giving’ 
with support flowing in a unidirectional manner from caregiver to care recipient [183]. A few 
qualitative studies have added the relational and often reciprocal dynamics of informal care giving 
[184, 185]. Lingler et al. recently pointed out the shortcoming of those perspectives: On the basis of 
three case examples they highlighted the diversity in care giving relationships and the need for a 
broader understanding of informal care giving, in order to yield findings and develop interventions 
that carry greater clinical relevance [126]. The different but connected positions of PLWH and CSPs, 
with the clear leadership of PLWH in symptom management and strong partnerships between both 
players, add an additional dimension to the debate, yet to our knowledge, prior discussions have not 
taken account of this perspective. This seems especially important in the field of HIV/AIDS, where 
most publications on informal care giving described situations before highly active antiretroviral 
treatments became well established and helped to reduce morbidity. In those early studies the 
importance of non stigmatizing and reciprocal caring partnerships was emphasized, yet the active lead 
of PLWH in the management process was not described [32, 186, 187]. 
In accordance with previous studies, PLWH experienced a fair number of symptoms. For example, 
this study revealed an average of 16 symptoms per person during the previous  week, whereas an 
earlier study for the same time period found an average of 14 symptoms for PLWH also on cART 
[10]. In contrast to a recent investigation into cancer patients and their CSPs, where a small to 
moderate trend for CSPs to overestimate symptoms was described [35], CSPs in this study reported on 
significantly less symptoms than PLWH. Not one single symptom was reported more often by CSPs. 
This might be explained by the different positions of PLWH and CSPs in the management process, 
with PLWH taking overall responsibility and integrating their CSP into different aspects of the 
management process. The different positions in the management process could also be influenced by 
health care systems that strongly focus on the individual and do not routinely integrate CSPs into their 
services.  
Describing the collaboration in symptom management from a qualitative and quantitative perspective 
has broadened understanding of the issue. For example, the intense monitoring described by PLWH 
but not by CSPs, described as ‘putting symptoms into place’ could also be reflected in the quantitative 
survey results, illustrating that PLWH report on more symptoms than CSPs do. Yet the mixed method 
approach also provided unexpected results which were not easy to interpret. For example the sub 
theme ‘not talking about it’ illustrated that participants withheld symptoms in order to protect each 
other. CSPs in particular mentioned diverse neurocognitive problems they recognized but did not want 
to talk about with PLWH in order not to hurt them. This led to the hypothesis that some symptoms 
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were reported more often by CSPs. Interestingly however this could not be proved. Symptoms such as 
‘difficulty concentrating,’ ‘memory loss,’ and ‘forgetfulness’ were reported discordantly but more 
often named by PLWH. Further research is needed to shed light on this situation. One explanation for 
the somewhat unexpected results might be that in our society, cognitive impairments are highly 
stigmatized, especially in a middle aged population as was involved in this study. Goffman explained 
stigma as an attribute that is deeply discrediting and separates people with an undesired differentness 
from others [188]. To protect themselves from shame and social rejection, the affected persons 
continuously struggle with the decision of whether or not to talk about their stigmatizing attributes 
[92]. Even though the PLWH in this study had disclosed a stigmatized attribute such as their HIV 
infection to their CSP, it could be the case that they still struggled to talk about possible 
neurocognitive problems. The qualitative results clearly revealed such difficulties in communication 
for the CSPs. During the past few years, neurocognitive deficits in PLWH have received growing 
attention. However, the discourse has remained mostly on an epidemiological and biomedical level, 
describing the aging HIV population and neurocognitive deficits, the influence of cART on 
neurocognitive deficits, and associations of biological processes such as chronic infections on 
neurocognitive deficits [189, 190]. Health care providers should broaden this discussion and include 
patient perspectives in order to provide everyday symptom management support for PLWH and their 
CSPs. This seems highly important since it has been shown that neurocognitive deficits in PLWH 
influence activities of daily living and work performance [115, 191]. 
Overall the exploratory mixed method approach moved the two described phenomena of symptom 
experience and symptom management, which have previously often been treated as distinct, closer 
together. This provided new insights into the collaboration between PLWH and CSPs on both tasks. 
The described active and leading position of PLWH in the symptom management process and the 
active companionship (support) of CSPs appears to be a prerequisite for successful symptom 
management. Nevertheless this collaboration and in particular symptom communication should be 
supported by health care providers in order to improve health outcomes for PLWH. This requires a 
more family or dyad oriented approach with the integration of CSPs into some of the clinical services. 
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Chapter 7 
Discussion 
Patient self-management and the collaboration of patients, close support persons and health care 
providers have been strongly linked with improved health outcomes in chronically ill populations [19, 
58]. The research presented above contributes to improving chronic care services for the population 
affected by HIV by improving understanding of PLWH’s self-management and the various 
collaborations this process entails.  
Six main areas have been covered: a) The different tasks of HIV self-management described in the 
literature have been summarized and categorized; b) The complexity of evidence based HIV specific 
self-management support in clinical care has been described, with a case report presented in Chapter 
Three; c) Evidence on interventions to enhance adherence of PLWH has been reviewed and presented, 
in Chapter Four; d) Insights into the tasks of medication and symptom management have been 
provided, from the perspectives of PLWH and CSPs, in Chapters Five and Six. One key finding was 
the aim of PLWH to maintain a grip on their HIV and of the dynamics that could lead to the loss – or 
the sense of loss – of that grip; e) Collaborations between PLWH, CSPs and HCPs regarding 
medication and symptom management – thus so far the focus of little attention – have been described 
in depth in Chapters Five and Six. This underscored the importance for PLWH of building working 
relationships with CSPs and HCPs to better manage their condition, and provided insights into the 
different roles PLWH and CSPs assume regarding collaboration. f) The symptom management 
experiences of PLWH and CSP have also been tested for concordance with symptom experience 
reports as presented in Chapter Six. This isolated a cluster of neurocognitive symptoms that some 
CSPs recognized but did not wish to discuss with their PLWH, whereas, in a larger sample assessment 
of the concordance between symptom reports revealed that all symptoms were reported more often by 
PLWH. 
Several findings of this research program have already been discussed in the presented articles. This 
discussion will focus on a broader discussion of key findings across articles and on the discussion of 
methodological issues. Implications for further research and suggestions for clinical implementations 
will also be presented. 
Discussion of key findings 
The discussion of the key findings across the research program has been structured into three key 
points: the complexity of HIV self-management, PLWH as active self-managers and collaborations 
within self-management. 
The complexity of HIV self-management  
Growing evidence suggests that HIV self-management is a phenomenon incorporating diverse tasks 
and numerous interactive dimensions; nevertheless, this phenomenon has not yet been well described 
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[18, 22]. This research program casts light on the complexity of this phenomenon by integrating and 
contrasting perspectives on HIV medication and symptom management from the perspectives of 
different players and by reviewing the literature on HIV specific self-management. These two aspects, 
i.e., the different perspectives on HIV self-management and the literature review on HIV self-
management, will be further discussed below. 
Self-management of chronic conditions is influenced both by the characteristics of the respective 
conditions and by characteristics of the social and political context in which self-management takes 
place. This is especially relevant for a chronic condition such as HIV/AIDS, which bears a stigma 
[96]. Despite efforts to educate the public, this stigma persists, alongside false beliefs that HIV/AIDS 
is a highly contagious disease leading inevitably to great suffering and death. Further, the stigma and 
its connected assumptions discount the condition as a consequence of socially devalued behavior, such 
as homo- or bi- sexuality, promiscuity and illicit drug use [93, 96]. Thus, when speaking about 
experiences with HIV self-management, different players such as policy makers, HCPs, PLWH and 
their CSPs construe different discourses about these experiences [192]. Whether in the form of written 
texts or conversations, such discourses always inherit social norms that shape the involved 
relationships and therefore produce meaning [180]. This research program provides insights into the 
discourses of PLWH and CSPs, and a limited description of HCP perspectives.  
The perspective of HCPs was, however, integrated in the description of a published clinical case 
report. The presentation of such texts is influenced by explanatory models and language used in the 
medical community and therefore also provides insights into this group’s dominant perspective on 
HIV self-management [192]. However, critiquing medical texts on HIV self-management has not been 
a focus of this research program and its depiction of the medical perspective is therefore limited.  
Körner and Treloar conducted an analysis of discourses in medical journal editorials regarding their 
representations of people with HIV as opposed to those with hepatitis C. They noted that the discourse 
on Hepatitis C patients remained almost exclusively on a biomedical level, whereas, in HIV editorials, 
after the biomedical aspects had been accounted for, PLWH were described as active participants that 
belonged to cultures and subcultures and had a diversity of needs [192]. We agree with Körner and 
Treloar that such diverse discourse is important for the development of the medical field, adding that it 
is also crucial for developments on a policy level. By giving voice to the experiences of PLWH and in 
particular CSPs actively managing medications and symptoms, this paper expands the diversity of 
perspectives discussed in the medical setting. 
The complexity of HIV self-management is also constituted by the challenges of the condition itself. 
Despite descriptions of many issues relevant to HIV specific self-management, including adherence, 
transmission risk or symptom management, to our knowledge, HIV self-management has been neither 
described comprehensively nor fully summarized. Based on a literature search including publications 
until June 2009, and on the Lorig and Holman’s self-management conceptualization, we summarized 
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and categorized HIV specific self-management tasks and skills [17]. The result was a comprehensive 
description of HIV self-management tasks and skills usable as a guiding framework to plan both 
clinical self-management support interventions and HIV self-management oriented research projects. 
Both aspects will be further elaborated below. 
Respecting clinical care, the complexity of self-management support is highlighted in the clinical case 
report in chapter three. Based on a comprehensive assessment of self-management support needs, 
health care providers had to implement a range of evidence based and individualized intervention 
strategies to improve health outcomes for the described patient. These strategies focused on multiple 
self-management tasks combining such categories as adherence, symptom management and substance 
use. To structure and plan these interventions, we used the self-regulatory HIV/AIDS Symptom 
management model (SSMM-HIV) developed by our team [28].  
However the strong focus of this research model on one self-management task (symptom 
management) might have hindered the assessment of self-management support needs in other areas. 
For example, the model includes symptom management, adherence and social support, yet such a 
close concentration on that model may have led researchers to neglect self-management deficits 
relating to transmission risk management. We therefore propose that in clinical care a more 
comprehensive framework, centered, for example, on the described self-management tasks and skills, 
would be helpful to form an overview of deficits in self-management tasks; we additionally propose 
that models developed for research focusing on one or two self-management tasks, such as the SSMM-
HIV, might be employed to explore the respective tasks in depth [28]. 
Regarding research, the description of HIV self-management tasks and skills might also serve as a 
guiding framework to better plan intervention programs focusing on combinations of self-management 
tasks and skills. To serve as a research model, the description will require further refinement regarding 
those tasks and skills. Later, the completeness and distinctness of the various tasks should be evaluated 
and relations between them worked out more clearly.  
Additionally, the relational components of HIV-self-management should be integrated into the 
framework. Our own results show that PLWH actively collaborate with CSPs and HCPs to manage 
medications and symptoms, and that these collaborations clearly reinforce PLWH’s self-management. 
The influences of HCPs’ communication skills and other specific aspects of collaboration on PLWH’s 
self-management have been documented elsewhere [36, 38, 193]. As proposed above, based on a 
comprehensive literature review, a relational component could be integrated by describing the tasks 
and skills of HCPs and CSPs – parallel to those of PLWH – for self-management support. 
PLWH as active self-managers 
PLWH narratives provide rich descriptions of active medication and symptom management strategies. 
They describe, for example, how PLWH develop expertise, constantly monitor and evaluate their 
condition, and learn from different sources to improve their medication and symptom management. 
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These findings are consistent with the mostly qualitative existing research describing chronically ill 
participants who perceive themselves as actively managing and drawing on a range of support in doing 
the long and often hard work [18, 194, 195]. In this study, PLWH additionally illustrated active self-
management through their collaborative roles with their CSPs. Whereas PLWH felt responsible for the 
overall management of their condition, their CSP felt responsible to support defined aspects of that 
management.  
This study replicated an important result described by Thorne et al., who showed that, at some point, 
participants with diverse chronic conditions (diabetes, multiple sclerosis, HIV/AIDS) decided 
unequivocally to assume control over their conditions. This development presented a shift in their 
relationships to their diseases and their management. “Being in control” meant being able to mediate 
the effects of the disease so that they could live as normally as possible [18]. With the constitutive 
pattern described in the qualitative results of Chapter Five (‘I have a grip on HIV - HIV has a grip on 
me’) PLWH in this study described a similar phenomenon.  
However, our findings additionally reveal a dynamic process with two interchanging conditions. At 
one pole, PLWH felt fully able to manage the difficulties of their condition and keep up a meaningful 
life; at the other, they felt overwhelmed by difficulties and unable to manage. If changes in health and 
treatment were not sufficiently manageable, participants described changes in their ability to ‘keep a 
grip on HIV’. Such changes were described by all participants, regardless of their experiences and 
self-management competencies, throughout the course of the illness. This phenomenon of a constantly 
changing condition that can not always be successfully managed might results largely from the 
unpredictability of HIV infection compared to other chronic conditions [45]. Thus, with regard to self-
management support for PLWH, the perceptual shift between ‘I have a grip on HIV’ and ‘HIV has a 
grip on me’ is a matter of considerable concern: participants who perceived that they were losing their 
grip on HIV described feelings of uncertainty, fear, and loss of morale. This can have serious 
repercussions: a range of studies have indicated that symptoms of depression can hinder effective self-
management. For example, evidence indicates that depressive symptoms influence readiness to initiate 
cART, adherence to cART and health improving behaviors, and overall quality of life [6, 21, 27, 30, 
46]. 
Individual behaviors, including those involved in self-management of a chronic condition, are further 
influenced by social norms and values [180]. In western societies, health and related productivity are a 
dominant expression of quality of life: physical wellbeing has become achievable for virtually 
everyone. With improvements in diet and medical care, social expectations have grown, so that even 
the chronically ill assume a responsibility to actively monitor and maintain their health [196]. 
Therefore, the high priority of maintaining a chronic condition, as illustrated by our results, which 
concur with those of other investigations, might be influenced by such values.  
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However, the findings of this study do not allow for broad generalization, as there could be differences 
across subgroups of PLWH. For example, a qualitative investigation in Australia described differences 
between an English speaking test group and their Arabic / Turkish speaking counterparts regarding 
their emotional reactions to diabetes: whereas the English speaking group emphasized the need to 
control the condition, the Arabic / Turkish speaking group emphasized the need to minimize the stress 
it caused [37].  
Nevertheless, across a broad range of chronically ill populations the often challenging work that lies 
beyond self-management does not seem well recognized, whether in society at large or in the 
healthcare community [17, 195, 197]. For PLWH in particular, society’s under-valuing of their 
contribution to their own health is exacerbated partly by their condition’s general lack of visibility, and 
partly because a fear of  stigmatization means PLWH generally inform only a close circle of persons 
about their condition [33].  
The stigma of HIV, a social context where individuals are expected to maintain optimal health, and 
professionals’ frequent under-recognition of self-management support needs could increase PLWH’s 
risk of negative health outcomes. 
Self-management collaboration 
As with previous research, this study’s PLWH’s narratives described purposeful integration of close 
support persons and health care providers to better manage their condition (Thorne, Furler, Chenard). 
HCPs, for example, were consistently described as important sources of information [18, 37, 93], 
whereas CSPs were recognized as providers of various kinds of functional and emotional support on 
an everyday level [31, 33, 187].  
However, the integration of persons from one’s social network into the process of self-management is 
clearly influenced by HIV related stigma [33]. In this study, PLWH described how carefully they 
weighed HIV disclosure to family members and friends related to their self-management. For 
example, in order to avoid complications with medication intake, they might disclose HIV status to 
friends before spending vacations together.  
Concordant with such behavior, Thorne et al. pointed out that disclosure decisions were relevant to 
PLWH’s participation in group based self-management education programs [18], while Chenard 
described that gay men used various disclosure management strategies to build up a social support 
system [93]. An earlier qualitative investigation, also conducted in Switzerland, revealed that HIV 
disclosure prompted family members to adopt stances of closeness, ambivalence, or distance regarding 
PLWH and that few close family caregivers were willing to assume care-giving tasks [33].  
Altogether, these findings highlight that HIV related stigma still shapes the social networks of PLWH, 
the support they receive from others and, therefore, their ability to manage their condition. Healthcare 
providers should therefore always consider stigma associated issues when planning clinical 
interventions or research. 
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A particularly important outcome of this research program is the deepening of our understanding of 
the collaboration of PLWH and CSPs. The description of the different roles these two groups adopt in 
the management of symptoms provides new insights into informal care interactions, which, to our 
knowledge, had not previously been described. In the current literature, collaboration between PLWH 
and CSPs has received considerable attention regarding populations subject to age-related dysfunction, 
Alzheimers disease and other chronic conditions such as cancer [126, 185]. 
Much of this literature focused on caregiving and care receiving as distinct constructs, suggesting that 
informal support flows unidirectionally from caregiver to care recipient [126]. Few qualitative studies 
added the relational and often reciprocal dynamics of informal caregiving [184, 185]. Regarding 
HIV/AIDS most literature on informal caregiving was conducted before cART became widely 
available and reduced HIV related morbidity significantly. In those early studies, CSPs revealed 
uncertainty about the timing and meaning of PLWH’s deaths, symptoms and disclosure of HIV status 
as their main social and psychological issues [198]. Further non stigmatizing and reciprocal 
partnerships were also described [33, 186, 187, 198].  
Concordant with the pre-cART reports, the PLWH and CSP narratives presented in chapter six 
revealed that the two groups collaborated closely to manage the condition. Yet, in contrast to earlier 
investigations, this collaboration was characterized by distinct roles, in which the PLWH typically 
assumed clear leadership roles regarding the overall management of the condition, whereas their CSP, 
as ‘companions’, tried to recognize and support aspects of self-management where they could. This 
reflects partnership to an extent; compared to the earlier investigations, though, the PLWH have 
emerged much more as the drivers of the care process. This insight into the collaborative dynamics of 
PLWH and CSPs is fundamental to any plans to integrate CSPs into research based clinical 
interventions. 
To our knowledge, concordance between patient and CSP symptom reports has not been analyzed for 
the PLWH population; we therefore provide the first insights into the issue. A recent study of cancer 
patients and their CSPs detected a small to moderate tendency among CSPs to overestimate the 
presence of symptoms [35]. In contrast, the current study’s CSPs reported significantly fewer 
symptoms than the PLWH they supported. Not a single symptom was reported more often by CSPs. 
 This difference regarding symptom perceptions in the cancer population’s CSPs compared to those of 
the HIV population may result, to some extant, from the different roles of PLWH and CSPs in the 
management process, as described above in this study’s qualitative results. Nevertheless, until further 
research is conducted to clarify such matters, no conclusions can be drawn.  
Additionally, two of our hypotheses based on participants’ narratives could not be proved in the 
quantitative analysis. The first was that some symptoms would be reported more often by CSP; the 
second was that the most distressing symptoms would be reported concordantly. Several content based 
explanations are included in the discussion section of the article presented in Chapter Six.  
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A more method oriented discussion is presented in the following section. However, one issue might 
still be highlighted at this point. CSP narratives revealed that they specifically did not wish to discuss a 
range of neurocognitive symptoms with the PLWHs. In the quantitative analysis, two such symptoms 
– memory loss and forgetfulness – which were reported as most distressing by PLWH, were also 
reported significantly more often by PLWH.  
Despite any inter-method inconsistencies, the fact that CSPs cite difficulties talking about such 
symptoms, while PLWHs report some of the same symptoms as most distressing, highlights the need 
for increased attention to self-management support regarding neurocognitive symptoms. So far, 
neurocognitive symptoms have mainly been discussed on a biomedical level, with management 
approaches focusing on antiretroviral regimens offering better cerebrospinal fluid penetration [199]. 
However our results point out the need to integrate PLWH and CSP perspectives into the medical 
discourse in order to reinforce their self-management collaboration. 
From the perspectives of PLWH in this study, health care providers are important partners in ‘keeping 
a grip on HIV’. This is congruent with the observations other investigations on the importance of 
HCPs to PLWH in gathering information, gaining confidence and developing a sense of control [18, 
37, 38].  
The current study adds to the existing knowledge not only by describing the PLWH-HCP 
collaboration but by giving insights into collaboration with a third player: CSPs. To our knowledge, 
research on the collaboration between CSPs and HCPs has focused only marginally in HIV research. 
A qualitative study conducted before cART was available revealed that CSP’s actively negotiated 
partnerships with HCPs in order to provide the best possible care to PLWH [198].  
In contrast, our study’s PLWH and CSP narratives revealed almost no CSP interaction with HCP’s. 
Further, PLWH often passed on information they had received from health care providers to their 
CSPs: PLWH educated their CSPs with the goal of establishing partnerships to maintain their grip on 
HIV. We therefore assume that improvements in medical management of HIV have led to changes not 
only to the collaboration between PLWH and CSPs, but to the overall involvement of CSPs in the 
health care system.  
However CSPs have proved an important source of support for PLWH regarding self-management 
[18, 123, 124]; it can be proposed that better prepared CSP’s will be able to provide better support. We 
therefore propose that neglecting CSPs’ contributions to self-management support represents a missed 
opportunity to strengthen self-management for PLWH and therefore to improve health outcomes.  
Discussion of methods 
The presented research program was guided by an exploratory mixed method design with priority on 
the qualitative elements [47]. This design is particularly useful to explore issues where very limited 
knowledge is available, such as, in this case, the collaboration of PLWH, CSP and HCP on medication 
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and symptom management [200]. It also clearly helped to broaden the existing understanding of the 
various players’ collaborations in symptom and medication management, and to gauge the 
concordance between reports of experienced versus observed symptoms. Most importantly, though, 
this design helped connect the concepts of symptom management and symptom experience (e.g, 
occurence, intensity, bothersomeness or distress of symptoms).  
This study has three methodical limitations, all of which will be further discussed below. The first is 
the concurrent collection of qualitative and quantitative data, whereas sequential data collection 
strategies are general recommended for exploratory mixed method designs, with the goal of using 
results of the first phase to determine data collection strategies for the second phase [47].  
In this case, though, the recommended sequential data collection was impossible: by the time the 
associated research program was approved, the quantitative data collection, which was connected to 
the Solexa Study (see introduction), had already been started. Therefore, the presented research 
program’s qualitative findings could not influence quantitative data collection. Nevertheless, the 
hypotheses that guided the quantitative investigation were built on findings from the previous 
qualitative data analysis.  
The chief limitation this entailed was that the scope of hypotheses was restricted to the data available 
for testing. In practice, participants’ narratives were rich and the process of qualitative data 
interpretation revealed diverse themes that could be transformed into hypotheses, which could then be 
answered with the available quantitative data. This very likely also reflects the close relations 
(similarities) between the investigated concepts of symptom management and symptom experience. 
The second limitation is that data collection occurred separately for PLWH and CSPs. In particular, 
for the qualitative exploration, pair based interviews might have helped to uncover some of the 
dynamics and interactions between the two players that were not shown in the individual based 
interviews. Nevertheless, findings from the qualitative study section revealed that separate interviews 
had advantages: both PLWH and CSPs mentioned issues such as symptoms or feelings they did not 
talk about with their counterparts. It can be assumed that those themes, which were also integrated into 
the hypothesis and therefore also guided the second quantitative research phase, would not have arisen 
in pair based interviews. Nevertheless, pair interviews might have provided further insights into the 
processes of collaborative management of symptoms and medications. 
The third limitation is the sampling strategy used for the quantitative study. Normally the second 
phase of an exploratory mixed method design, this step’s goal is to generalize the findings from the 
first, qualitative study sample to a population [47]. Due to the convenience sampling strategy used for 
this study’s quantitative sample, findings can not be generalized for the Swiss population or be applied 
globally. According to the qualitative priority of our research program the sampling strategy is 
stronger in the qualitative study part: the purposive sampling strategy, screening according to gender, 
transmission category and health care center, ensured that perspectives of participants with known 
Chapter 7 
126 
differences were integrated. Nevertheless, both study samples were restricted to a German speaking 
group of PLWH/CSP, which probably led to the exclusion of a sub-sample with backgrounds of 
migration and limited German language skills. 
We consider the sequential and hypothetically (i.e., through our hypothesis) connected process of data 
analysis as strengths of the study. First, the qualitative interviews provided rich narratives, conveying, 
from the perspectives of PLWH and CSPs, a broad understanding of symptom and medication 
management and the related collaborations, along with insights into hitherto undescribed aspects, such 
as the roles assumed in collaboration or the dynamics behind the phenomenon of keeping a grip on 
HIV. Second, despite the limited evidence on symptom management collaborations between PLWH 
and CSPs, we were able to formulate informed hypotheses based on the two players’ narratives. These 
allowed a focused quantitative investigation on the concordance of symptom reports. Overall, this 
approach allowed us to combine the strengths of qualitative and qualitative research: the qualitative 
phase allowed an open, in-depth assessment and extensive interpretation; the quantitative phase 
produced a focused, clearly defined analysis.  
Further, regarding the two unconfirmed hypotheses, unexpected results were generated raising further 
questions and demanding further interpretation. We propose that such questions and interpretations, 
which result from inter-method inconsistencies, are instrumental to the development of knowledge 
about the phenomena at hand, and would not have arisen from an approach that was either purely 
qualitative or purely quantitative. For example, the hypothesis that some symptoms would be reported 
more often by CSP than by PLWH was not supported. In fact, without exception, all symptoms were 
reported more often by PLWH; and, interestingly, while CSPs mentioned symptoms such as ‘difficulty 
concentrating’, ‘memory loss’ and ‘forgetfulness’ in their qualitative interviews, all were reported 
significantly more often by PLWH. And only a qualitative approach could have revealed such 
narratives as those fitting the theme of “not talking about symptoms”.  
On the other hand, only a quantitative approach could have provided statistics on concordances 
between PLWH’s and their CSPs’ symptom reports. Since very little HIV literature exists on the topic, 
it is unlikely that our results could otherwise either have arisen or been tested as fully as a mixed 
methods approach permitted. Only an approach that combined the narratives, statistics, and especially 
the inconsistencies of findings could raise the types of questions raised here, which demand 
interpretation, leading to still more research questions.  
Previously, inter-method inconsistencies in mixed method designs have been explained by the 
confounding complexity either of the phenomena studied or of the method combination [201]. Chapter 
Six of this study includes a discussion on the possibility that the studied phenomena (i.e., 
collaborations between PLWH and their CSPs regarding medication and symptom self-management) 
might be influenced by the stigmatization of neurocognitive problems in a relatively young population. 
As described in the first study phase, individual experiences of a small group of participants do not 
Chapter 7 
127 
necessarily reflect the experiences of a larger population, as many unspecified variables influence the 
experiences of the individuals and pairs studied. Our knowledge of the characteristics of PLWH/CSP 
pairs is particularly limited. Additionally, the quantitative analysis used is not particularly sensitive to 
possibly diverse ‘symptom concordance patterns’ in specific pairs. Still, focusing on such patterns 
with case oriented analyses, however limited the generalizeability of the results, would nevertheless 
offer further insights and understanding [202]. 
Implications for future research and clinical practice 
The descriptive/explorative character of this research program does not lend itself to final conclusions. 
However, the information obtained provides a basis for insightful questions, possibilities for further 
research, and suggestions regarding clinical implications. 
Future research 
HIV self-management has consistently been acknowledged as a complex phenomenon. This study 
provides an initial description of HIV self-management tasks and skills, which we offer as a guiding 
framework for research and clinical practice. As proposed above, HIV self-management should also 
be further conceptualized to integrate the dimension of collaboration. 
A range of qualitative studies focusing on chronically ill persons’ perspectives of self-management 
report on the phenomenon of patients ‘taking and maintaining control’, or, in the parlance of our 
study, of ‘having and keeping a grip” on their diseases. A meta–synthesis (i.e., a qualitatively oriented 
aggregation of qualitative findings developed to accommodate the distinctive features of qualitative 
survey by extraction, grouping and formatting of findings [203, 204]) of qualitative studies describing 
aspects of this phenomenon could help develop further insights.  
The presented research program integrated the perspectives of PLWH and their CSPs. However, 
HCPs’ perspectives were only integrated via case reports; no specific, systematic reports yet exist on 
HCPs’ self-management roles in relation to PLWH. We therefore propose that a study focused directly 
on gathering and interpreting HCPs’ narratives of their collaboration in the processes of managing 
medication and symptoms would provide further insights. In particular, the emotions connected with 
such experiences cannot be shown through medical reports. Therefore, our plans include to integrate 
and contrast already conducted data from HCP narratives with those of PLWH and CSPs. 
This study described, for the first time, aspects of the concordance between PLWH’s and their CSPs 
symptom reports. However the quantitative description was very limited and a range of aspects, e.g., 
concordance across all dimensions of the symptom experience, remain to be investigated. 
Additionally, as discussed above in the context of study limitations, longitudinal research and case 
oriented techniques of analysis might provide further insights.  
In accordance with previous research, our findings clearly illustrated that PLWH’s collaborations with 
HCPs and CSPs are part of their self-management process [18, 37, 38, 193]. Further, these 
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collaborations have been shown to either enable or hinder PLWH’s self-management [18, 193]. We 
therefore propose that future research on self-management support for PLWH should also focus more 
strongly on the collaborations inherent in the process.  
For example, knowledge is needed on how to effectively access and integrate close support persons in 
intervention programs or clinical care. In this direction, the Swiss HIV Cohort study has approved a 
pilot study to test the feasibility of integrating CSP into clinical care services focusing on transmission 
prevention (SHCS project No 518). If successful, that study’s results will inform the development of 
intervention studies that focus not only on PLWH but on their CSPs to improve self-management and 
therefore health outcomes. Additionally, since pairs or groups of self-management tasks have been 
closely connected, and since many single task oriented interventions such as adherence or transmission 
risk management have used similar approaches, such intervention programs should focus on multiple 
self-management tasks, including skill building activities [88]. 
Previous researchers have successfully conducted self-management education in group programs [16, 
23, 65, 130]. Nevertheless, such approaches do not reach all patients and long term success appears to 
require a combination of program based and clinic based interventions [136, 205, 206]. We propose 
that studies are needed to test the best combination of both approaches for various sub-groups of 
PLWH. For example, a group based program could provide basic self-management education, 
followed by individual clinical follow up interventions. Alternatively, a program could begin with 
structured interventions for individuals in clinical care who were hesitant or unable to join a group, 
followed by other, e.g., pair based (PLWH and CSP), interventions. 
Our findings match those of other researchers that HCPs’ combination of communication skills and 
medical experience is a key issue related regarding their influence on PLWH’s self-management [38, 
205]. In the general care setting, teaching specific patient centered communication techniques has 
been shown to improve patients’ satisfaction with care, along with health care providers’ confidence in 
their skills [207, 208]. However, overall self-management support requires a much broader range of 
communication and behavioral change strategies. Some evidence suggests that teams of health care 
providers with strong skill mixes can manage such challenges most effectively [209]. However, 
regarding HIV specific care, such programs also call for development and testing specific to the needs 
and capabilities of their health care organizations.  
Implications for clinical practice 
Ongoing implementation of research findings into clinical practice drives improvement in health care 
services. And while the explorative character of this research program does not allow definite 
recommendations regarding practice, it does provide in-depth descriptions, helping to develop a 
clearer understanding of PLWH’s self-management processes, including the related collaborations. 
Combined with an extensive literature review, assessing PLWH’s and CSPs’ perspectives has 
indicated the following key points for clinicians that guided the following suggestions.  
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Key points: 
• HIV self-management includes diverse tasks and skills. 
• The feeling either of ‘having a grip on HIV’ or that ‘HIV has a grip on me’ reflected PLWH’s 
perceptions of their current ability to manage medications and symptoms. 
• A PLWH with the feeling of losing his/her grip on HIV might react with feelings of anxiety 
and symptoms of depression. 
• Changes from ‘having a grip on HIV’ toward losing control were described by all PLWH 
interviewed and can occur quickly. 
• Collaboration with close support persons influences PLWH’s ability to manage medications 
and symptoms. 
• The collaboration of PLWH and CSP appears to involve the assumption of different roles 
(managers/companions). 
• CSPs reported learning about HIV from PLWH, while experiencing almost no integration into 
clinical care. 
• HCPs were recognized by PLWH as important players who either enabled or hindered self-
management. 
These key points guided the following suggestions for HIV self-management support in clinical 
practice. These suggestions are not immediately applicable to every situation or every patient. On the 
contrary, their implications require careful reflection and adaptation to the respective context and 
individual patient.  
As discussed above, PLWH’s self-management is complex, incorporating diverse tasks and skills. Our 
results illustrate that for some PLWH learning the skills necessary to manage medications and 
symptoms requires a process of trial and error (Chapter Five; theme: ‘find out what works with 
symptoms’). Health care providers should therefore ensure that every patient receives basic self-
management education, covering the most important information across all of the described self-
management tasks, and integrating skill building activities as described by Lorig and colleague [17].  
Due to the limited counseling time available in the clinical care setting, such basic self-management 
education should be considered in community based group programs or with internet based education 
systems, as research has shown positive results with both approaches [210]. Naturally, such 
approaches would have to be adapted and evaluated systematically in the context of each specific 
target group.  
In cases where such programs are for any reason unworkable, health care providers can either set 
agendas for self-management education via routine consultations or plan additional counseling time to 
focus on self-management education. One project, which integrated self-management support 
regarding transmission risk management into routine clinical care, illustrated that such interventions 
were feasible but required extra education of health care providers [211].  
Evidence supports social support as an important factor related to PLWH’s health [122, 124, 211]. The 
current study’s results revealed the importance of collaboration between PLWH and CSPs in the 
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management of medications and symptoms, and highlighted the different roles CSPs and PLWH play 
to facilitate that collaboration.  
Based on these insights we propose that it would be helpful to encourage PLWH to bring their CSPs to 
clinical consultations on basic self-management. Integrating a discussion of self-management roles, 
for example, using open ended and circular questions, could be helpful to build an understanding of 
the PLWH/CSP partnership’s needs [212].  
However, examples of how to reach and integrate CSPs into clinical services are very scarce [132, 
213]. Regarding the current study, our own experiences recruiting PLWH and their CSP in HIV 
outpatient clinics revealed that many PLWH welcomed the opportunity to bring their CSPs to the 
clinic. PLWH who did not wish to do so cited time constraints, the clinic’s opening hours (closed 
evenings), fear of HIV disclosure and relationship problems.  
Apart from PLWH and CSPs’ willingness to participate, other barriers also hinder CSPs’ integration 
into clinical services. One is the additional expense to the clinic, to participants or both. In most 
countries, health care systems focus on the individual patient and only reimburse services at the 
individual health care level. Nevertheless, experiences of health care providers who have integrated 
PLWH and CSPs into paired self-management support and clinical consultations are vital to the 
development of projects that aim to do the same, and can also influence health care policy. 
After basic self-management education, ongoing self-management support appears to be necessary, 
since longitudinal research has revealed changing patterns in PLWH’s cART adherence, symptom 
clusters and transmission risk behavior [21, 89, 131]. Additionally, qualitative research has illustrated 
that self-management decisions are made on an everyday level [18, 22]. Continuous monitoring of 
self-management support needs across the full range of self-management tasks should therefore be 
integrated into clinical care services.  
To our knowledge there is no tool that monitors PLWHs’ self-management across all tasks. Based on 
the constitutive pattern ‘I have a grip on HIV - HIV as a grip on me’, developed from PLWH’s 
narratives, we suggest to use an open ended question about PLWH’s perception of having a grip on 
HIV. This could be helpful to build an understanding of their perceived ability to manage and the 
problems they see as related to self-management.  
After such an open and patient centered opening, a structured interview regarding the performance of 
self-management tasks, using evaluated assessment tools, could be conducted. Instruments have been 
developed and tested for a range of self-management tasks, e.g., adherence to cART [6, 7, 129], 
symptom assessment [21, 109, 214], substance use, and depression and lifestyle [215, 216]. In the 
current investigation, PLWH narratives revealed that the impression of loosing one’s grip on HIV 
provoked fear and a loss of morale. Checking for symptoms of depression, followed, if necessary, by 
effective treatment, is a potentially valuable issue related self management support that has probably 
in many settings not yet been integrated systematically into routine clinical care [29]. 
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Once problems with PLWH’s self-management have been identified, effective support should be 
provided. Intervention strategies always need to focus on the problems perceived by the individual 
patient [17], but not exclusively. Health care providers might identify problems such as insufficient 
adherence or smoking, often not perceived as such by the PLWH. Conversely, the PLWH might 
consider the cART associated side effects such as nausea and bloating his/her major problem. Self-
management support therefore has to be focused on those symptoms to be effective. This does not 
mean prevent self-management support from integrating interventions to raise awareness to other 
problematic issues [217, 218]. Stage based approaches that raise awareness and support PLWH to 
overcome ambivalences have proved effective across a range of self-management behaviors [217], 
even if such changes demand considerable time, motivation, and effort from patients.  
In planning interventions, setting priorities is therefore important [17, 218]. For several HIV self-
management tasks, health care providers have to begin this prioritizing while selecting the most 
appropriate strategy for each PLWH from the range available. To name a few of the choices available: 
Adherence interventions are summarized in Chapter Two of this study; a recent review by Simoni and 
colleagues summarizes adherence support strategies [23]; a proposal for cART treatment decision 
making support described by our team has been integrated into the European antiretorviral treatment 
guidelines ; symptom management support and self-care strategies have been explored extensively by 
Holzemer and group and a description is provided on their homepage (http://hivinsite.ucsf.edu); 
transmission risk management interventions have been summarized in a meta-analytic review by 
Crepaz and colleagues [65]; clinical based transmission risk interventions are described by 
Richardson and colleagues [211]; interventions related to disclosure management, role management, 
emotional management and lifestyle management are less well summarized and have to rely on 
individual studies [37, 92, 211]. Substance use management is described according to the substance(s) 
used. A nicotine cessation intervention for PLWH and an alcohol reduction intervention has been 
described by our team and can be well integrated into HIV specific care [73, 76, 219, 220]. Other 
substance use interventions might require referrals to specialized services.  
However, even with a range of interventions at our disposal, behavioral change remains a complex 
issue. Support in self-management tasks often requires more than one intervention, followed by an 
evaluation of the effect. Our own qualitative results provide an example of an HCP who provided a 
patient with information related to symptom management but did not follow up, and the strategies did 
not work. Follow-up by health care providers is essential across all self-management interventions; 
even if they have been delegated to community based external programs in order to provide care 
continuity [221]. 
The evidence that can inform individualized clinical intervention approaches comes from clinical trials 
performed with carefully selected populations. This situation is often not comparable to real life 
conditions, where HCPs may find themselves caring, for example, for a PLWH with psychiatric 
Chapter 7 
132 
comorbidities, who shows up for consultations infrequently and presents a range of self-management 
problems. Still, evidence based interventions – or their applicable elements – are such a patient’s best 
hope.  
Naturally, health care providers working in the clinical setting have to adapt their strategies to 
individual patients and contexts. And while every situation is different, learning and exchanging about 
intervention strategies that worked or did not work in specific clinical situations remains imperative. 
Case reports that integrate biomedical perspectives and self-management support, as presented in 
Chapter Two above, also offer valuable learning opportunities for professionals across diverse health 
care settings. And even if the number of case reports that focusing on self-management support is 
limited, what reports exist are certainly worth reading and further reports focusing on self management 
support success of failure in clinical care should be written.  
To return to the current study, findings illustrated that despite PLWH’s commitment to building 
working partnerships with health care providers, the relationship was sometimes described as non-
supportive regarding medication and symptom management. Unsupportive health care providers were 
described as disinterested, inattentive, not taking symptom reports seriously, and even not medically 
competent (Chapter Five; theme ‘work with providers’).  
These results highlight the need for a patient centered communication approach in the clinical care 
setting. Studies in chronic disease populations including diabetics and hypertensives have 
convincingly linked patient centered communication with improved health outcomes and patient 
satisfaction [36, 39]. We propose that basic skills in patient oriented communication techniques are 
indispensable for all health care providers caring for PLWH.  
Nevertheless, in some cases, self-management support calls for either more advanced communication 
skills or a range of communication techniques. For example, motivational interviewing techniques for 
patients with problems in behavioral change; or if, for example, the collaboration of PLWH and CSP 
requires attention, a more family oriented systemic approach, as described by Wright and Leahey, 
might be most appropriate [212].  
Extensive self-management support cannot, therefore, be provided by an individual provider. Rather, a 
team of HCPs with a broad mix of individual skills and orchestrated teamwork, also ensuring 
continuity of care, is needed [221]. Bodenheimer, for example described a “teamlet” model that 
addressed the inadequate resources of short consultations by changing health care providers from a 
lone physician to a two-person team for patients needing support for self-management. This team, 
whose second member was normally an advanced practice nurse, collaborated closely within defined 
functions to provide medical care and self-management support [222].  
Self-management support of chronically ill patients is influenced not only by individual providers or 
teams but also by the structure of the health care organization and the social values incorporated in it, 
as described in the Chronic Care Model [15, 60]. The above-described self-management support has to 
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be strongly supported by leaders of the organizantion, has to be integrated into a health care system 
that provides decision support and education for health care providers, that is based on a care delivery 
system that allows regular follow up visits and support by practice teams, and finally, that provides 
information systems that allow documentation of all important medical and self-management 
information, including clinical reminders [209, 222] 
Within such a system three levels of continuity of care for PLWH are generally considered most 
important: 1) informational continuity, i.e., formally documented information, including patients’ 
preferences and values; 2) management continuity, i.e., management plans, follow ups and 
coordination of services; and 3) relationship continuity, i.e., the accumulation of knowledge of patient 
preferences and interpersonal trust based on experiences with patient /provider collaboration. The 
importance of continuity is also reflected in our own results. PLWH described their outpatient clinic as 
a place where they are known, where they don’t have to continually repeat their health stories, and 
where they can talk about HIV openly.  
This last point illustrates the fear of stigmatization in the health care system, which patients maintain 
remains widespread. For example, in a nationally representative US sample, 26% of PLWH receiving 
health care reported perceiving discrimination among health care providers. In a French national 
survey, 24% of PLWH reported experiences of discrimination in their close social environments 
(relatives, friends and colleagues). In the subgroup of PLWH with a history of intravenous drug use, 
32% reported discrimination in their close social environment (Peretti, 2007). It is widely agreed that 
HIV stigma remains a major barrier to effective care and responses to the epidemic in general. Careful 
reflection on stigmatizing behavior and policies should therefore be integrated into the clinical care of 
PLWH [96].  
 
Conclusion 
In order to provide HIV specific self-management support in clinical care or research settings the 
focus should be broadened from single tasks (e.g. adherence) to include pairs and groups of 
reciprocally influencing self-management tasks, as well as other relational components of the process. 
The ongoing changes in PLWH’s perceptions of having or losing their grip on HIV highlights the need 
for continuous monitoring of self-management support needs and individualized support interventions. 
This phenomenon should be further investigated across diverse chronic conditions.  
Enabling self management support by health care providers encompasses a patient centred 
communication approach, HIV specific medical competence, assistance in decision making, 
assessment of symptom experience, collaborative development of strategies, ongoing patient 
education, and support in coordination of care. Particularly in teaching hospitals, this requires a broad 
skill mix among individual providers, and well-coordinated teamwork.  
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Close support persons have proved themselves valuable partners for PLWH in self-management; 
however, their integration into research programs or clinical care has been marginal and should be 
improved. In doing so the distinct PLWH/CSP collaborative roles i.e., the clear leadership of the 
PLWH revealed here, should be considered. 
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